CHEBI ONTOLOGY - ANNOTATIONS |
|
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
|
Term: | EC 1.14.14.* (oxidoreductase acting on paired donors, incorporating of 1 atom of oxygen, with reduced flavin or flavoprotein as one donor) inhibitor |
|
Accession: | CHEBI:76838
|
browse the term
|
Definition: | An EC 1.14.* (oxidoreductase acting on paired donors, with incorporation or reduction of molecular oxygen) inhibitor that interferes with the action of any such enzyme incorporating one atom of oxygen and using reduced flavin or flavoprotein as donor (EC 1.14.14.*). |
Synonyms: | related_synonym: | EC 1.14.14.* (oxidoreductase acting on paired donors, incorporating of 1 atom of oxygen, with reduced flavin or flavoprotein as one donor) inhibitors; EC 1.14.14.* (oxidoreductase acting on paired donors, with incorporation of 1 atom of oxygen, with reduced flavin or flavoprotein as one donor) inhibitor; EC 1.14.14.* (oxidoreductase acting on paired donors, with incorporation of 1 atom of oxygen, with reduced flavin or flavoprotein as one donor) inhibitors; EC 1.14.14.* inhibitor; EC 1.14.14.* inhibitors |
|
|
|
G |
Acat1 |
acetyl-CoA acetyltransferase 1 |
multiple interactions |
ISO |
1-aminobenzotriazole affects the reaction [propylene dichloride results in decreased expression of ACAT1 protein] |
CTD |
PMID:32435916 |
|
NCBI chr 8:53,979,813...54,008,861
Ensembl chr 8:53,979,813...54,008,855
|
|
G |
Ache |
acetylcholinesterase |
multiple interactions |
ISO |
1-aminobenzotriazole inhibits the reaction [Chlorpyrifos metabolite results in decreased activity of ACHE protein] |
CTD |
PMID:30625376 |
|
NCBI chr12:19,406,133...19,413,713
Ensembl chr12:19,407,360...19,413,651
|
|
G |
Acot2 |
acyl-CoA thioesterase 2 |
multiple interactions |
ISO |
1-aminobenzotriazole affects the reaction [propylene dichloride results in increased expression of ACOT2 protein] |
CTD |
PMID:32435916 |
|
NCBI chr 6:103,611,738...103,619,404
Ensembl chr 6:103,611,544...103,619,245
|
|
G |
Aldh1b1 |
aldehyde dehydrogenase 1 family, member B1 |
multiple interactions |
ISO |
1-aminobenzotriazole affects the reaction [propylene dichloride results in increased expression of ALDH1B1 protein] |
CTD |
PMID:32435916 |
|
NCBI chr 5:60,063,370...60,068,378
Ensembl chr 5:60,063,225...60,068,378
|
|
G |
Car3 |
carbonic anhydrase 3 |
multiple interactions |
ISO |
1-aminobenzotriazole affects the reaction [propylene dichloride results in decreased expression of CAR3 protein] |
CTD |
PMID:32435916 |
|
NCBI chr 2:86,770,418...86,780,011
Ensembl chr 2:86,770,420...86,784,280
|
|
G |
Cd86 |
CD86 molecule |
multiple interactions |
ISO |
1-aminobenzotriazole inhibits the reaction [Benzo(a)pyrene results in increased expression of CD86 protein] |
CTD |
PMID:21742781 |
|
NCBI chr11:64,142,193...64,200,816
Ensembl chr11:64,163,828...64,200,818
|
|
G |
Ces3a |
carboxylesterase 3a |
multiple interactions |
ISO |
1-aminobenzotriazole affects the reaction [propylene dichloride results in decreased expression of CES3B protein] |
CTD |
PMID:32435916 |
|
NCBI chr19:32,992,386...33,000,562
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
multiple interactions increases expression |
ISO EXP |
1-aminobenzotriazole inhibits the reaction [Skatole results in increased expression of CYP1A1 mRNA] 1-aminobenzotriazole results in increased expression of CYP1A1 protein 1-aminobenzotriazole inhibits the reaction [Oxygen results in increased activity of CYP1A1 protein]; [1-aminobenzotriazole co-treated with Oxygen] results in increased activity of CYP1A1 protein |
CTD |
PMID:10640292 PMID:20187624 |
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
increases expression decreases activity multiple interactions |
EXP ISO |
1-aminobenzotriazole results in increased expression of CYP1A2 protein 1-aminobenzotriazole results in decreased activity of CYP1A2 protein [1-aminobenzotriazole co-treated with Oxygen] results in increased activity of CYP1A2 protein; [Oxygen co-treated with 1-aminobenzotriazole] results in increased expression of CYP1A2 protein |
CTD |
PMID:10640292 PMID:15618748 |
|
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
|
|
G |
Cyp2d4 |
cytochrome P450, family 2, subfamily d, polypeptide 4 |
multiple interactions decreases activity |
ISO |
1-aminobenzotriazole inhibits the reaction [CYP2D6 protein results in increased hydroxylation of bufuralol] 1-aminobenzotriazole results in decreased activity of CYP2D6 protein |
CTD |
PMID:11375247 PMID:15618748 |
|
NCBI chr 7:113,882,584...113,891,754
Ensembl chr 7:113,881,618...113,891,759
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
decreases activity multiple interactions |
ISO |
1-aminobenzotriazole results in decreased activity of CYP2E1 protein 1-aminobenzotriazole inhibits the reaction [CYP2E1 protein affects the metabolism of Urethane]; 1-aminobenzotriazole inhibits the reaction [CYP2E1 protein results in increased oxidation of 1,3-butadiene] 1-aminobenzotriazole inhibits the reaction [[[SULT1A1 protein co-treated with CYP2E1 protein] results in increased susceptibility to 1-methylpyrene] which results in increased mutagenesis of HPRT1 gene] |
CTD |
PMID:10828257 PMID:12704224 PMID:15618748 PMID:25243916 PMID:27421776 |
|
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
|
|
G |
Cyp2f4 |
cytochrome P450, family 2, subfamily f, polypeptide 4 |
multiple interactions |
ISO |
1-aminobenzotriazole inhibits the reaction [Skatole results in increased expression of CYP2F1 mRNA] |
CTD |
PMID:20187624 |
|
NCBI chr 1:82,416,107...82,429,897
Ensembl chr 1:82,416,130...82,429,896
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
decreases activity |
ISO |
1-aminobenzotriazole results in decreased activity of CYP3A4 protein |
CTD |
PMID:11375247 |
|
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
|
|
G |
Cyp3a9 |
cytochrome P450, family 3, subfamily a, polypeptide 9 |
multiple interactions |
ISO |
1-aminobenzotriazole inhibits the reaction [Beclomethasone results in increased expression of CYP3A5 mRNA] |
CTD |
PMID:24555085 |
|
NCBI chr12:16,806,222...16,846,428
Ensembl chr12:16,806,207...16,846,422
|
|
G |
Ech1 |
enoyl-CoA hydratase 1 |
multiple interactions |
ISO |
1-aminobenzotriazole affects the reaction [propylene dichloride results in increased expression of ECH1 protein] |
CTD |
PMID:32435916 |
|
NCBI chr 1:84,114,494...84,120,788
Ensembl chr 1:84,112,751...84,120,795
|
|
G |
Ftcd |
formimidoyltransferase cyclodeaminase |
multiple interactions |
ISO |
1-aminobenzotriazole affects the reaction [propylene dichloride results in decreased expression of FTCD protein] |
CTD |
PMID:32435916 |
|
NCBI chr20:12,055,203...12,068,717
Ensembl chr20:12,055,208...12,068,735
|
|
G |
Fth1 |
ferritin heavy chain 1 |
multiple interactions |
ISO |
1-aminobenzotriazole inhibits the reaction [propylene dichloride results in increased expression of FTH1 protein] |
CTD |
PMID:32435916 |
|
NCBI chr 1:206,627,142...206,629,430
Ensembl chr 1:206,627,103...206,725,424
|
|
G |
Ftl1 |
ferritin light chain 1 |
multiple interactions |
ISO |
1-aminobenzotriazole affects the reaction [propylene dichloride results in increased expression of FTL1 protein] |
CTD |
PMID:32435916 |
|
NCBI chr 1:95,936,387...95,938,234
Ensembl chr 1:95,936,387...95,939,725 Ensembl chr10:95,936,387...95,939,725 Ensembl chr 2:95,936,387...95,939,725
|
|
G |
Gpt |
glutamic--pyruvic transaminase |
multiple interactions |
ISO |
1-aminobenzotriazole inhibits the reaction [Acetaminophen results in increased activity of GPT protein]; 1-aminobenzotriazole promotes the reaction [Amiodarone promotes the reaction [Dexamethasone results in increased expression of GPT protein]]; [1-aminobenzotriazole co-treated with ochratoxin A] results in increased activity of GPT protein; [Emodin co-treated with 1-aminobenzotriazole] results in increased expression of GPT protein |
CTD |
PMID:25900201 PMID:34492313 PMID:36227364 |
|
NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
|
|
G |
Gstm1 |
glutathione S-transferase mu 1 |
multiple interactions |
ISO |
1-aminobenzotriazole affects the reaction [propylene dichloride results in increased expression of GSTM1 protein] |
CTD |
PMID:32435916 |
|
NCBI chr 2:195,649,845...195,655,402
Ensembl chr 2:195,649,845...195,655,411
|
|
G |
H2ax |
H2A.X variant histone |
multiple interactions |
ISO |
1-aminobenzotriazole inhibits the reaction [captax results in increased expression of H2AX protein]; 1-aminobenzotriazole inhibits the reaction [propylene dichloride results in increased phosphorylation of H2AX protein]; 1-aminobenzotriazole inhibits the reaction [Trichloroethylene results in increased phosphorylation of H2AX protein] |
CTD |
PMID:28300663 PMID:29722447 PMID:35279910 |
|
NCBI chr 8:44,671,907...44,673,262
Ensembl chr 8:44,671,786...44,673,239 Ensembl chr 4:44,671,786...44,673,239
|
|
G |
Havcr1 |
hepatitis A virus cellular receptor 1 |
multiple interactions |
ISO |
[1-aminobenzotriazole co-treated with ochratoxin A] results in increased expression of HAVCR1 protein |
CTD |
PMID:36227364 |
|
NCBI chr10:31,118,667...31,151,730
Ensembl chr10:31,119,088...31,151,698
|
|
G |
Hmox1 |
heme oxygenase 1 |
multiple interactions |
ISO |
1-aminobenzotriazole inhibits the reaction [[Acetaminophen co-treated with Buthionine Sulfoximine] results in increased expression of HMOX1 mRNA]; 1-aminobenzotriazole inhibits the reaction [[Butylated Hydroxyanisole co-treated with Buthionine Sulfoximine] results in increased expression of HMOX1 mRNA]; 1-aminobenzotriazole inhibits the reaction [[Diclofenac co-treated with Buthionine Sulfoximine] results in increased expression of HMOX1 mRNA]; 1-aminobenzotriazole inhibits the reaction [[Ticlopidine co-treated with Buthionine Sulfoximine] results in increased expression of HMOX1 mRNA] |
CTD |
PMID:18227147 |
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Hprt1 |
hypoxanthine phosphoribosyltransferase 1 |
multiple interactions |
ISO |
1-aminobenzotriazole inhibits the reaction [[[SULT1A1 protein co-treated with CYP2E1 protein] results in increased susceptibility to 1-methylpyrene] which results in increased mutagenesis of HPRT1 gene] |
CTD |
PMID:25243916 |
|
NCBI chr X:132,736,175...132,768,149
Ensembl chr X:132,736,096...132,768,154
|
|
G |
Inmt |
indolethylamine N-methyltransferase |
multiple interactions |
ISO |
1-aminobenzotriazole affects the reaction [propylene dichloride results in decreased expression of INMT protein] |
CTD |
PMID:32435916 |
|
NCBI chr 4:84,318,197...84,322,493
Ensembl chr 4:84,318,197...84,322,493
|
|
G |
Krt8 |
keratin 8 |
multiple interactions |
ISO |
1-aminobenzotriazole affects the reaction [propylene dichloride results in decreased expression of KRT8 protein] |
CTD |
PMID:32435916 |
|
NCBI chr 7:133,124,203...133,131,656
Ensembl chr 7:133,124,203...133,131,728
|
|
G |
Lcn2 |
lipocalin 2 |
multiple interactions |
ISO |
[1-aminobenzotriazole co-treated with ochratoxin A] results in increased expression of LCN2 protein |
CTD |
PMID:36227364 |
|
NCBI chr 3:15,680,688...15,684,033
Ensembl chr 3:15,680,687...15,684,095
|
|
G |
Rgn |
regucalcin |
multiple interactions |
ISO |
1-aminobenzotriazole affects the reaction [propylene dichloride results in decreased expression of RGN protein] |
CTD |
PMID:32435916 |
|
NCBI chr X:1,619,030...1,634,456
Ensembl chr X:1,619,032...1,634,450
|
|
G |
Sult1a1 |
sulfotransferase family 1A member 1 |
multiple interactions |
ISO |
1-aminobenzotriazole inhibits the reaction [[[SULT1A1 protein co-treated with CYP2E1 protein] results in increased susceptibility to 1-methylpyrene] which results in increased mutagenesis of HPRT1 gene] |
CTD |
PMID:25243916 |
|
NCBI chr 1:181,272,022...181,276,750
Ensembl chr 1:181,272,023...181,275,562
|
|
G |
Ubp1 |
upstream binding protein 1 |
multiple interactions |
ISO |
1-aminobenzotriazole affects the reaction [propylene dichloride results in decreased expression of UBP1 protein] |
CTD |
PMID:32435916 |
|
NCBI chr 8:113,869,771...113,915,625
Ensembl chr 8:113,869,979...113,915,625
|
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
multiple interactions |
EXP |
1-phenylimidazole inhibits the reaction [[[[CYP2E1 protein results in increased oxidation of furan] which results in increased chemical synthesis of malealdehyde] which co-treated with Glutathione] results in increased glutathionylation of malealdehyde]; 1-phenylimidazole inhibits the reaction [CYP2E1 protein results in increased reduction of Tirapazamine] |
CTD |
PMID:7710944 PMID:21842885 |
|
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
|
|
|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
increases expression multiple interactions |
ISO |
3,3'-diindolylmethane results in increased expression of ABCB1 mRNA [3,3'-diindolylmethane results in increased activity of NR1I2 protein] which results in increased expression of ABCB1 mRNA; Ketoconazole inhibits the reaction [3,3'-diindolylmethane results in increased expression of ABCB1 mRNA] |
CTD |
PMID:25542144 |
|
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
|
|
G |
Actg1 |
actin, gamma 1 |
multiple interactions |
ISO |
3,3'-diindolylmethane promotes the reaction [Estradiol results in decreased expression of ACTG1 mRNA] |
CTD |
PMID:11179685 |
|
NCBI chr10:105,619,738...105,622,587
Ensembl chr10:105,619,737...105,624,232 Ensembl chr 3:105,619,737...105,624,232
|
|
G |
Adgre1 |
adhesion G protein-coupled receptor E1 |
multiple interactions |
ISO |
3,3'-diindolylmethane inhibits the reaction [Lipopolysaccharides results in increased expression of ADGRE1 mRNA] |
CTD |
PMID:24162184 |
|
NCBI chr 9:2,242,476...2,398,000
Ensembl chr 9:2,242,474...2,398,000
|
|
G |
Ahr |
aryl hydrocarbon receptor |
affects response to substance affects localization multiple interactions |
ISO EXP |
AHR protein affects the susceptibility to 3,3'-diindolylmethane 3,3'-diindolylmethane affects the localization of AHR protein 3,3'-diindolylmethane binds to and results in decreased activity of AHR protein; 3,3'-diindolylmethane inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of AHR protein] 3,3'-diindolylmethane binds to and results in increased activity of AHR protein; 3,3'-diindolylmethane inhibits the reaction [Tetrachlorodibenzodioxin binds to AHR protein] 3,3'-diindolylmethane binds to and results in increased activity of AHR protein; 3,3'-diindolylmethane inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to PTGS2 promoter]]; 3,3'-diindolylmethane promotes the reaction [AHR protein binds to CYP1A1 promoter]; AHR mutant form inhibits the reaction [3,3'-diindolylmethane promotes the reaction [sulforaphane results in increased expression of HMOX1 mRNA]]; AHR mutant form inhibits the reaction [3,3'-diindolylmethane promotes the reaction [sulforaphane results in increased expression of NQO1 mRNA]] |
CTD |
PMID:8384853 PMID:9771935 PMID:11294972 PMID:16972788 PMID:19056653 PMID:19223575 PMID:20435555 PMID:23583297 More...
|
|
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
|
|
G |
Aif1 |
allograft inflammatory factor 1 |
multiple interactions |
ISO |
3,3'-diindolylmethane inhibits the reaction [Lipopolysaccharides results in increased expression of AIF1 protein] |
CTD |
PMID:24162184 |
|
NCBI chr20:3,646,784...3,652,670
Ensembl chr20:3,646,777...3,652,668
|
|
G |
Ar |
androgen receptor |
decreases activity |
ISO |
3,3'-diindolylmethane results in decreased activity of AR protein |
CTD |
PMID:30247711 |
|
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
|
|
G |
Arnt |
aryl hydrocarbon receptor nuclear translocator |
multiple interactions |
ISO |
3,3'-diindolylmethane promotes the reaction [ARNT protein binds to CYP1A1 promoter] |
CTD |
PMID:16972788 |
|
NCBI chr 2:182,997,731...183,056,584
Ensembl chr 2:182,997,736...183,056,580
|
|
G |
Atf3 |
activating transcription factor 3 |
increases expression |
ISO |
3,3'-diindolylmethane results in increased expression of ATF3 |
CTD |
PMID:15670751 |
|
NCBI chr13:102,751,278...102,800,520
Ensembl chr13:102,751,321...102,764,631
|
|
G |
Atp5f1a |
ATP synthase F1 subunit alpha |
multiple interactions |
ISO |
3,3'-diindolylmethane inhibits the reaction [Estradiol results in increased expression of ATP5F1A mRNA] |
CTD |
PMID:11179685 |
|
NCBI chr18:71,292,406...71,300,342
Ensembl chr18:71,292,374...71,300,794
|
|
G |
Bad |
BCL2-associated agonist of cell death |
decreases phosphorylation |
ISO |
3,3'-diindolylmethane results in decreased phosphorylation of BAD protein |
CTD |
PMID:22290291 |
|
NCBI chr 1:204,133,502...204,142,829
Ensembl chr 1:204,131,501...204,142,823
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
increases expression |
ISO |
3,3'-diindolylmethane results in increased expression of BAX protein |
CTD |
PMID:22290291 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bbc3 |
Bcl-2 binding component 3 |
multiple interactions |
ISO |
[3,3'-diindolylmethane results in increased phosphorylation of and results in increased activity of TP53 protein] which results in increased expression of BBC3 |
CTD |
PMID:22290291 |
|
NCBI chr 1:77,013,281...77,022,509
Ensembl chr 1:77,014,543...77,022,509
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
multiple interactions decreases expression |
ISO |
3,3'-diindolylmethane promotes the reaction [Paclitaxel results in decreased expression of BCL2 protein] 3,3'-diindolylmethane analog results in decreased expression of BCL2 mRNA 3,3'-diindolylmethane analog results in decreased expression of BCL2 protein; 3,3'-diindolylmethane results in decreased expression of BCL2 protein |
CTD |
PMID:16051428 PMID:16580691 PMID:22290291 PMID:26593444 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bcl2l1 |
Bcl2-like 1 |
increases expression |
ISO |
3,3'-diindolylmethane results in increased expression of BCL2L1 mRNA; 3,3'-diindolylmethane results in increased expression of BCL2L1 protein |
CTD |
PMID:18025290 |
|
NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479 Ensembl chr 1:141,253,523...141,303,479
|
|
G |
Bcl2l10 |
Bcl2-like 10 |
increases expression |
ISO |
3,3'-diindolylmethane results in increased expression of BCL2L10 mRNA |
CTD |
PMID:22514694 |
|
NCBI chr 8:76,107,326...76,113,373
Ensembl chr 8:76,107,326...76,113,367
|
|
G |
Birc5 |
baculoviral IAP repeat-containing 5 |
decreases expression |
ISO |
3,3'-diindolylmethane results in decreased expression of BIRC5 protein |
CTD |
PMID:22290291 |
|
NCBI chr10:103,072,530...103,081,382
Ensembl chr10:103,073,408...103,081,380
|
|
G |
Brd2 |
bromodomain containing 2 |
multiple interactions |
ISO |
3,3'-diindolylmethane inhibits the reaction [Estradiol results in increased expression of BRD2 mRNA] |
CTD |
PMID:11179685 |
|
NCBI chr20:4,727,078...4,735,389
Ensembl chr20:4,728,151...4,735,388
|
|
G |
Calm2 |
calmodulin 2 |
multiple interactions |
ISO |
3,3'-diindolylmethane promotes the reaction [Estradiol results in decreased expression of CALM2 mRNA] |
CTD |
PMID:11179685 |
|
NCBI chr 6:7,091,624...7,104,284
Ensembl chr 6:7,091,567...7,104,287 Ensembl chr15:7,091,567...7,104,287
|
|
G |
Casp3 |
caspase 3 |
increases activity |
ISO |
3,3'-diindolylmethane results in increased activity of CASP3 protein |
CTD |
PMID:21820497 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Ccn1 |
cellular communication network factor 1 |
affects methylation |
ISO |
3,3'-diindolylmethane affects the methylation of CCN1 promoter |
CTD |
PMID:24466240 |
|
NCBI chr 2:234,562,410...234,565,370
Ensembl chr 2:234,562,408...234,565,484
|
|
G |
Ccnb1 |
cyclin B1 |
decreases expression |
ISO |
3,3'-diindolylmethane results in decreased expression of CCNB1 |
CTD |
PMID:22290291 |
|
NCBI chr 2:31,912,190...31,921,163
Ensembl chr 2:31,912,193...31,921,172
|
|
G |
Ccnd1 |
cyclin D1 |
decreases expression multiple interactions |
ISO |
3,3'-diindolylmethane analog results in decreased expression of CCND1 protein; 3,3'-diindolylmethane results in decreased expression of CCND1 protein benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [3,3'-diindolylmethane analog results in decreased expression of CCND1 protein] |
CTD |
PMID:16051428 PMID:22290291 |
|
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
|
|
G |
Ccnd3 |
cyclin D3 |
decreases expression |
ISO |
3,3'-diindolylmethane results in decreased expression of CCND3 protein |
CTD |
PMID:22514694 |
|
NCBI chr 9:13,394,161...13,400,341
Ensembl chr 9:13,394,169...13,489,371
|
|
G |
Ccr4 |
C-C motif chemokine receptor 4 |
affects methylation |
ISO |
3,3'-diindolylmethane affects the methylation of CCR4 promoter |
CTD |
PMID:24466240 |
|
NCBI chr 8:114,176,291...114,182,033
Ensembl chr 8:114,176,974...114,178,056
|
|
G |
Cd40lg |
CD40 ligand |
increases expression |
ISO |
3,3'-diindolylmethane results in increased expression of CD40LG mRNA |
CTD |
PMID:22514694 |
|
NCBI chr X:135,127,052...135,138,768
Ensembl chr X:135,126,969...135,138,306
|
|
G |
Cd69 |
Cd69 molecule |
multiple interactions |
ISO |
3,3'-diindolylmethane inhibits the reaction [enterotoxin B, staphylococcal results in increased expression of CD69 protein] |
CTD |
PMID:24200994 |
|
NCBI chr 4:162,725,446...162,733,364
Ensembl chr 4:162,725,446...162,733,542
|
|
G |
Cdc25c |
cell division cycle 25C |
decreases expression |
ISO |
3,3'-diindolylmethane results in decreased expression of CDC25C |
CTD |
PMID:22290291 |
|
NCBI chr18:26,335,156...26,356,199
Ensembl chr18:26,335,834...26,356,185
|
|
G |
Cdh1 |
cadherin 1 |
multiple interactions |
ISO |
3,3'-diindolylmethane inhibits the reaction [bisphenol A results in decreased expression of CDH1 protein]; 3,3'-diindolylmethane inhibits the reaction [Estradiol results in decreased expression of CDH1 protein]; 3,3'-diindolylmethane inhibits the reaction [Triclosan results in decreased expression of CDH1 protein] |
CTD |
PMID:28844962 |
|
NCBI chr19:34,492,371...34,561,775
Ensembl chr19:34,492,371...34,561,775
|
|
G |
Cdh11 |
cadherin 11 |
decreases expression |
ISO |
3,3'-diindolylmethane results in decreased expression of CDH11 protein |
CTD |
PMID:18025290 |
|
NCBI chr19:2,148,447...2,305,754
Ensembl chr19:2,148,458...2,304,272
|
|
G |
Cdh2 |
cadherin 2 |
multiple interactions |
ISO |
3,3'-diindolylmethane inhibits the reaction [bisphenol A results in increased expression of CDH2 protein]; 3,3'-diindolylmethane inhibits the reaction [Estradiol results in increased expression of CDH2 protein]; 3,3'-diindolylmethane inhibits the reaction [Triclosan results in increased expression of CDH2 protein] |
CTD |
PMID:28844962 |
|
NCBI chr18:7,776,704...7,990,934
Ensembl chr18:7,776,704...7,990,167
|
|
G |
Cdk2 |
cyclin dependent kinase 2 |
multiple interactions decreases activity |
ISO |
3,3'-diindolylmethane promotes the reaction [CDK2 protein binds to CDKN1A protein] 3,3'-diindolylmethane results in decreased activity of CDK2 protein |
CTD |
PMID:15611077 |
|
NCBI chr 7:1,129,878...1,137,431
Ensembl chr 7:1,129,811...1,137,403
|
|
G |
Cdk4 |
cyclin-dependent kinase 4 |
decreases expression |
ISO |
3,3'-diindolylmethane results in decreased expression of CDK4 protein |
CTD |
PMID:22514694 |
|
NCBI chr 7:62,886,124...62,889,562
Ensembl chr 7:62,883,105...62,942,403
|
|
G |
Cdk6 |
cyclin-dependent kinase 6 |
decreases expression |
ISO |
3,3'-diindolylmethane results in decreased expression of CDK6 protein |
CTD |
PMID:22290291 PMID:22514694 |
|
NCBI chr 4:30,637,650...30,829,688
Ensembl chr 4:30,646,460...30,829,634
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
multiple interactions increases expression |
ISO |
3,3'-diindolylmethane promotes the reaction [CDK2 protein binds to CDKN1A protein] 3,3'-diindolylmethane results in increased expression of CDKN1A mRNA; 3,3'-diindolylmethane results in increased expression of CDKN1A protein |
CTD |
PMID:12203118 PMID:15611077 PMID:18025290 PMID:22290291 PMID:22495798 |
|
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
increases expression |
ISO |
3,3'-diindolylmethane results in increased expression of CDKN1B protein |
CTD |
PMID:22290291 |
|
NCBI chr 4:167,760,067...167,765,177
Ensembl chr 4:167,760,181...167,764,982
|
|
G |
Cdkn2d |
cyclin dependent kinase inhibitor 2D |
increases expression |
ISO |
3,3'-diindolylmethane results in increased expression of CDKN2D protein |
CTD |
PMID:22290291 |
|
NCBI chr 8:19,831,874...19,834,640
Ensembl chr 8:19,831,866...19,834,674
|
|
G |
Chuk |
component of inhibitor of nuclear factor kappa B kinase complex |
decreases phosphorylation |
ISO |
3,3'-diindolylmethane results in decreased phosphorylation of CHUK protein |
CTD |
PMID:22290291 |
|
NCBI chr 1:242,959,539...242,995,066
Ensembl chr 1:242,959,760...242,995,065
|
|
G |
Cks1b |
CDC28 protein kinase regulatory subunit 1B |
multiple interactions |
ISO |
3,3'-diindolylmethane promotes the reaction [Estradiol results in decreased expression of CKS1B mRNA] |
CTD |
PMID:11179685 |
|
NCBI chr 2:174,833,025...174,837,614
Ensembl chr 2:174,833,050...174,837,636
|
|
G |
Ctsb |
cathepsin B |
multiple interactions |
ISO |
3,3'-diindolylmethane inhibits the reaction [bisphenol A results in increased expression of CTSB protein]; 3,3'-diindolylmethane inhibits the reaction [Estradiol results in increased expression of CTSB protein]; 3,3'-diindolylmethane inhibits the reaction [Triclosan results in increased expression of CTSB protein] |
CTD |
PMID:28844962 |
|
NCBI chr15:37,389,636...37,410,508
Ensembl chr15:37,389,629...37,410,500
|
|
G |
Ctsd |
cathepsin D |
multiple interactions |
ISO |
3,3'-diindolylmethane inhibits the reaction [bisphenol A results in increased expression of CTSD protein]; 3,3'-diindolylmethane inhibits the reaction [Estradiol results in increased expression of CTSD protein]; 3,3'-diindolylmethane inhibits the reaction [Triclosan results in increased expression of CTSD protein] |
CTD |
PMID:28844962 |
|
NCBI chr 1:197,527,467...197,539,343
Ensembl chr 1:197,527,467...197,539,488
|
|
G |
Cxcr4 |
C-X-C motif chemokine receptor 4 |
affects methylation multiple interactions |
ISO |
3,3'-diindolylmethane affects the methylation of CXCR4 promoter 3,3'-diindolylmethane inhibits the reaction [bisphenol A results in increased expression of CXCR4 protein]; 3,3'-diindolylmethane inhibits the reaction [Estradiol results in increased expression of CXCR4 protein]; 3,3'-diindolylmethane inhibits the reaction [Triclosan results in increased expression of CXCR4 protein] |
CTD |
PMID:24466240 PMID:28844962 |
|
NCBI chr13:40,077,976...40,081,883
Ensembl chr13:40,077,976...40,081,883
|
|
G |
Cycs |
cytochrome c, somatic |
multiple interactions |
ISO |
3,3'-diindolylmethane analog affects the localization of and results in increased expression of CYCS protein |
CTD |
PMID:16051428 |
|
NCBI chr 4:79,651,894...79,653,994
Ensembl chr 4:79,651,378...79,654,054 Ensembl chr18:79,651,378...79,654,054
|
|
G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
increases expression |
ISO |
3,3'-diindolylmethane analog results in increased expression of CYP19A1 mRNA; 3,3'-diindolylmethane results in increased expression of CYP19A1 mRNA |
CTD |
PMID:11294972 |
|
NCBI chr 8:54,552,978...54,580,375
Ensembl chr 8:54,553,165...54,580,758
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
multiple interactions increases activity increases expression decreases activity |
ISO EXP |
3,3'-diindolylmethane promotes the reaction [AHR protein binds to CYP1A1 promoter]; 3,3'-diindolylmethane promotes the reaction [ARNT protein binds to CYP1A1 promoter]; 3,3'-diindolylmethane promotes the reaction [ESR1 protein binds to CYP1A1 promoter]; [3,3'-diindolylmethane results in increased expression of CYP1A1 mRNA] which results in increased abundance of aflatoxin B1-DNA adduct 3,3'-diindolylmethane analog results in increased activity of CYP1A1 protein; 3,3'-diindolylmethane results in increased activity of CYP1A1 protein 3,3'-diindolylmethane results in increased expression of CYP1A1 protein 3,3'-diindolylmethane analog results in increased expression of CYP1A1 mRNA; 3,3'-diindolylmethane results in increased expression of CYP1A1 mRNA; 3,3'-diindolylmethane results in increased expression of CYP1A1 protein 3,3'-diindolylmethane results in decreased activity of CYP1A1 protein |
CTD |
PMID:8384853 PMID:9771935 PMID:11179685 PMID:11294972 PMID:11597580 PMID:15672752 PMID:16972788 PMID:19770484 PMID:22495798 PMID:23583297 More...
|
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
multiple interactions increases expression decreases activity increases oxidation |
ISO EXP |
[3,3'-diindolylmethane results in increased expression of CYP1A2 mRNA] which results in increased abundance of aflatoxin B1-DNA adduct; Quercetin inhibits the reaction [CYP1A2 protein results in increased oxidation of 3,3'-diindolylmethane]; resveratrol inhibits the reaction [CYP1A2 protein results in increased oxidation of 3,3'-diindolylmethane] 3,3'-diindolylmethane results in increased expression of CYP1A2 protein 3,3'-diindolylmethane results in increased expression of CYP1A2 mRNA; 3,3'-diindolylmethane results in increased expression of CYP1A2 protein 3,3'-diindolylmethane results in decreased activity of CYP1A2 protein |
CTD |
PMID:8384853 PMID:15672752 PMID:16544949 PMID:19770484 |
|
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
|
|
G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
increases expression |
ISO |
3,3'-diindolylmethane analog results in increased expression of CYP1B1 mRNA; 3,3'-diindolylmethane results in increased expression of CYP1B1 mRNA |
CTD |
PMID:11294972 |
|
NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917
|
|
G |
Cyp2b1 |
cytochrome P450, family 2, subfamily b, polypeptide 1 |
increases expression |
EXP |
3,3'-diindolylmethane results in increased expression of CYP2B1 protein |
CTD |
PMID:8384853 |
|
NCBI chr 1:81,518,387...81,544,999
Ensembl chr 1:81,518,408...81,542,052
|
|
G |
Cyp2b2 |
cytochrome P450, family 2, subfamily b, polypeptide 2 |
increases expression |
EXP |
3,3'-diindolylmethane results in increased expression of CYP2B2 protein |
CTD |
PMID:8384853 |
|
NCBI chr 1:81,594,534...81,608,567
Ensembl chr 1:81,594,555...81,608,566
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
increases expression decreases activity multiple interactions |
ISO |
3,3'-diindolylmethane results in increased expression of CYP3A4 mRNA 3,3'-diindolylmethane results in decreased activity of CYP3A4 protein [3,3'-diindolylmethane results in increased activity of NR1I2 protein] which results in increased expression of CYP3A4 mRNA; Ketoconazole inhibits the reaction [3,3'-diindolylmethane results in increased expression of CYP3A4 mRNA] |
CTD |
PMID:19770484 PMID:25542144 |
|
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
|
|
G |
Ddit3 |
DNA-damage inducible transcript 3 |
increases expression |
ISO |
3,3'-diindolylmethane results in increased expression of DDIT3 protein |
CTD |
PMID:22290291 |
|
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
|
|
G |
Dnmt1 |
DNA methyltransferase 1 |
decreases expression |
ISO |
3,3'-diindolylmethane results in decreased expression of DNMT1 mRNA |
CTD |
PMID:24466240 |
|
NCBI chr 8:19,440,611...19,486,659
Ensembl chr 8:19,440,611...19,486,659
|
|
G |
Dnmt3b |
DNA methyltransferase 3 beta |
decreases expression |
ISO |
3,3'-diindolylmethane results in decreased expression of DNMT3B mRNA |
CTD |
PMID:24466240 |
|
NCBI chr 3:142,130,588...142,169,128
Ensembl chr 3:142,130,592...142,169,124
|
|
G |
Eef1g |
eukaryotic translation elongation factor 1 gamma |
multiple interactions |
ISO |
3,3'-diindolylmethane promotes the reaction [Estradiol results in increased expression of EEF1G mRNA] |
CTD |
PMID:11179685 |
|
NCBI chr 1:205,860,713...205,871,319
Ensembl chr 1:205,860,698...205,872,382
|
|
G |
Erbb2 |
erb-b2 receptor tyrosine kinase 2 |
multiple interactions |
ISO |
3,3'-diindolylmethane promotes the reaction [Paclitaxel results in decreased phosphorylation of and results in decreased activity of ERBB2 protein]; 3,3'-diindolylmethane results in decreased phosphorylation of and results in decreased activity of ERBB2 protein |
CTD |
PMID:16580691 |
|
NCBI chr10:83,411,197...83,435,078
Ensembl chr10:83,411,313...83,435,078
|
|
G |
Esr1 |
estrogen receptor 1 |
multiple interactions decreases expression |
ISO |
3,3'-diindolylmethane binds to and results in increased activity of ESR1 protein; 3,3'-diindolylmethane promotes the reaction [ESR1 protein binds to CYP1A1 promoter]; 3,3'-diindolylmethane promotes the reaction [ESR1 protein binds to TFF1 promoter]; ESR1 mutant form promotes the reaction [3,3'-diindolylmethane promotes the reaction [sulforaphane results in increased expression of HMOX1 mRNA]] 3,3'-diindolylmethane results in decreased expression of ESR1 |
CTD |
PMID:16972788 PMID:19223575 PMID:23583297 |
|
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
|
|
G |
Esr2 |
estrogen receptor 2 |
multiple interactions increases expression |
ISO |
3,3'-diindolylmethane promotes the reaction [ESR2 protein binds to KRT19 promoter]; 3,3'-diindolylmethane promotes the reaction [ESR2 protein binds to TMEM121B promoter]; ESR2 affects the reaction [3,3'-diindolylmethane promotes the reaction [NCOA2 protein binds to KRT19 promoter]]; ESR2 affects the reaction [3,3'-diindolylmethane results in increased expression of KRT19 mRNA]; ESR2 affects the reaction [3,3'-diindolylmethane results in increased expression of TMEM121B mRNA]; Raloxifene Hydrochloride inhibits the reaction [3,3'-diindolylmethane results in increased expression of ESR2 mRNA]; Tamoxifen inhibits the reaction [3,3'-diindolylmethane results in increased expression of ESR2 mRNA] |
CTD |
PMID:20160136 |
|
NCBI chr 6:94,858,438...94,909,630
Ensembl chr 6:94,809,547...94,908,919
|
|
G |
Fau |
FAU ubiquitin like and ribosomal protein S30 fusion |
multiple interactions |
ISO |
3,3'-diindolylmethane promotes the reaction [Estradiol results in decreased expression of FAU mRNA] |
CTD |
PMID:11179685 |
|
NCBI chr 1:203,350,226...203,351,741
Ensembl chr 1:203,350,189...203,351,742 Ensembl chr 1:203,350,189...203,351,742 Ensembl chr 6:203,350,189...203,351,742
|
|
G |
Gdf15 |
growth differentiation factor 15 |
increases expression |
ISO |
3,3'-diindolylmethane results in increased expression of GDF15 mRNA |
CTD |
PMID:15670751 |
|
NCBI chr16:18,804,457...18,808,043
Ensembl chr16:18,805,239...18,808,055
|
|
G |
Gnas |
GNAS complex locus |
multiple interactions |
ISO |
3,3'-diindolylmethane inhibits the reaction [Estradiol results in decreased expression of GNAS mRNA] |
CTD |
PMID:11179685 |
|
NCBI chr 3:163,071,003...163,136,350
Ensembl chr 3:163,071,417...163,127,262 Ensembl chr 3:163,071,417...163,127,262
|
|
G |
Greb1 |
growth regulating estrogen receptor binding 1 |
increases expression |
ISO |
3,3'-diindolylmethane results in increased expression of GREB1 mRNA |
CTD |
PMID:23583297 |
|
NCBI chr 6:39,440,522...39,562,364
Ensembl chr 6:39,440,504...39,581,633
|
|
G |
Gsk3b |
glycogen synthase kinase 3 beta |
decreases phosphorylation |
ISO |
3,3'-diindolylmethane results in decreased phosphorylation of GSK3B protein |
CTD |
PMID:22290291 |
|
NCBI chr11:62,498,997...62,648,665
Ensembl chr11:62,504,316...62,648,646
|
|
G |
Gstm1 |
glutathione S-transferase mu 1 |
decreases expression multiple interactions |
ISO |
3,3'-diindolylmethane results in decreased expression of GSTM1 mRNA [3,3'-diindolylmethane results in decreased expression of GSTM1 mRNA] which results in increased abundance of aflatoxin B1-DNA adduct |
CTD |
PMID:19770484 |
|
NCBI chr 2:195,649,845...195,655,402
Ensembl chr 2:195,649,845...195,655,411
|
|
G |
H3f3a |
H3.3 histone A |
multiple interactions |
ISO |
3,3'-diindolylmethane promotes the reaction [Estradiol results in increased expression of H3-3A mRNA] |
CTD |
PMID:11179685 |
|
NCBI chr13:92,533,289...92,544,902
Ensembl chr13:92,533,298...92,544,908
|
|
G |
Hdac1 |
histone deacetylase 1 |
multiple interactions |
ISO |
3,3'-diindolylmethane inhibits the reaction [enterotoxin B, staphylococcal results in increased expression of HDAC1 mRNA] |
CTD |
PMID:24200994 |
|
NCBI chr 5:141,853,992...141,881,057
Ensembl chr 5:141,853,989...141,881,111
|
|
G |
Hdac10 |
histone deacetylase 10 |
multiple interactions |
ISO |
3,3'-diindolylmethane promotes the reaction [enterotoxin B, staphylococcal results in decreased expression of HDAC10 mRNA] |
CTD |
PMID:24200994 |
|
NCBI chr 7:120,199,126...120,205,850
Ensembl chr 7:120,199,129...120,204,228
|
|
G |
Hdac2 |
histone deacetylase 2 |
decreases expression multiple interactions |
ISO |
3,3'-diindolylmethane results in decreased expression of HDAC2 protein 3,3'-diindolylmethane inhibits the reaction [enterotoxin B, staphylococcal results in increased expression of HDAC2 mRNA] |
CTD |
PMID:22800507 PMID:24200994 |
|
NCBI chr20:40,548,244...40,571,609
Ensembl chr20:40,548,250...40,571,609
|
|
G |
Hdac5 |
histone deacetylase 5 |
multiple interactions |
ISO |
3,3'-diindolylmethane promotes the reaction [enterotoxin B, staphylococcal results in decreased expression of HDAC5 mRNA] |
CTD |
PMID:24200994 |
|
NCBI chr10:87,152,978...87,187,921
Ensembl chr10:87,152,978...87,188,235
|
|
G |
Hdac8 |
histone deacetylase 8 |
multiple interactions |
ISO |
3,3'-diindolylmethane inhibits the reaction [enterotoxin B, staphylococcal results in increased expression of HDAC8 mRNA] |
CTD |
PMID:24200994 |
|
NCBI chr X:67,385,288...67,593,014
Ensembl chr X:67,385,289...67,592,923
|
|
G |
Hmox1 |
heme oxygenase 1 |
multiple interactions |
ISO |
3,3'-diindolylmethane promotes the reaction [sulforaphane results in increased expression of HMOX1 mRNA]; AHR mutant form inhibits the reaction [3,3'-diindolylmethane promotes the reaction [sulforaphane results in increased expression of HMOX1 mRNA]]; ESR1 mutant form promotes the reaction [3,3'-diindolylmethane promotes the reaction [sulforaphane results in increased expression of HMOX1 mRNA]] |
CTD |
PMID:23583297 |
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Hrk |
harakiri, BCL2 interacting protein |
increases expression |
ISO |
3,3'-diindolylmethane results in increased expression of HRK mRNA |
CTD |
PMID:22514694 |
|
NCBI chr12:38,387,484...38,409,652
|
|
G |
Hspa5 |
heat shock protein family A (Hsp70) member 5 |
decreases expression multiple interactions |
ISO |
3,3'-diindolylmethane analog results in decreased expression of HSPA5 protein 3,3'-diindolylmethane analog promotes the reaction [HSPA5 protein affects the expression of and affects the activity of MMP9 protein] |
CTD |
PMID:25794856 |
|
NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891
|
|
G |
Hspb1 |
heat shock protein family B (small) member 1 |
multiple interactions |
ISO |
3,3'-diindolylmethane inhibits the reaction [Estradiol results in increased expression of HSPB1 mRNA] |
CTD |
PMID:11179685 |
|
NCBI chr12:20,794,014...20,795,675
Ensembl chr12:20,794,028...20,795,743
|
|
G |
Ifng |
interferon gamma |
multiple interactions |
ISO |
3,3'-diindolylmethane inhibits the reaction [enterotoxin B, staphylococcal results in increased secretion of IFNG protein] |
CTD |
PMID:24200994 |
|
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
|
|
G |
Il2 |
interleukin 2 |
multiple interactions |
ISO |
3,3'-diindolylmethane inhibits the reaction [enterotoxin B, staphylococcal results in increased secretion of IL2 protein] |
CTD |
PMID:24200994 |
|
NCBI chr 2:120,004,862...120,009,566
Ensembl chr 2:120,004,862...120,009,566
|
|
G |
Il6 |
interleukin 6 |
increases expression multiple interactions |
ISO |
3,3'-diindolylmethane results in increased expression of IL6 mRNA 3,3'-diindolylmethane inhibits the reaction [enterotoxin B, staphylococcal results in increased secretion of IL6 protein] |
CTD |
PMID:18025290 PMID:24200994 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Kdr |
kinase insert domain receptor |
decreases expression |
ISO |
3,3'-diindolylmethane analog results in decreased expression of KDR protein |
CTD |
PMID:25794856 |
|
NCBI chr14:32,217,871...32,261,018
Ensembl chr14:32,217,871...32,261,018
|
|
G |
Klf10 |
KLF transcription factor 10 |
multiple interactions |
ISO |
3,3'-diindolylmethane inhibits the reaction [Estradiol results in decreased expression of KLF10 mRNA] |
CTD |
PMID:11179685 |
|
NCBI chr 7:69,467,658...69,473,726
Ensembl chr 7:69,465,619...69,473,994
|
|
G |
Klk1c10 |
kallikrein 1-related peptidase C10 |
decreases expression |
ISO |
3,3'-diindolylmethane results in decreased expression of KLK3 mRNA |
CTD |
PMID:22495798 |
|
NCBI chr 1:94,402,993...94,407,052
Ensembl chr 1:94,402,993...94,407,052
|
|
G |
Krt18 |
keratin 18 |
multiple interactions |
ISO |
3,3'-diindolylmethane inhibits the reaction [Estradiol results in increased expression of KRT18 mRNA] |
CTD |
PMID:11179685 |
|
NCBI chr 7:133,157,486...133,161,162
Ensembl chr 7:133,157,475...133,161,166 Ensembl chr10:133,157,475...133,161,166
|
|
G |
Krt19 |
keratin 19 |
multiple interactions increases expression |
ISO |
3,3'-diindolylmethane inhibits the reaction [Estradiol results in increased expression of KRT19 mRNA]; 3,3'-diindolylmethane promotes the reaction [ESR2 protein binds to KRT19 promoter]; 3,3'-diindolylmethane promotes the reaction [NCOA2 protein binds to KRT19 promoter]; ESR2 affects the reaction [3,3'-diindolylmethane promotes the reaction [NCOA2 protein binds to KRT19 promoter]]; ESR2 affects the reaction [3,3'-diindolylmethane results in increased expression of KRT19 mRNA]; NCOA2 mutant form inhibits the reaction [3,3'-diindolylmethane results in increased expression of KRT19 mRNA] |
CTD |
PMID:11179685 PMID:20160136 |
|
NCBI chr10:85,075,835...85,080,552
Ensembl chr10:85,066,802...85,171,799
|
|
G |
Magea9 |
MAGE family member A9 |
multiple interactions |
ISO |
3,3'-diindolylmethane inhibits the reaction [Estradiol results in increased expression of MAGEA9 mRNA] |
CTD |
PMID:11179685 |
|
NCBI chr X:142,619,282...142,624,654
Ensembl chr X:142,619,395...142,624,653
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
multiple interactions decreases phosphorylation |
ISO |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [3,3'-diindolylmethane results in decreased phosphorylation of MAPK1 protein]; 3,3'-diindolylmethane promotes the reaction [Paclitaxel results in decreased phosphorylation of and results in decreased activity of MAPK1 protein]; 3,3'-diindolylmethane results in decreased phosphorylation of and results in decreased activity of MAPK1 protein |
CTD |
PMID:16580691 PMID:22290291 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
decreases phosphorylation multiple interactions |
ISO |
3,3'-diindolylmethane results in decreased phosphorylation of MAPK3 protein 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [3,3'-diindolylmethane results in decreased phosphorylation of MAPK3 protein]; 3,3'-diindolylmethane promotes the reaction [Paclitaxel results in decreased phosphorylation of and results in decreased activity of MAPK3 protein]; 3,3'-diindolylmethane results in decreased phosphorylation of and results in decreased activity of MAPK3 protein |
CTD |
PMID:16580691 PMID:22290291 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mdm2 |
MDM2 proto-oncogene |
decreases expression |
ISO |
3,3'-diindolylmethane analog results in decreased expression of MDM2 mRNA |
CTD |
PMID:26593444 |
|
NCBI chr 7:53,290,660...53,315,205
Ensembl chr 7:53,290,664...53,314,915
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
multiple interactions |
ISO |
3,3'-diindolylmethane inhibits the reaction [bisphenol A results in increased expression of MMP2 protein]; 3,3'-diindolylmethane inhibits the reaction [Estradiol results in increased expression of MMP2 protein]; 3,3'-diindolylmethane inhibits the reaction [Triclosan results in increased expression of MMP2 protein] |
CTD |
PMID:28844962 |
|
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
multiple interactions |
ISO |
3,3'-diindolylmethane analog promotes the reaction [HSPA5 protein affects the expression of and affects the activity of MMP9 protein]; 3,3'-diindolylmethane analog results in decreased expression of and results in decreased activity of MMP9 protein; 3,3'-diindolylmethane inhibits the reaction [bisphenol A results in increased expression of MMP9 protein]; 3,3'-diindolylmethane inhibits the reaction [Estradiol results in increased expression of MMP9 protein]; 3,3'-diindolylmethane inhibits the reaction [Triclosan results in increased expression of MMP9 protein] |
CTD |
PMID:25794856 PMID:28844962 |
|
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
|
|
G |
Mt-co2 |
mitochondrially encoded cytochrome c oxidase II |
multiple interactions |
ISO |
3,3'-diindolylmethane inhibits the reaction [Estradiol results in decreased expression of COX2 mRNA] |
CTD |
PMID:11179685 |
|
NCBI chr MT:7,006...7,689 NCBI chr MT:7,006...7,689 NCBI chr MT:7,006...7,689 NCBI chr MT:7,006...7,689 NCBI chr MT:7,006...7,689 NCBI chr MT:7,006...7,689 NCBI chr MT:7,006...7,689 NCBI chr MT:7,006...7,689 NCBI chr MT:7,006...7,689 NCBI chr MT:7,006...7,689
Ensembl chr MT:7,006...7,689
|
|
G |
Myb |
MYB proto-oncogene, transcription factor |
decreases expression |
ISO |
3,3'-diindolylmethane analog results in decreased expression of MYB mRNA |
CTD |
PMID:26593444 |
|
NCBI chr 1:15,939,771...15,973,367
Ensembl chr 1:15,939,761...15,973,057
|
|
G |
Myc |
MYC proto-oncogene, bHLH transcription factor |
decreases expression |
ISO |
3,3'-diindolylmethane results in decreased expression of MYC protein 3,3'-diindolylmethane analog results in decreased expression of MYC mRNA |
CTD |
PMID:22290291 PMID:26593444 |
|
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
|
|
G |
Myl6 |
myosin light chain 6 |
multiple interactions |
ISO |
3,3'-diindolylmethane inhibits the reaction [Estradiol results in increased expression of MYL6 mRNA] |
CTD |
PMID:11179685 |
|
NCBI chr 7:910,764...914,062
Ensembl chr 7:910,774...933,791
|
|
G |
Ncoa2 |
nuclear receptor coactivator 2 |
multiple interactions |
ISO |
3,3'-diindolylmethane promotes the reaction [NCOA2 protein binds to KRT19 promoter]; ESR2 affects the reaction [3,3'-diindolylmethane promotes the reaction [NCOA2 protein binds to KRT19 promoter]]; NCOA2 mutant form inhibits the reaction [3,3'-diindolylmethane results in increased expression of KRT19 mRNA]; NCOA2 mutant form inhibits the reaction [3,3'-diindolylmethane results in increased expression of TMEM121B mRNA] |
CTD |
PMID:20160136 |
|
NCBI chr 5:5,835,642...6,069,693
Ensembl chr 5:5,835,706...6,067,451
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
increases expression multiple interactions |
ISO |
3,3'-diindolylmethane results in increased expression of NFE2L2 mRNA; 3,3'-diindolylmethane results in increased expression of NFE2L2 protein sulforaphane promotes the reaction [3,3'-diindolylmethane results in increased expression of NFE2L2 mRNA]; sulforaphane promotes the reaction [3,3'-diindolylmethane results in increased expression of NFE2L2 protein] |
CTD |
PMID:23583297 |
|
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
|
|
G |
Nos2 |
nitric oxide synthase 2 |
multiple interactions |
ISO |
3,3'-diindolylmethane inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] |
CTD |
PMID:24162184 |
|
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
multiple interactions increases expression |
ISO |
3,3'-diindolylmethane promotes the reaction [sulforaphane results in increased expression of NQO1 mRNA]; AHR mutant form inhibits the reaction [3,3'-diindolylmethane promotes the reaction [sulforaphane results in increased expression of NQO1 mRNA]] 3,3'-diindolylmethane results in increased expression of NQO1 mRNA |
CTD |
PMID:15672752 PMID:22495798 PMID:23583297 |
|
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
|
|
G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
increases activity multiple interactions |
ISO |
3,3'-diindolylmethane results in increased activity of NR1I2 protein [3,3'-diindolylmethane results in increased activity of NR1I2 protein] which results in increased expression of ABCB1 mRNA; [3,3'-diindolylmethane results in increased activity of NR1I2 protein] which results in increased expression of CYP3A4 mRNA |
CTD |
PMID:25542144 |
|
NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
|
|
G |
Numa1 |
nuclear mitotic apparatus protein 1 |
multiple interactions |
EXP |
3,3'-diindolylmethane inhibits the reaction [[Butylhydroxybutylnitrosamine co-treated with Cacodylic Acid] results in increased expression of NUMA1 protein] |
CTD |
PMID:26251508 |
|
NCBI chr 1:156,297,907...156,372,855
Ensembl chr 1:156,326,259...156,372,855
|
|
G |
Nup133 |
nucleoporin 133 |
multiple interactions |
ISO |
3,3'-diindolylmethane inhibits the reaction [Estradiol results in decreased expression of NUP133 mRNA] |
CTD |
PMID:11179685 |
|
NCBI chr19:51,891,606...51,941,243
Ensembl chr19:51,891,629...51,941,239
|
|
G |
Papola |
poly (A) polymerase alpha |
multiple interactions |
ISO |
3,3'-diindolylmethane inhibits the reaction [Estradiol results in increased expression of PAPOLA mRNA] |
CTD |
PMID:11179685 |
|
NCBI chr 6:124,682,015...124,734,706
Ensembl chr 6:124,682,105...124,734,468
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
multiple interactions |
ISO |
[3,3'-diindolylmethane co-treated with Paclitaxel] results in increased cleavage of and results in increased activity of PARP1 protein |
CTD |
PMID:16580691 |
|
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
|
|
G |
Plau |
plasminogen activator, urokinase |
increases expression |
ISO |
3,3'-diindolylmethane results in increased expression of PLAU mRNA |
CTD |
PMID:18025290 |
|
NCBI chr15:3,456,230...3,462,732
Ensembl chr15:3,456,232...3,462,775
|
|
G |
Pmaip1 |
phorbol-12-myristate-13-acetate-induced protein 1 |
multiple interactions |
ISO |
[3,3'-diindolylmethane results in increased phosphorylation of and results in increased activity of TP53 protein] which results in increased expression of PMAIP1 |
CTD |
PMID:22290291 |
|
NCBI chr18:59,986,020...59,992,434
Ensembl chr18:59,986,017...59,992,429
|
|
G |
Pten |
phosphatase and tensin homolog |
multiple interactions |
EXP |
3,3'-diindolylmethane inhibits the reaction [[Butylhydroxybutylnitrosamine co-treated with Cacodylic Acid] results in decreased expression of PTEN protein] |
CTD |
PMID:26251508 |
|
NCBI chr 1:230,630,443...230,697,070
Ensembl chr 1:230,630,338...230,696,838
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions decreases expression |
ISO EXP |
3,3'-diindolylmethane inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to PTGS2 promoter]]; 3,3'-diindolylmethane inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA]; 3,3'-diindolylmethane inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PTGS2 protein] 3,3'-diindolylmethane inhibits the reaction [[Butylhydroxybutylnitrosamine co-treated with Cacodylic Acid] results in increased expression of PTGS2 protein] 3,3'-diindolylmethane inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA] 3,3'-diindolylmethane results in decreased expression of PTGS2 mRNA; 3,3'-diindolylmethane results in decreased expression of PTGS2 protein |
CTD |
PMID:19056653 PMID:22290291 PMID:24162184 PMID:26251508 |
|
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
decreases expression multiple interactions |
ISO EXP |
3,3'-diindolylmethane results in decreased expression of RELA protein 3,3'-diindolylmethane inhibits the reaction [[Butylhydroxybutylnitrosamine co-treated with Cacodylic Acid] results in increased phosphorylation of RELA protein] |
CTD |
PMID:22290291 PMID:26251508 |
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Ribc1 |
RIB43A domain with coiled-coils 1 |
multiple interactions |
ISO |
3,3'-diindolylmethane inhibits the reaction [Estradiol results in increased expression of RIBC1 mRNA] |
CTD |
PMID:11179685 |
|
NCBI chr X:21,091,717...21,103,688
Ensembl chr X:21,091,717...21,103,200
|
|
G |
Rpl10 |
ribosomal protein L10 |
multiple interactions |
ISO |
3,3'-diindolylmethane inhibits the reaction [Estradiol results in increased expression of RPL10 mRNA]; 3,3'-diindolylmethane promotes the reaction [Estradiol results in increased expression of RPL10 mRNA] |
CTD |
PMID:11179685 |
|
NCBI chr X:152,054,562...152,056,769
Ensembl chr X:152,054,452...152,056,761
|
|
G |
Rpl13a |
ribosomal protein L13A |
multiple interactions |
ISO |
3,3'-diindolylmethane promotes the reaction [Estradiol results in increased expression of RPL13A mRNA] |
CTD |
PMID:11179685 |
|
NCBI chr 1:95,609,374...95,612,557
Ensembl chr 1:95,609,370...95,620,463
|
|
G |
Rpl31 |
ribosomal protein L31 |
multiple interactions |
ISO |
3,3'-diindolylmethane inhibits the reaction [Estradiol results in increased expression of RPL31 mRNA] |
CTD |
PMID:11179685 |
|
NCBI chr 9:41,647,397...41,651,441
Ensembl chr 9:41,647,426...41,662,129 Ensembl chr 8:41,647,426...41,662,129
|
|
G |
Rpl41 |
ribosomal protein L41 |
multiple interactions |
ISO |
3,3'-diindolylmethane inhibits the reaction [Estradiol results in decreased expression of RPL41 mRNA] |
CTD |
PMID:11179685 |
|
NCBI chr 7:977,885...978,965
|
|
G |
Rpl7 |
ribosomal protein L7 |
multiple interactions |
ISO |
3,3'-diindolylmethane inhibits the reaction [Estradiol results in increased expression of RPL7 mRNA] |
CTD |
PMID:11179685 |
|
NCBI chr 5:3,217,184...3,220,192
|
|
G |
Rplp0 |
ribosomal protein lateral stalk subunit P0 |
multiple interactions |
ISO |
3,3'-diindolylmethane inhibits the reaction [Estradiol results in decreased expression of RPLP0 mRNA] |
CTD |
PMID:11179685 |
|
NCBI chr12:41,054,363...41,057,632
Ensembl chr12:41,054,179...41,057,632
|
|
G |
Rps15a |
ribosomal protein S15a |
multiple interactions |
ISO |
3,3'-diindolylmethane inhibits the reaction [Estradiol results in decreased expression of RPS15A mRNA] |
CTD |
PMID:11179685 |
|
NCBI chr 1:172,420,151...172,427,021
Ensembl chr 1:172,419,761...172,426,995
|
|
G |
Rps17 |
ribosomal protein S17 |
multiple interactions |
ISO |
3,3'-diindolylmethane inhibits the reaction [Estradiol results in decreased expression of RPS17 mRNA] |
CTD |
PMID:11179685 |
|
NCBI chr 1:135,295,920...135,298,506
Ensembl chr 1:135,295,919...135,298,535 Ensembl chr 8:135,295,919...135,298,535
|
|
G |
Rps3 |
ribosomal protein S3 |
multiple interactions |
ISO |
3,3'-diindolylmethane inhibits the reaction [Estradiol results in increased expression of RPS3 mRNA] |
CTD |
PMID:11179685 |
|
NCBI chr 1:153,778,363...153,783,663
Ensembl chr 1:153,777,472...153,783,680
|
|
G |
Rps4x |
ribosomal protein S4, X-linked |
multiple interactions |
ISO |
3,3'-diindolylmethane promotes the reaction [Estradiol results in increased expression of RPS4X mRNA] |
CTD |
PMID:11179685 |
|
NCBI chr X:67,298,522...67,302,965
Ensembl chr X:67,298,525...67,303,019 Ensembl chr 4:67,298,525...67,303,019
|
|
G |
Rps6 |
ribosomal protein S6 |
multiple interactions |
ISO |
3,3'-diindolylmethane promotes the reaction [Estradiol results in increased expression of RPS6 mRNA] |
CTD |
PMID:11179685 |
|
NCBI chr 5:101,371,716...101,374,576
Ensembl chr 5:101,371,136...101,374,602 Ensembl chr 5:101,371,136...101,374,602
|
|
G |
Snai1 |
snail family transcriptional repressor 1 |
multiple interactions |
ISO |
3,3'-diindolylmethane inhibits the reaction [bisphenol A results in increased expression of SNAI1 protein]; 3,3'-diindolylmethane inhibits the reaction [Estradiol results in increased expression of SNAI1 protein]; 3,3'-diindolylmethane inhibits the reaction [Triclosan results in increased expression of SNAI1 protein] |
CTD |
PMID:28844962 |
|
NCBI chr 3:156,248,479...156,252,969
Ensembl chr 3:156,248,485...156,252,969
|
|
G |
Snai2 |
snail family transcriptional repressor 2 |
multiple interactions |
ISO |
3,3'-diindolylmethane inhibits the reaction [bisphenol A results in increased expression of SNAI2 protein]; 3,3'-diindolylmethane inhibits the reaction [Estradiol results in increased expression of SNAI2 protein]; 3,3'-diindolylmethane inhibits the reaction [Triclosan results in increased expression of SNAI2 protein] |
CTD |
PMID:28844962 |
|
NCBI chr11:86,182,788...86,186,203
Ensembl chr11:86,181,909...86,186,200
|
|
G |
Tff1 |
trefoil factor 1 |
multiple interactions |
ISO |
3,3'-diindolylmethane promotes the reaction [ESR1 protein binds to TFF1 promoter] |
CTD |
PMID:16972788 |
|
NCBI chr20:9,235,736...9,239,597
Ensembl chr20:9,235,736...9,239,597
|
|
G |
Tgfbr1 |
transforming growth factor, beta receptor 1 |
affects methylation |
ISO |
3,3'-diindolylmethane affects the methylation of TGFBR1 promoter |
CTD |
PMID:24466240 |
|
NCBI chr 5:61,653,773...61,710,777
Ensembl chr 5:61,653,233...61,710,777
|
|
G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
increases expression |
ISO |
3,3'-diindolylmethane analog results in increased expression of TIMP1 protein |
CTD |
PMID:25794856 |
|
NCBI chr X:1,212,969...1,217,714
Ensembl chr X:1,212,972...1,217,664
|
|
G |
Tmem121b |
transmembrane protein 121B |
multiple interactions increases expression |
ISO |
3,3'-diindolylmethane promotes the reaction [ESR2 protein binds to TMEM121B promoter]; ESR2 affects the reaction [3,3'-diindolylmethane results in increased expression of TMEM121B mRNA]; NCOA2 mutant form inhibits the reaction [3,3'-diindolylmethane results in increased expression of TMEM121B mRNA] |
CTD |
PMID:20160136 |
|
NCBI chr 4:153,695,191...153,700,104
Ensembl chr 4:153,698,194...153,699,912
|
|
G |
Tnf |
tumor necrosis factor |
decreases expression multiple interactions |
ISO EXP |
3,3'-diindolylmethane results in decreased expression of TNF mRNA 3,3'-diindolylmethane inhibits the reaction [[Butylhydroxybutylnitrosamine co-treated with Cacodylic Acid] results in increased expression of TNF protein] 3,3'-diindolylmethane inhibits the reaction [enterotoxin B, staphylococcal results in increased secretion of TNF protein] |
CTD |
PMID:22514694 PMID:24200994 PMID:26251508 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tnfrsf1a |
TNF receptor superfamily member 1A |
increases expression |
ISO |
3,3'-diindolylmethane results in increased expression of TNFRSF1A mRNA |
CTD |
PMID:22514694 |
|
NCBI chr 4:158,150,815...158,163,592
Ensembl chr 4:158,150,820...158,163,591
|
|
G |
Tnfrsf25 |
TNF receptor superfamily member 25 |
decreases expression |
ISO |
3,3'-diindolylmethane results in decreased expression of TNFRSF25 mRNA |
CTD |
PMID:22514694 |
|
NCBI chr 5:162,621,669...162,626,341
Ensembl chr 5:162,622,075...162,626,341
|
|
G |
Tnfsf8 |
TNF superfamily member 8 |
increases expression |
ISO |
3,3'-diindolylmethane results in increased expression of TNFSF8 mRNA |
CTD |
PMID:22514694 |
|
NCBI chr 5:77,250,942...77,277,364
Ensembl chr 5:77,251,373...77,277,421
|
|
G |
Tp53 |
tumor protein p53 |
multiple interactions |
ISO |
3,3'-diindolylmethane results in increased expression of and results in increased phosphorylation of and results in increased activity of TP53 protein; [3,3'-diindolylmethane results in increased phosphorylation of and results in increased activity of TP53 protein] which results in increased expression of BBC3; [3,3'-diindolylmethane results in increased phosphorylation of and results in increased activity of TP53 protein] which results in increased expression of PMAIP1; wortmannin inhibits the reaction [3,3'-diindolylmethane results in increased phosphorylation of TP53 protein] |
CTD |
PMID:22290291 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Traf4 |
Tnf receptor associated factor 4 |
decreases expression |
ISO |
3,3'-diindolylmethane results in decreased expression of TRAF4 mRNA |
CTD |
PMID:22514694 |
|
NCBI chr10:63,054,169...63,060,284
Ensembl chr10:63,054,181...63,060,284
|
|
G |
Tyms |
thymidylate synthetase |
multiple interactions |
ISO |
3,3'-diindolylmethane inhibits the reaction [Estradiol results in increased expression of TYMS mRNA] |
CTD |
PMID:11179685 |
|
NCBI chr 9:113,313,454...113,329,551
Ensembl chr 9:113,313,452...113,329,536
|
|
G |
Ubb |
ubiquitin B |
multiple interactions |
ISO |
3,3'-diindolylmethane promotes the reaction [Estradiol results in increased expression of UBB mRNA] |
CTD |
PMID:11179685 |
|
NCBI chr10:47,247,630...47,249,335
Ensembl chr10:47,245,637...47,249,333
|
|
G |
Xiap |
X-linked inhibitor of apoptosis |
decreases expression |
ISO |
3,3'-diindolylmethane results in decreased expression of XIAP protein |
CTD |
PMID:22290291 |
|
NCBI chr X:120,890,537...120,938,413
Ensembl chr X:120,897,907...120,934,700
|
|
G |
Xrcc6 |
X-ray repair cross complementing 6 |
multiple interactions |
ISO |
3,3'-diindolylmethane inhibits the reaction [Estradiol results in increased expression of XRCC6 mRNA] |
CTD |
PMID:11179685 |
|
NCBI chr 7:113,542,992...113,563,762
Ensembl chr 7:113,543,057...113,563,762
|
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
increases expression |
EXP |
5-hydroxymethylomeprazole results in increased expression of CYP1A1 protein |
CTD |
PMID:10103034 |
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
|
G |
Adamts1 |
ADAM metallopeptidase with thrombospondin type 1 motif, 1 |
multiple interactions |
EXP |
[alpha-naphthoflavone co-treated with Methylcholanthrene] results in decreased acetylation of ADAMTS1 promoter; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in decreased acetylation of ADAMTS1 promoter]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in decreased expression of ADAMTS1 mRNA]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased methylation of ADAMTS1 promoter] |
CTD |
PMID:29094188 |
|
NCBI chr11:24,932,227...24,941,068
Ensembl chr11:24,931,761...24,941,103
|
|
G |
Ahr |
aryl hydrocarbon receptor |
affects binding decreases activity multiple interactions |
ISO EXP |
[alpha-naphthoflavone binds to AHR protein] which binds to ESR1 protein; [alpha-naphthoflavone binds to AHR protein] which binds to ESRRA protein; [alpha-naphthoflavone binds to AHR protein] which binds to NR2F1 protein; alpha-naphthoflavone binds to AHR protein alpha-naphthoflavone results in decreased activity of AHR protein [alpha-naphthoflavone results in decreased activity of AHR protein] which results in decreased expression of CYP1A1 mRNA; AHR gene mutant form inhibits the reaction [alpha-naphthoflavone results in increased expression of IGFBP4 protein]; AHR protein promotes the reaction [alpha-naphthoflavone results in decreased expression of CDH13 mRNA]; alpha-naphthoflavone binds to and results in decreased activity of AHR protein; alpha-naphthoflavone binds to and results in increased activity of AHR protein; alpha-naphthoflavone inhibits the reaction [[Tetrachlorodibenzodioxin results in increased activity of AHR protein] which results in increased expression of CYP1A1 mRNA]; alpha-naphthoflavone inhibits the reaction [hydroquinone results in increased expression of AHR protein]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene promotes the reaction [AHR protein binds to BAX promoter]]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene promotes the reaction [AHR protein binds to CASP9 promoter]]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene promotes the reaction [AHR protein binds to CDK2 promoter]]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene promotes the reaction [AHR protein binds to DNAJB6 promoter]]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene promotes the reaction [AHR protein binds to HES1 promoter]]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene promotes the reaction [AHR protein binds to ICAM1 promoter]]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene promotes the reaction [AHR protein binds to IGF2 promoter]]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene promotes the reaction [AHR protein binds to JAG1 promoter]]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene promotes the reaction [AHR protein binds to SP1 promoter]]; alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of AHR protein]; alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased localization of and results in increased activity of AHR protein]; alpha-naphthoflavone promotes the reaction [beta-Naphthoflavone results in decreased expression of AHR mRNA] [alpha-naphthoflavone binds to and results in decreased activity of AHR protein] inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of IL10 protein]; [alpha-naphthoflavone binds to and results in decreased activity of AHR protein] results in decreased susceptibility to [SB 203580 results in increased expression of CYP1A1]; [alpha-naphthoflavone binds to and results in decreased activity of AHR protein] which results in decreased susceptibility to Benzo(a)pyrene; alpha-naphthoflavone binds to and results in decreased activity of AHR protein; alpha-naphthoflavone binds to and results in increased activity of AHR protein; alpha-naphthoflavone inhibits the reaction [AHR protein promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1B1 mRNA]]; alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of AHR protein]; alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased localization of and results in increased activity of AHR protein] [alpha-naphthoflavone binds to and results in decreased activity of AHR protein] inhibits the reaction [Hexachlorobenzene results in increased phosphorylation of and results in increased activity of MAPK1 protein]; [alpha-naphthoflavone binds to and results in decreased activity of AHR protein] inhibits the reaction [Hexachlorobenzene results in increased phosphorylation of and results in increased activity of MAPK3 protein]; [alpha-naphthoflavone binds to and results in decreased activity of AHR protein] inhibits the reaction [Hexachlorobenzene results in increased phosphorylation of and results in increased activity of STAT5B protein]; [alpha-naphthoflavone binds to and results in decreased activity of AHR protein] inhibits the reaction [Skatole results in increased expression of CYP1A1 mRNA]; [alpha-naphthoflavone binds to and results in decreased activity of AHR protein] inhibits the reaction [Skatole results in increased expression of CYP2F1 mRNA]; [alpha-naphthoflavone binds to and results in decreased activity of AHR protein] inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of FLG mRNA]; [alpha-naphthoflavone binds to and results in decreased activity of AHR protein] which results in decreased susceptibility to Hexachlorobenzene; [alpha-naphthoflavone results in decreased activity of AHR protein] inhibits the reaction [Tetrachlorodibenzodioxin results in increased abundance of Reactive Oxygen Species]; alpha-naphthoflavone analog inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of AHR protein]; alpha-naphthoflavone analog results in increased activity of [AHR protein binds to ARNT protein]; alpha-naphthoflavone binds to and results in decreased activity of AHR protein; alpha-naphthoflavone inhibits the reaction [[AHR protein binds to ARNT protein] which binds to CYP1A1 enhancer]; alpha-naphthoflavone inhibits the reaction [[AHR protein binds to ARNT protein] which results in increased expression of CYP1A1 mRNA]; alpha-naphthoflavone inhibits the reaction [[Benzo(a)pyrene binds to and results in increased activity of AHR protein] which results in increased expression of CYP1A1 mRNA]; alpha-naphthoflavone inhibits the reaction [[benzo(k)fluoranthene binds to and results in increased activity of AHR protein] which results in increased expression of CYP1A1 mRNA]; alpha-naphthoflavone inhibits the reaction [[chrysene binds to and results in increased activity of AHR protein] which results in increased expression of CYP1A1 mRNA]; alpha-naphthoflavone inhibits the reaction [[Oxygen deficiency co-treated with Tetrachlorodibenzodioxin] results in decreased stability of AHR protein]; alpha-naphthoflavone inhibits the reaction [[Tetrachlorodibenzodioxin binds to AHR protein] which results in increased activity of BRCA1 protein]; alpha-naphthoflavone inhibits the reaction [AHR promotes the reaction [Tetrachlorodibenzodioxin results in decreased uptake of Glucose]]; alpha-naphthoflavone inhibits the reaction [AHR protein binds to and results in increased metabolism of Benzo(a)pyrene]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased activity of AHR protein]; alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin affects the localization of AHR protein]; alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of AHR protein]; alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of AHR protein]; alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of AHR protein]; alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased localization of and results in increased activity of AHR protein]; alpha-naphthoflavone results in increased activity of [AHR protein binds to ARNT protein] |
CTD |
PMID:1329656 PMID:7669069 PMID:8390116 PMID:8738555 PMID:9006915 PMID:10593590 PMID:10620335 PMID:11165043 PMID:11516172 PMID:11577022 PMID:11768231 PMID:12051995 PMID:12093619 PMID:12111005 PMID:12559965 PMID:12644593 PMID:12799773 PMID:14993811 PMID:15019843 PMID:15041469 PMID:15364539 PMID:15459018 PMID:15797623 PMID:16054781 PMID:16359657 PMID:17669606 PMID:17681673 PMID:18072750 PMID:18259752 PMID:19828881 PMID:20187624 PMID:20634293 PMID:21127131 PMID:21205633 PMID:21732638 PMID:21835898 PMID:22975028 PMID:23639626 PMID:24161567 PMID:26519956 PMID:29094188 PMID:29935983 More...
|
|
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
multiple interactions increases methylation |
EXP |
alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in decreased acetylation of AKT1 promoter]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased expression of AKT1 mRNA] alpha-naphthoflavone results in increased methylation of AKT1 promoter |
CTD |
PMID:29094188 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Ar |
androgen receptor |
multiple interactions increases expression |
ISO |
alpha-naphthoflavone inhibits the reaction [Benzo(a)pyrene results in decreased expression of AR protein]; alpha-naphthoflavone inhibits the reaction [Particulate Matter analog inhibits the reaction [Dihydrotestosterone results in increased activity of AR protein]]; alpha-naphthoflavone inhibits the reaction [Vehicle Emissions analog inhibits the reaction [Dihydrotestosterone results in increased activity of AR protein]]; bicalutamide inhibits the reaction [alpha-naphthoflavone inhibits the reaction [Particulate Matter analog inhibits the reaction [Dihydrotestosterone results in increased activity of AR protein]]]; bicalutamide inhibits the reaction [alpha-naphthoflavone inhibits the reaction [Vehicle Emissions analog inhibits the reaction [Dihydrotestosterone results in increased activity of AR protein]]] alpha-naphthoflavone results in increased expression of AR protein |
CTD |
PMID:12970580 PMID:15041469 |
|
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
|
|
G |
Arnt |
aryl hydrocarbon receptor nuclear translocator |
multiple interactions |
ISO |
alpha-naphthoflavone analog results in increased activity of [AHR protein binds to ARNT protein]; alpha-naphthoflavone inhibits the reaction [[AHR protein binds to ARNT protein] which binds to CYP1A1 enhancer]; alpha-naphthoflavone inhibits the reaction [[AHR protein binds to ARNT protein] which results in increased expression of CYP1A1 mRNA]; alpha-naphthoflavone results in increased activity of [AHR protein binds to ARNT protein] ARNT protein affects the reaction [alpha-naphthoflavone results in increased expression of DDIT3 protein] |
CTD |
PMID:11768231 PMID:21127131 PMID:30508555 |
|
NCBI chr 2:182,997,731...183,056,584
Ensembl chr 2:182,997,736...183,056,580
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
multiple interactions |
ISO EXP |
alpha-naphthoflavone inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of BAX mRNA] alpha-naphthoflavone inhibits the reaction [Methylcholanthrene promotes the reaction [AHR protein binds to BAX promoter]]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased expression of BAX mRNA]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased methylation of BAX promoter] |
CTD |
PMID:20562217 PMID:29094188 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bmp15 |
bone morphogenetic protein 15 |
multiple interactions |
EXP |
[Methylcholanthrene co-treated with alpha-naphthoflavone] results in increased expression of BMP15 mRNA |
CTD |
PMID:29094188 |
|
NCBI chr X:16,169,123...16,174,187
Ensembl chr X:16,169,123...16,174,187
|
|
G |
Bpgm |
bisphosphoglycerate mutase |
multiple interactions increases expression |
ISO |
alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of BPGM mRNA] alpha-naphthoflavone results in increased expression of BPGM mRNA |
CTD |
PMID:23152189 |
|
NCBI chr 4:63,139,730...63,168,581
Ensembl chr 4:63,140,018...63,168,581
|
|
G |
Brca1 |
BRCA1, DNA repair associated |
multiple interactions |
ISO |
alpha-naphthoflavone inhibits the reaction [[Tetrachlorodibenzodioxin binds to AHR protein] which results in increased activity of BRCA1 protein]; alpha-naphthoflavone inhibits the reaction [Estradiol results in increased expression of BRCA1 mRNA] |
CTD |
PMID:16489025 PMID:18259752 |
|
NCBI chr10:86,417,441...86,477,762
Ensembl chr10:86,418,000...86,477,304
|
|
G |
Calr |
calreticulin |
multiple interactions |
EXP |
alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased expression of CALR mRNA] |
CTD |
PMID:29094188 |
|
NCBI chr19:23,308,525...23,313,420
Ensembl chr19:23,308,351...23,313,414
|
|
G |
Casp12 |
caspase 12 |
increases cleavage |
ISO |
alpha-naphthoflavone results in increased cleavage of CASP12 protein |
CTD |
PMID:30508555 |
|
NCBI chr 8:2,642,296...2,669,549
Ensembl chr 8:2,642,434...2,674,037
|
|
G |
Casp3 |
caspase 3 |
increases activity multiple interactions increases cleavage decreases activity |
ISO EXP |
alpha-naphthoflavone results in increased activity of CASP3 protein alpha-naphthoflavone inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased cleavage of CASP3 protein] alpha-naphthoflavone results in increased cleavage of CASP3 protein alpha-naphthoflavone results in decreased activity of CASP3 protein |
CTD |
PMID:15710172 PMID:18334599 PMID:30508555 PMID:35908932 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp8 |
caspase 8 |
increases activity |
ISO |
alpha-naphthoflavone results in increased activity of CASP8 protein |
CTD |
PMID:18334599 |
|
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
Casp9 |
caspase 9 |
increases activity multiple interactions |
ISO EXP |
alpha-naphthoflavone results in increased activity of CASP9 protein [alpha-naphthoflavone co-treated with Methylcholanthrene] results in decreased acetylation of CASP9 promoter; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene promotes the reaction [AHR protein binds to CASP9 promoter]]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased expression of CASP9 mRNA]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased methylation of CASP9 promoter] |
CTD |
PMID:18334599 PMID:29094188 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Cat |
catalase |
multiple interactions |
ISO |
alpha-naphthoflavone inhibits the reaction [Benzo(a)pyrene results in decreased activity of CAT protein] |
CTD |
PMID:20600218 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Ccl1 |
C-C motif chemokine ligand 1 |
multiple interactions |
ISO |
alpha-naphthoflavone inhibits the reaction [Benzo(a)pyrene results in increased expression of CCL1] |
CTD |
PMID:16679317 |
|
NCBI chr10:67,128,331...67,131,109
Ensembl chr10:67,128,331...67,131,159
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
decreases expression increases expression multiple interactions |
ISO |
alpha-naphthoflavone results in decreased expression of CCL2 mRNA alpha-naphthoflavone results in increased expression of CCL2 mRNA alpha-naphthoflavone inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of CCL2 mRNA]; alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CCL2 mRNA] |
CTD |
PMID:22262711 |
|
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Ccnb1 |
cyclin B1 |
multiple interactions |
ISO |
alpha-naphthoflavone inhibits the reaction [Plant Extracts results in decreased expression of CCNB1 mRNA] |
CTD |
PMID:25051199 |
|
NCBI chr 2:31,912,190...31,921,163
Ensembl chr 2:31,912,193...31,921,172
|
|
G |
Ccnd1 |
cyclin D1 |
multiple interactions |
ISO |
alpha-naphthoflavone inhibits the reaction [4-hydroxyestradiol results in increased expression of CCND1 mRNA]; alpha-naphthoflavone inhibits the reaction [4-hydroxyestradiol results in increased expression of CCND1 protein] |
CTD |
PMID:31364906 |
|
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
|
|
G |
Cd9 |
CD9 molecule |
multiple interactions |
EXP |
alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in decreased expression of CD9 mRNA] |
CTD |
PMID:29094188 |
|
NCBI chr 4:158,256,328...158,289,136
Ensembl chr 4:158,256,328...158,289,222
|
|
G |
Cdc25c |
cell division cycle 25C |
multiple interactions |
ISO |
alpha-naphthoflavone inhibits the reaction [Plant Extracts results in decreased expression of CDC25C mRNA]; alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased phosphorylation of CDC25C protein] |
CTD |
PMID:22266097 PMID:25051199 |
|
NCBI chr18:26,335,156...26,356,199
Ensembl chr18:26,335,834...26,356,185
|
|
G |
Cdh1 |
cadherin 1 |
multiple interactions |
ISO |
alpha-naphthoflavone inhibits the reaction [4-hydroxyestradiol results in decreased expression of CDH1 mRNA]; alpha-naphthoflavone inhibits the reaction [4-hydroxyestradiol results in decreased expression of CDH1 protein] |
CTD |
PMID:31364906 |
|
NCBI chr19:34,492,371...34,561,775
Ensembl chr19:34,492,371...34,561,775
|
|
G |
Cdh13 |
cadherin 13 |
multiple interactions |
EXP |
AHR protein promotes the reaction [alpha-naphthoflavone results in decreased expression of CDH13 mRNA]; alpha-naphthoflavone inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CDH13 mRNA]; alpha-naphthoflavone inhibits the reaction [Benzo(a)pyrene results in decreased expression of CDH13 mRNA]; alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of CDH13 mRNA] |
CTD |
PMID:12559965 |
|
NCBI chr19:46,349,562...47,387,462
Ensembl chr19:46,349,430...47,387,459
|
|
G |
Cdk1 |
cyclin-dependent kinase 1 |
multiple interactions |
ISO |
alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased phosphorylation of CDK1 protein] |
CTD |
PMID:22266097 |
|
NCBI chr20:19,266,226...19,281,417
Ensembl chr20:19,266,248...19,281,408
|
|
G |
Cdk2 |
cyclin dependent kinase 2 |
multiple interactions decreases methylation |
EXP |
alpha-naphthoflavone inhibits the reaction [Methylcholanthrene promotes the reaction [AHR protein binds to CDK2 promoter]]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in decreased methylation of CDK2 promoter]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased acetylation of CDK2 promoter]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased expression of CDK2 mRNA] alpha-naphthoflavone results in decreased methylation of CDK2 promoter |
CTD |
PMID:29094188 |
|
NCBI chr 7:1,129,878...1,137,431
Ensembl chr 7:1,129,811...1,137,403
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
multiple interactions |
ISO |
alpha-naphthoflavone inhibits the reaction [Benzo(a)pyrene promotes the reaction [eupatorin-5-methyl ether results in increased expression of CDKN1A protein]]; alpha-naphthoflavone inhibits the reaction [Benzo(a)pyrene results in increased expression of CDKN1A mRNA]; alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of CDKN1A protein] |
CTD |
PMID:21887816 PMID:22266097 PMID:23994263 PMID:24361490 |
|
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
multiple interactions |
ISO |
alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of CDKN1B protein]; alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CDKN1B protein] |
CTD |
PMID:15157999 PMID:22266097 |
|
NCBI chr 4:167,760,067...167,765,177
Ensembl chr 4:167,760,181...167,764,982
|
|
G |
Cebpd |
CCAAT/enhancer binding protein delta |
multiple interactions |
ISO |
alpha-naphthoflavone promotes the reaction [Particulate Matter results in increased expression of CEBPD mRNA] |
CTD |
PMID:21652769 |
|
NCBI chr11:84,764,670...84,765,808
Ensembl chr11:84,764,565...84,765,829
|
|
G |
Csf2 |
colony stimulating factor 2 |
multiple interactions |
ISO |
alpha-naphthoflavone inhibits the reaction [Particulate Matter results in increased expression of CSF2 mRNA] |
CTD |
PMID:20801209 |
|
NCBI chr10:38,386,945...38,388,926
Ensembl chr10:38,386,945...38,389,199
|
|
G |
Ctsd |
cathepsin D |
multiple interactions |
ISO |
alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin inhibits the reaction [Estradiol results in increased expression of CTSD mRNA]] |
CTD |
PMID:11165043 |
|
NCBI chr 1:197,527,467...197,539,343
Ensembl chr 1:197,527,467...197,539,488
|
|
G |
Cygb |
cytoglobin |
multiple interactions |
ISO |
alpha-naphthoflavone inhibits the reaction [2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole results in increased expression of CYGB mRNA] |
CTD |
PMID:25781201 |
|
NCBI chr10:101,877,675...101,887,442
Ensembl chr10:101,877,676...101,887,442
|
|
G |
Cyp11b2 |
cytochrome P450, family 11, subfamily b, polypeptide 2 |
multiple interactions increases expression |
ISO |
alpha-naphthoflavone promotes the reaction [CYP11B1 protein results in increased chemical synthesis of Hydrocortisone] alpha-naphthoflavone results in increased expression of CYP11B1 mRNA |
CTD |
PMID:22172629 |
|
NCBI chr 7:106,838,590...106,845,004
Ensembl chr 7:106,838,590...106,845,004
|
|
G |
Cyp17a1 |
cytochrome P450, family 17, subfamily a, polypeptide 1 |
decreases expression |
ISO |
alpha-naphthoflavone results in decreased expression of CYP17A1 mRNA |
CTD |
PMID:24875446 |
|
NCBI chr 1:245,535,462...245,543,148
Ensembl chr 1:245,535,462...245,541,573
|
|
G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
multiple interactions increases expression |
ISO |
[alpha-naphthoflavone results in decreased activity of CYP19A1 protein] which results in decreased susceptibility to o,p'-DDT; alpha-naphthoflavone binds to and results in decreased activity of CYP19A1 protein; alpha-naphthoflavone inhibits the reaction [Aflatoxin B1 results in increased expression of CYP19A1 mRNA]; alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of CYP19A1 protein] alpha-naphthoflavone results in increased expression of CYP19A1 protein |
CTD |
PMID:9435150 PMID:20678559 PMID:20823264 PMID:21296134 |
|
NCBI chr 8:54,552,978...54,580,375
Ensembl chr 8:54,553,165...54,580,758
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
increases activity affects binding increases expression multiple interactions decreases activity |
ISO EXP |
alpha-naphthoflavone results in increased activity of CYP1A1 protein CYP1A1 protein binds to alpha-naphthoflavone alpha-naphthoflavone results in increased expression of CYP1A1 mRNA alpha-naphthoflavone analog results in increased expression of CYP1A1 mRNA; alpha-naphthoflavone results in increased expression of CYP1A1 mRNA; alpha-naphthoflavone results in increased expression of CYP1A1 protein [alpha-naphthoflavone binds to and results in decreased activity of AHR protein] inhibits the reaction [Skatole results in increased expression of CYP1A1 mRNA]; alpha-naphthoflavone inhibits the reaction [2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased expression of CYP1A1 mRNA]; alpha-naphthoflavone inhibits the reaction [2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline results in increased expression of CYP1A1 mRNA]; alpha-naphthoflavone inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased activity of CYP1A1 protein]; alpha-naphthoflavone inhibits the reaction [[3,4,5,3',4'-pentachlorobiphenyl co-treated with Benzo(a)pyrene] results in increased activity of CYP1A1 protein]; alpha-naphthoflavone inhibits the reaction [[AHR protein binds to ARNT protein] which binds to CYP1A1 enhancer]; alpha-naphthoflavone inhibits the reaction [[AHR protein binds to ARNT protein] which results in increased expression of CYP1A1 mRNA]; alpha-naphthoflavone inhibits the reaction [[Benzo(a)pyrene binds to and results in increased activity of AHR protein] which results in increased expression of CYP1A1 mRNA]; alpha-naphthoflavone inhibits the reaction [[benzo(k)fluoranthene binds to and results in increased activity of AHR protein] which results in increased expression of CYP1A1 mRNA]; alpha-naphthoflavone inhibits the reaction [[chrysene binds to and results in increased activity of AHR protein] which results in increased expression of CYP1A1 mRNA]; alpha-naphthoflavone inhibits the reaction [[Tetrachlorodibenzodioxin results in increased activity of CYP1A1 protein] which results in increased metabolism of Benzo(a)pyrene]; alpha-naphthoflavone inhibits the reaction [afimoxifene results in increased expression of CYP1A1 mRNA]; alpha-naphthoflavone inhibits the reaction [Benzo(a)pyrene results in increased activity of CYP1A1 protein]; alpha-naphthoflavone inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1A1 mRNA]; alpha-naphthoflavone inhibits the reaction [beta-Naphthoflavone results in increased expression of CYP1A1 mRNA]; alpha-naphthoflavone inhibits the reaction [Calcitriol promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A1 mRNA]]; alpha-naphthoflavone inhibits the reaction [Carbaryl results in increased expression of CYP1A1 mRNA]; alpha-naphthoflavone inhibits the reaction [Cycloheximide results in increased expression of CYP1A1 mRNA]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased expression of CYP1A1 mRNA]; alpha-naphthoflavone inhibits the reaction [Particulate Matter results in increased expression of CYP1A1 mRNA]; alpha-naphthoflavone inhibits the reaction [Resveratrol results in increased expression of CYP1A1 protein]; alpha-naphthoflavone inhibits the reaction [STO 609 results in increased expression of CYP1A1 mRNA]; alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A1 protein]; alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA]; alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 protein]; alpha-naphthoflavone inhibits the reaction [Vehicle Emissions results in increased expression of CYP1A1 mRNA]; alpha-naphthoflavone promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A1 mRNA] alpha-naphthoflavone results in decreased activity of CYP1A1 protein [alpha-naphthoflavone results in decreased activity of AHR protein] which results in decreased expression of CYP1A1 mRNA; [alpha-naphthoflavone results in decreased activity of CYP1A1 protein] inhibits the reaction [Vinyl Compounds analog results in decreased susceptibility to sodium arsenite]; alpha-naphthoflavone inhibits the reaction [[Tetrachlorodibenzodioxin results in increased activity of AHR protein] which results in increased expression of CYP1A1 mRNA]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased acetylation of CYP1A1 promoter]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased expression of CYP1A1 mRNA]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased methylation of CYP1A1 promoter]; alpha-naphthoflavone inhibits the reaction [norisoboldine results in increased expression of CYP1A1 mRNA]; alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A1 protein]; alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA]; alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 protein]; alpha-naphthoflavone promotes the reaction [beta-Naphthoflavone results in increased expression of CYP1A1 mRNA] [[alpha-naphthoflavone results in decreased activity of CYP1A2 protein] co-treated with [alpha-naphthoflavone results in decreased activity of CYP1A1 protein]] inhibits the reaction [aristolochic acid I results in increased abundance of [7-(deoxyadenosin-N(6)-yl)aristolactam I co-treated with 7-(deoxyguanosin-N(2)-yl)aristolactam I co-treated with 7-(deoxyadenosin-N(6)--yl)aristolactam II]]; [alpha-naphthoflavone binds to and results in decreased activity of AHR protein] results in decreased susceptibility to [SB 203580 results in increased expression of CYP1A1]; alpha-naphthoflavone inhibits the reaction [3,4,3',4'-tetrachlorobiphenyl results in increased expression of CYP1A1 mRNA]; alpha-naphthoflavone inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1A1 mRNA]; alpha-naphthoflavone inhibits the reaction [Particulate Matter results in increased expression of CYP1A1 mRNA]; alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A1 protein]; alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA]; SRC protein affects the reaction [alpha-naphthoflavone results in increased expression of CYP1A1 mRNA]; SU 6656 inhibits the reaction [alpha-naphthoflavone results in increased expression of CYP1A1 mRNA] alpha-naphthoflavone analog results in increased activity of CYP1A1 protein |
CTD |
PMID:1329656 PMID:6477826 PMID:7669069 PMID:8390116 PMID:8637871 PMID:9169082 PMID:10496962 PMID:11339718 PMID:11516172 PMID:11768231 PMID:12051995 PMID:12093619 PMID:12111005 PMID:12799773 PMID:12859983 PMID:14993811 PMID:15075337 PMID:15276085 PMID:15306208 PMID:15385644 PMID:15456928 PMID:15698582 PMID:15766918 PMID:15893423 PMID:16426572 PMID:16906435 PMID:17069994 PMID:17275222 PMID:17872374 PMID:18308446 PMID:18493746 PMID:18755850 PMID:19244278 PMID:19553035 PMID:19828881 PMID:19901195 PMID:20187624 PMID:20801209 PMID:20816883 PMID:20823264 PMID:21053930 PMID:21127131 PMID:21162728 PMID:21621526 PMID:21652769 PMID:21732638 PMID:21932800 PMID:22837390 PMID:22975028 PMID:23099484 PMID:24161567 PMID:24361490 PMID:26221077 PMID:27163632 PMID:27393915 PMID:27966929 PMID:29094188 PMID:29274324 PMID:30508555 More...
|
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
multiple interactions affects binding increases expression increases metabolic processing affects metabolic processing decreases activity |
ISO EXP |
[alpha-naphthoflavone results in decreased activity of CYP1A2 protein] which results in decreased metabolism of Phenacetin; alpha-naphthoflavone binds to and results in decreased activity of CYP1A2 protein; alpha-naphthoflavone inhibits the reaction [2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased expression of CYP1A2 mRNA]; alpha-naphthoflavone inhibits the reaction [2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline results in increased expression of CYP1A2 mRNA]; alpha-naphthoflavone inhibits the reaction [CYP1A2 protein results in increased metabolism of Triazines]; alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] CYP1A2 protein binds to alpha-naphthoflavone alpha-naphthoflavone results in increased expression of CYP1A2 protein [2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline co-treated with alpha-naphthoflavone] results in increased expression of CYP1A2 protein; alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] [[alpha-naphthoflavone results in decreased activity of CYP1A2 protein] co-treated with [alpha-naphthoflavone results in decreased activity of CYP1A1 protein]] inhibits the reaction [aristolochic acid I results in increased abundance of [7-(deoxyadenosin-N(6)-yl)aristolactam I co-treated with 7-(deoxyguanosin-N(2)-yl)aristolactam I co-treated with 7-(deoxyadenosin-N(6)--yl)aristolactam II]]; [alpha-naphthoflavone results in decreased activity of CYP1A2 protein] which results in decreased reduction of and results in decreased oxidation of 9-anthraldehyde CYP1A2 protein results in increased metabolism of alpha-naphthoflavone alpha-naphthoflavone results in increased expression of CYP1A2 mRNA; alpha-naphthoflavone results in increased expression of CYP1A2 protein CYP1A2 protein affects the metabolism of alpha-naphthoflavone |
CTD |
PMID:2180560 PMID:9305587 PMID:15306208 PMID:15766918 PMID:15860655 PMID:17702393 PMID:18493746 PMID:19828881 PMID:20448087 PMID:20816883 PMID:21053930 PMID:21766881 PMID:21932800 PMID:26599973 PMID:27966929 PMID:28887089 PMID:29074051 PMID:33253783 PMID:33438235 More...
|
|
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
|
|
G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
multiple interactions affects binding increases metabolic processing increases expression decreases expression decreases activity |
ISO EXP |
alpha-naphthoflavone binds to and results in decreased activity of CYP1B1 protein; alpha-naphthoflavone inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of CYP1B1 mRNA]; alpha-naphthoflavone inhibits the reaction [6-formylindolo(3,2-b)carbazole results in increased expression of CYP1B1 mRNA]; alpha-naphthoflavone inhibits the reaction [[CYP1B1 protein co-treated with NADP] results in increased metabolism of 2,4,3',5'-tetramethoxystilbene]; alpha-naphthoflavone inhibits the reaction [[CYP1B1 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene] which results in increased expression of TP53 protein modified form]; alpha-naphthoflavone inhibits the reaction [CYP1B1 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene]; alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1B1 mRNA] CYP1B1 protein binds to alpha-naphthoflavone alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased expression of CYP1B1 mRNA] CYP1B1 protein results in increased metabolism of alpha-naphthoflavone alpha-naphthoflavone inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased activity of CYP1B1 protein]; alpha-naphthoflavone inhibits the reaction [AHR protein promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1B1 mRNA]] alpha-naphthoflavone results in increased expression of CYP1B1 mRNA alpha-naphthoflavone results in decreased expression of CYP1B1 mRNA alpha-naphthoflavone results in decreased activity of CYP1B1 protein |
CTD |
PMID:11577022 PMID:15075337 PMID:15280921 PMID:16120791 PMID:19182260 PMID:19563207 PMID:20823264 PMID:21053930 PMID:22262711 PMID:27163632 PMID:27966929 PMID:29146461 PMID:32553695 PMID:35908932 More...
|
|
NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917
|
|
G |
Cyp24a1 |
cytochrome P450, family 24, subfamily a, polypeptide 1 |
multiple interactions |
ISO |
alpha-naphthoflavone inhibits the reaction [Benzo(a)pyrene inhibits the reaction [Calcitriol promotes the reaction [VDR protein binds to CYP24A1 promoter]]]; alpha-naphthoflavone inhibits the reaction [Benzo(a)pyrene promotes the reaction [Calcitriol results in increased expression of CYP24A1 mRNA]]; alpha-naphthoflavone inhibits the reaction [Cycloheximide promotes the reaction [Calcitriol results in increased expression of CYP24A1 mRNA]] |
CTD |
PMID:19244278 |
|
NCBI chr 3:159,275,947...159,290,383
Ensembl chr 3:159,275,947...159,290,383
|
|
G |
Cyp2c11 |
cytochrome P450, subfamily 2, polypeptide 11 |
multiple interactions |
ISO |
alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP2C11 mRNA] |
CTD |
PMID:18467041 |
|
NCBI chr 1:236,762,719...236,799,069
Ensembl chr 1:236,762,842...236,799,066
|
|
G |
Cyp2f4 |
cytochrome P450, family 2, subfamily f, polypeptide 4 |
multiple interactions |
ISO |
[alpha-naphthoflavone binds to and results in decreased activity of AHR protein] inhibits the reaction [Skatole results in increased expression of CYP2F1 mRNA] |
CTD |
PMID:20187624 |
|
NCBI chr 1:82,416,107...82,429,897
Ensembl chr 1:82,416,130...82,429,896
|
|
G |
Cyp2j4 |
cytochrome P450, family 2, subfamily j, polypeptide 4 |
decreases activity |
ISO |
alpha-naphthoflavone results in decreased activity of CYP2J2 protein |
CTD |
PMID:12851038 |
|
NCBI chr 5:111,179,981...111,207,490
Ensembl chr 5:111,178,703...111,244,794
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
decreases activity multiple interactions affects binding increases activity |
ISO |
alpha-naphthoflavone results in decreased activity of CYP3A4 protein [[alpha-naphthoflavone results in increased activity of CYP3A4 protein] which results in increased metabolism of Midazolam] which results in increased chemical synthesis of 1-hydroxymethylmidazolam; [alpha-naphthoflavone results in increased activity of CYP3A4 protein] which results in increased metabolism of Midazolam; alpha-naphthoflavone binds to and results in decreased activity of CYP3A4 protein; alpha-naphthoflavone inhibits the reaction [CYP3A4 protein results in increased hydrolysis of Testosterone]; alpha-naphthoflavone inhibits the reaction [CYP3A4 protein results in increased oxidation of 7-benzyloxy-4-trifluoromethylcoumarin]; alpha-naphthoflavone inhibits the reaction [CYP3A4 protein results in increased oxidation of Methylenebis(chloroaniline)] alpha-naphthoflavone binds to CYP3A4 protein |
CTD |
PMID:1740010 PMID:2271712 PMID:15005856 PMID:17198380 PMID:19299527 PMID:21053930 PMID:31756459 More...
|
|
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
|
|
G |
Dazl |
deleted in azoospermia-like |
multiple interactions |
ISO |
alpha-naphthoflavone inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of DAZL mRNA] |
CTD |
PMID:20562217 |
|
NCBI chr 9:10,695,593...10,712,330
Ensembl chr 9:10,695,592...10,712,323
|
|
G |
Ddit3 |
DNA-damage inducible transcript 3 |
increases expression multiple interactions |
ISO |
alpha-naphthoflavone results in increased expression of DDIT3 protein 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [alpha-naphthoflavone results in increased expression of DDIT3 protein]; 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [alpha-naphthoflavone results in increased expression of DDIT3 protein]; Acetylcysteine inhibits the reaction [alpha-naphthoflavone results in increased expression of DDIT3 protein]; ARNT protein affects the reaction [alpha-naphthoflavone results in increased expression of DDIT3 protein]; pyrazolanthrone inhibits the reaction [alpha-naphthoflavone results in increased expression of DDIT3 protein]; salubrinal inhibits the reaction [alpha-naphthoflavone results in increased expression of DDIT3 protein]; SB 203580 inhibits the reaction [alpha-naphthoflavone results in increased expression of DDIT3 protein]; SRC protein affects the reaction [alpha-naphthoflavone results in increased expression of DDIT3 protein]; SU 6656 inhibits the reaction [alpha-naphthoflavone results in increased expression of DDIT3 protein] |
CTD |
PMID:30508555 |
|
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
|
|
G |
Ddr2 |
discoidin domain receptor tyrosine kinase 2 |
multiple interactions |
EXP |
alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased expression of DDR2 mRNA] |
CTD |
PMID:29094188 |
|
NCBI chr13:82,193,623...82,318,229
Ensembl chr13:82,195,463...82,317,363
|
|
G |
Ddx4 |
DEAD-box helicase 4 |
multiple interactions |
ISO |
alpha-naphthoflavone inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of DDX4 mRNA] |
CTD |
PMID:20562217 |
|
NCBI chr 2:44,227,946...44,282,867
Ensembl chr 2:44,227,946...44,282,723
|
|
G |
Ddx5 |
DEAD-box helicase 5 |
multiple interactions |
EXP |
alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased expression of DDX5 mRNA] |
CTD |
PMID:29094188 |
|
NCBI chr10:91,723,508...91,732,210
Ensembl chr10:91,723,508...91,732,283
|
|
G |
Dll1 |
delta like canonical Notch ligand 1 |
multiple interactions |
EXP |
alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased expression of DLL1 mRNA] |
CTD |
PMID:29094188 |
|
NCBI chr 1:56,312,062...56,320,177
Ensembl chr 1:56,312,066...56,320,179
|
|
G |
Dnajb6 |
DnaJ heat shock protein family (Hsp40) member B6 |
decreases methylation multiple interactions |
EXP |
alpha-naphthoflavone results in decreased methylation of DNAJB6 promoter alpha-naphthoflavone inhibits the reaction [Methylcholanthrene promotes the reaction [AHR protein binds to DNAJB6 promoter]]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased acetylation of DNAJB6 promoter]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased expression of DNAJB6 mRNA]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased methylation of DNAJB6 promoter] |
CTD |
PMID:29094188 |
|
NCBI chr 4:5,452,683...5,556,679
Ensembl chr 4:5,452,683...5,556,659
|
|
G |
Dusp5 |
dual specificity phosphatase 5 |
multiple interactions |
ISO |
alpha-naphthoflavone inhibits the reaction [[Tetrachlorodibenzodioxin co-treated with Oxygen deficiency] results in decreased expression of DUSP5 mRNA]; alpha-naphthoflavone inhibits the reaction [[Tetrachlorodibenzodioxin co-treated with Oxygen deficiency] results in decreased expression of DUSP5 protein] |
CTD |
PMID:19578757 |
|
NCBI chr 1:252,538,408...252,555,320
Ensembl chr 1:252,538,449...252,551,818
|
|
G |
Egfr |
epidermal growth factor receptor |
multiple interactions |
ISO |
alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased phosphorylation of and results in increased activity of EGFR protein] |
CTD |
PMID:17934341 |
|
NCBI chr14:91,176,979...91,349,722
Ensembl chr14:91,177,067...91,344,382
|
|
G |
Egln1 |
egl-9 family hypoxia-inducible factor 1 |
multiple interactions |
ISO |
alpha-naphthoflavone inhibits the reaction [[Tetrachlorodibenzodioxin co-treated with Oxygen deficiency] results in decreased expression of EGLN1 mRNA]; alpha-naphthoflavone inhibits the reaction [[Tetrachlorodibenzodioxin co-treated with Oxygen deficiency] results in decreased expression of EGLN1 protein]; alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of EGLN1 mRNA] |
CTD |
PMID:18072750 |
|
NCBI chr19:52,867,900...52,907,308
Ensembl chr19:52,869,486...52,907,777
|
|
G |
Eif2s1 |
eukaryotic translation initiation factor 2 subunit alpha |
increases phosphorylation |
ISO |
alpha-naphthoflavone results in increased phosphorylation of EIF2S1 protein |
CTD |
PMID:30508555 |
|
NCBI chr 6:97,672,829...97,697,499
Ensembl chr 6:97,672,766...97,706,225
|
|
G |
Eno1 |
enolase 1 |
multiple interactions |
ISO |
alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of ENO1 mRNA] |
CTD |
PMID:23152189 |
|
NCBI chr 5:160,719,951...160,731,337
Ensembl chr 5:160,719,951...160,731,336 Ensembl chr 3:160,719,951...160,731,336
|
|
G |
Enpp2 |
ectonucleotide pyrophosphatase/phosphodiesterase 2 |
multiple interactions |
ISO |
alpha-naphthoflavone inhibits the reaction [Oxygen deficiency inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of ENPP2 mRNA]]; alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of ENPP2 mRNA] |
CTD |
PMID:19028555 |
|
NCBI chr 7:86,202,345...86,325,050
Ensembl chr 7:86,202,350...86,324,827
|
|
G |
Ervfrd-1 |
endogenous retrovirus group FRD member 1, envelope |
multiple interactions |
ISO |
alpha-naphthoflavone inhibits the reaction [Benzo(a)pyrene results in increased expression of ERVFRD-1 mRNA] |
CTD |
PMID:24361490 |
|
NCBI chr12:22,151,211...22,158,264
Ensembl chr12:22,151,211...22,158,264
|
|
G |
Esr1 |
estrogen receptor 1 |
affects binding multiple interactions |
ISO EXP |
[alpha-naphthoflavone binds to AHR protein] which binds to ESR1 protein alpha-naphthoflavone inhibits the reaction [Benzo(a)pyrene inhibits the reaction [Estradiol binds to ESR1 protein]]; alpha-naphthoflavone inhibits the reaction [Hexachlorobenzene results in increased phosphorylation of ESR1 protein]; alpha-naphthoflavone inhibits the reaction [Particulate Matter analog inhibits the reaction [Estradiol binds to ESR1 protein]]; alpha-naphthoflavone inhibits the reaction [Vehicle Emissions analog inhibits the reaction [Estradiol binds to ESR1 protein]] [alpha-naphthoflavone co-treated with beta-Naphthoflavone] results in decreased expression of ESR1 mRNA; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in decreased expression of ESR1 mRNA] |
CTD |
PMID:10620335 PMID:15253042 PMID:22975028 PMID:29094188 PMID:35181438 |
|
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
|
|
G |
Esr2 |
estrogen receptor 2 |
multiple interactions |
EXP |
[alpha-naphthoflavone co-treated with beta-Naphthoflavone] results in decreased expression of ESR2 mRNA |
CTD |
PMID:22975028 |
|
NCBI chr 6:94,858,438...94,909,630
Ensembl chr 6:94,809,547...94,908,919
|
|
G |
Esrra |
estrogen related receptor, alpha |
affects binding |
ISO |
[alpha-naphthoflavone binds to AHR protein] which binds to ESRRA protein |
CTD |
PMID:10620335 |
|
NCBI chr 1:204,104,100...204,114,182
Ensembl chr 1:204,104,101...204,114,268
|
|
G |
Fas |
Fas cell surface death receptor |
multiple interactions |
ISO |
alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of FAS mRNA] |
CTD |
PMID:16940415 |
|
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
|
|
G |
Faslg |
Fas ligand |
multiple interactions |
ISO |
alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of FASL mRNA] |
CTD |
PMID:16940415 |
|
NCBI chr13:74,151,519...74,172,760
Ensembl chr13:74,154,954...74,162,215
|
|
G |
Fgf2 |
fibroblast growth factor 2 |
multiple interactions |
ISO |
alpha-naphthoflavone inhibits the reaction [Benzo(a)pyrene inhibits the reaction [FGF2 protein results in increased phosphorylation of MAPK1 protein]]; alpha-naphthoflavone inhibits the reaction [Benzo(a)pyrene inhibits the reaction [FGF2 protein results in increased phosphorylation of MAPK3 protein]] |
CTD |
PMID:20876236 |
|
NCBI chr 2:120,236,328...120,290,673
Ensembl chr 2:120,236,328...120,291,221
|
|
G |
Flg |
filaggrin |
multiple interactions |
ISO |
[alpha-naphthoflavone binds to and results in decreased activity of AHR protein] inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of FLG mRNA] |
CTD |
PMID:21835898 |
|
NCBI chr 2:178,884,793...178,912,986
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
multiple interactions |
ISO |
alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin inhibits the reaction [Estradiol results in increased expression of FOS mRNA]] |
CTD |
PMID:10478842 |
|
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
|
|
G |
Foxn3 |
forkhead box N3 |
multiple interactions |
EXP |
alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased expression of FOXN3 mRNA] |
CTD |
PMID:29094188 |
|
NCBI chr 6:118,462,018...118,842,442
Ensembl chr 6:118,466,025...118,842,401
|
|
G |
Foxo3 |
forkhead box O3 |
multiple interactions |
ISO EXP |
alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in decreased phosphorylation of FOXO3 protein] [Methylcholanthrene co-treated with alpha-naphthoflavone] results in increased expression of FOXO3 mRNA |
CTD |
PMID:22266097 PMID:29094188 |
|
NCBI chr20:45,669,708...45,764,606
Ensembl chr20:45,672,995...45,764,561
|
|
G |
Foxp3 |
forkhead box P3 |
multiple interactions |
ISO |
alpha-naphthoflavone inhibits the reaction [tetrandrine results in increased expression of FOXP3 mRNA] |
CTD |
PMID:26640276 |
|
NCBI chr X:14,908,494...14,924,994
Ensembl chr X:14,908,494...14,923,838
|
|
G |
Fshr |
follicle stimulating hormone receptor |
multiple interactions |
ISO |
alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of FSHR protein] |
CTD |
PMID:20823264 |
|
NCBI chr 6:5,198,825...5,406,785
Ensembl chr 6:5,198,825...5,406,785
|
|
G |
Gdf9 |
growth differentiation factor 9 |
increases expression multiple interactions |
EXP |
alpha-naphthoflavone results in increased expression of GDF9 mRNA [Methylcholanthrene co-treated with alpha-naphthoflavone] results in increased expression of GDF9 mRNA |
CTD |
PMID:29094188 |
|
NCBI chr10:37,589,200...37,599,970
Ensembl chr10:37,595,679...37,599,672
|
|
G |
Gpi |
glucose-6-phosphate isomerase |
multiple interactions increases expression |
ISO |
alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of GPI mRNA] alpha-naphthoflavone results in increased expression of GPI mRNA |
CTD |
PMID:23152189 |
|
NCBI chr 1:86,828,211...86,856,077
Ensembl chr 1:86,828,216...86,856,086
|
|
G |
Gsr |
glutathione-disulfide reductase |
multiple interactions |
ISO |
alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of GSR mRNA] |
CTD |
PMID:23152189 |
|
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
|
|
G |
Gstp1 |
glutathione S-transferase pi 1 |
decreases expression |
ISO |
alpha-naphthoflavone results in decreased expression of GSTP1 mRNA |
CTD |
PMID:18762178 |
|
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
|
|
G |
Hes1 |
hes family bHLH transcription factor 1 |
multiple interactions |
EXP |
alpha-naphthoflavone inhibits the reaction [Methylcholanthrene promotes the reaction [AHR protein binds to HES1 promoter]]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased expression of HES1 mRNA] |
CTD |
PMID:29094188 |
|
NCBI chr11:70,705,763...70,708,176
Ensembl chr11:70,705,764...70,708,192
|
|
G |
Hk1 |
hexokinase 1 |
multiple interactions increases expression |
ISO |
alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of HK1 mRNA] alpha-naphthoflavone results in increased expression of HK1 mRNA |
CTD |
PMID:23152189 |
|
NCBI chr20:30,230,488...30,332,099
Ensembl chr20:30,230,486...30,332,131
|
|
G |
Hmgcr |
3-hydroxy-3-methylglutaryl-CoA reductase |
multiple interactions |
EXP |
alpha-naphthoflavone inhibits the reaction [Benzo(a)pyrene results in decreased expression of HMGCR mRNA]; alpha-naphthoflavone inhibits the reaction [Benzo(a)pyrene results in decreased expression of HMGCR protein] |
CTD |
PMID:19931295 |
|
NCBI chr 2:27,997,523...28,018,983
Ensembl chr 2:27,997,525...28,019,703
|
|
G |
Hspa8 |
heat shock protein family A (Hsp70) member 8 |
multiple interactions |
EXP |
alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased expression of HSPA8 mRNA] |
CTD |
PMID:29094188 |
|
NCBI chr 8:41,183,397...41,187,260
Ensembl chr 8:41,183,264...41,187,259
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
multiple interactions |
EXP |
alpha-naphthoflavone inhibits the reaction [2,3',4,4',5-pentachlorobiphenyl results in increased expression of ICAM1 mRNA]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene promotes the reaction [AHR protein binds to ICAM1 promoter]]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased acetylation of ICAM1 promoter]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased expression of ICAM1 mRNA] |
CTD |
PMID:26519956 PMID:29094188 |
|
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
|
|
G |
Igf2 |
insulin-like growth factor 2 |
decreases acetylation multiple interactions |
EXP |
alpha-naphthoflavone results in decreased acetylation of IGF2 promoter alpha-naphthoflavone inhibits the reaction [Methylcholanthrene promotes the reaction [AHR protein binds to IGF2 promoter]]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased acetylation of IGF2 promoter]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased expression of IGF2 mRNA]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased methylation of IGF2 promoter] |
CTD |
PMID:29094188 |
|
NCBI chr 1:197,814,409...197,831,802
Ensembl chr 1:197,814,410...197,823,018
|
|
G |
Igfbp4 |
insulin-like growth factor binding protein 4 |
multiple interactions increases expression |
EXP |
AHR gene mutant form inhibits the reaction [alpha-naphthoflavone results in increased expression of IGFBP4 protein] |
CTD |
PMID:23639626 |
|
NCBI chr10:83,995,253...84,007,272
Ensembl chr10:83,989,591...84,007,225
|
|
G |
Il10 |
interleukin 10 |
multiple interactions |
ISO |
alpha-naphthoflavone inhibits the reaction [[Benzo(a)pyrene co-treated with Lipopolysaccharides] affects the expression of IL10 mRNA]; alpha-naphthoflavone inhibits the reaction [[Benzo(a)pyrene co-treated with Lipopolysaccharides] affects the expression of IL10 protein] [alpha-naphthoflavone binds to and results in decreased activity of AHR protein] inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of IL10 protein]; alpha-naphthoflavone inhibits the reaction [tetrandrine results in increased expression of IL10 mRNA] |
CTD |
PMID:11737050 PMID:17681673 PMID:26640276 |
|
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions increases expression decreases expression |
ISO |
alpha-naphthoflavone analog inhibits the reaction [IL1B protein results in increased expression of SAA1 mRNA]; alpha-naphthoflavone inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of IL1B mRNA]; alpha-naphthoflavone inhibits the reaction [Benzo(a)pyrene results in increased expression of IL1B mRNA]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased expression of IL1B mRNA]; alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of IL1B mRNA]; alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of IL1B protein] alpha-naphthoflavone inhibits the reaction [Particulate Matter results in increased expression of IL1B mRNA] alpha-naphthoflavone results in increased expression of IL1B mRNA alpha-naphthoflavone results in decreased expression of IL1B mRNA |
CTD |
PMID:14993811 PMID:15019843 PMID:18617548 PMID:21127131 PMID:22262711 PMID:27393915 More...
|
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il1rn |
interleukin 1 receptor antagonist |
multiple interactions increases expression |
ISO |
alpha-naphthoflavone inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of IL1RN mRNA]; alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of IL1RN mRNA] alpha-naphthoflavone results in increased expression of IL1RN mRNA |
CTD |
PMID:22262711 |
|
NCBI chr 3:7,111,567...7,127,451
Ensembl chr 3:7,111,550...7,127,445
|
|
G |
Il6 |
interleukin 6 |
multiple interactions increases expression |
ISO EXP |
alpha-naphthoflavone inhibits the reaction [Particulate Matter results in increased expression of IL6 mRNA]; alpha-naphthoflavone inhibits the reaction [Vehicle Emissions results in increased expression of IL6 mRNA] alpha-naphthoflavone inhibits the reaction [2,3',4,4',5-pentachlorobiphenyl results in increased expression of IL6 mRNA] alpha-naphthoflavone results in increased expression of IL6 mRNA |
CTD |
PMID:21162728 PMID:26519956 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Itgb8 |
integrin subunit beta 8 |
multiple interactions |
EXP |
alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in decreased expression of ITGB8 mRNA] |
CTD |
PMID:29094188 |
|
NCBI chr 6:140,125,002...140,208,261
Ensembl chr 6:140,127,203...140,208,476
|
|
G |
Jag1 |
jagged canonical Notch ligand 1 |
decreases methylation multiple interactions |
EXP |
alpha-naphthoflavone results in decreased methylation of JAG1 promoter alpha-naphthoflavone inhibits the reaction [Methylcholanthrene promotes the reaction [AHR protein binds to JAG1 promoter]]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased acetylation of JAG1 promoter]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased expression of JAG1 mRNA]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased methylation of JAG1 promoter] |
CTD |
PMID:29094188 |
|
NCBI chr 3:124,406,783...124,442,220
Ensembl chr 3:124,406,794...124,442,209
|
|
G |
Jun |
Jun proto-oncogene, AP-1 transcription factor subunit |
multiple interactions increases expression |
ISO EXP |
alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased phosphorylation of JUN protein] alpha-naphthoflavone results in increased expression of JUN mRNA |
CTD |
PMID:15019843 PMID:15897893 |
|
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
|
|
G |
Klk1c10 |
kallikrein 1-related peptidase C10 |
multiple interactions |
ISO |
alpha-naphthoflavone inhibits the reaction [Benzo(a)pyrene inhibits the reaction [Dihydrotestosterone results in increased expression of KLK3 mRNA]]; alpha-naphthoflavone inhibits the reaction [Benzo(a)pyrene inhibits the reaction [Dihydrotestosterone results in increased expression of KLK3 protein]]; alpha-naphthoflavone inhibits the reaction [benzo(k)fluoranthene inhibits the reaction [Dihydrotestosterone results in increased expression of KLK3 mRNA]]; alpha-naphthoflavone inhibits the reaction [benzo(k)fluoranthene inhibits the reaction [Dihydrotestosterone results in increased expression of KLK3 protein]]; alpha-naphthoflavone inhibits the reaction [chrysene inhibits the reaction [Dihydrotestosterone results in increased expression of KLK3 mRNA]]; alpha-naphthoflavone inhibits the reaction [chrysene inhibits the reaction [Dihydrotestosterone results in increased expression of KLK3 protein]] |
CTD |
PMID:12799773 |
|
NCBI chr 1:94,402,993...94,407,052
Ensembl chr 1:94,402,993...94,407,052
|
|
G |
Krt14 |
keratin 14 |
multiple interactions |
ISO |
alpha-naphthoflavone inhibits the reaction [Plant Extracts results in decreased expression of KRT14 mRNA] |
CTD |
PMID:25051199 |
|
NCBI chr10:85,137,786...85,142,054
Ensembl chr10:85,066,802...85,171,799
|
|
G |
Ldha |
lactate dehydrogenase A |
multiple interactions increases expression |
ISO |
alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of LDHA mRNA] alpha-naphthoflavone results in increased expression of LDHA mRNA |
CTD |
PMID:23152189 |
|
NCBI chr 1:97,371,823...97,381,247
Ensembl chr 1:97,366,021...97,433,472
|
|
G |
Lhcgr |
luteinizing hormone/choriogonadotropin receptor |
multiple interactions |
ISO |
alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of LHCGR protein] |
CTD |
PMID:20823264 |
|
NCBI chr 6:5,661,871...5,728,109
Ensembl chr 6:5,661,871...5,724,521
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
multiple interactions increases phosphorylation |
ISO |
[alpha-naphthoflavone binds to and results in decreased activity of AHR protein] inhibits the reaction [Hexachlorobenzene results in increased phosphorylation of and results in increased activity of MAPK1 protein]; alpha-naphthoflavone inhibits the reaction [[Tetrachlorodibenzodioxin co-treated with Oxygen deficiency] results in increased phosphorylation of MAPK1 protein]; alpha-naphthoflavone inhibits the reaction [Benzo(a)pyrene inhibits the reaction [FGF2 protein results in increased phosphorylation of MAPK1 protein]]; alpha-naphthoflavone inhibits the reaction [Hexachlorobenzene results in increased phosphorylation of MAPK1 protein] alpha-naphthoflavone results in increased phosphorylation of MAPK1 protein SU 6656 inhibits the reaction [alpha-naphthoflavone results in increased phosphorylation of MAPK1 protein] |
CTD |
PMID:19578757 PMID:20876236 PMID:21205633 PMID:26358519 PMID:30508555 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
multiple interactions increases phosphorylation |
ISO |
[alpha-naphthoflavone binds to and results in decreased activity of AHR protein] inhibits the reaction [Hexachlorobenzene results in increased phosphorylation of and results in increased activity of MAPK3 protein]; alpha-naphthoflavone inhibits the reaction [[Tetrachlorodibenzodioxin co-treated with Oxygen deficiency] results in increased phosphorylation of MAPK3 protein]; alpha-naphthoflavone inhibits the reaction [Benzo(a)pyrene inhibits the reaction [FGF2 protein results in increased phosphorylation of MAPK3 protein]]; alpha-naphthoflavone inhibits the reaction [Hexachlorobenzene results in increased phosphorylation of MAPK3 protein] SU 6656 inhibits the reaction [alpha-naphthoflavone results in increased phosphorylation of MAPK3 protein] |
CTD |
PMID:19578757 PMID:20876236 PMID:21205633 PMID:26358519 PMID:30508555 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mdm2 |
MDM2 proto-oncogene |
multiple interactions |
ISO |
alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [Oxygen deficiency results in increased expression of MDM2 mRNA]]; alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of MDM2 mRNA] |
CTD |
PMID:19578757 |
|
NCBI chr 7:53,290,660...53,315,205
Ensembl chr 7:53,290,664...53,314,915
|
|
G |
Mmp1 |
matrix metallopeptidase 1 |
multiple interactions |
EXP ISO |
alpha-naphthoflavone inhibits the reaction [Benzo(a)pyrene results in increased expression of MMP1 mRNA] alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of MMP1 mRNA]; alpha-naphthoflavone inhibits the reaction [Tretinoin promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of MMP1 mRNA]] |
CTD |
PMID:15075337 PMID:19022365 |
|
NCBI chr 8:4,658,588...4,679,099
Ensembl chr 8:4,658,588...4,679,097
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
multiple interactions |
EXP ISO |
alpha-naphthoflavone inhibits the reaction [Benzo(a)pyrene results in increased expression of MMP2 mRNA] alpha-naphthoflavone inhibits the reaction [4-hydroxyestradiol results in increased expression of MMP2 mRNA]; alpha-naphthoflavone inhibits the reaction [4-hydroxyestradiol results in increased expression of MMP2 protein] |
CTD |
PMID:19022365 PMID:31364906 |
|
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
|
|
G |
Mmp3 |
matrix metallopeptidase 3 |
multiple interactions |
EXP |
alpha-naphthoflavone inhibits the reaction [Benzo(a)pyrene results in increased expression of MMP3 mRNA] |
CTD |
PMID:19022365 |
|
NCBI chr 8:4,640,397...4,653,963
Ensembl chr 8:4,640,416...4,653,961
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
multiple interactions |
EXP ISO |
alpha-naphthoflavone inhibits the reaction [Benzo(a)pyrene results in increased expression of MMP9 mRNA] alpha-naphthoflavone inhibits the reaction [4-hydroxyestradiol results in increased expression of MMP9 mRNA]; alpha-naphthoflavone inhibits the reaction [4-hydroxyestradiol results in increased expression of MMP9 protein]; alpha-naphthoflavone inhibits the reaction [Hexachlorobenzene results in increased secretion of and results in increased activity of MMP9 protein] |
CTD |
PMID:19022365 PMID:23462309 PMID:31364906 |
|
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
|
|
G |
Mt1 |
metallothionein 1 |
increases expression |
ISO |
alpha-naphthoflavone results in increased expression of MT1 mRNA |
CTD |
PMID:14998373 |
|
NCBI chr19:10,826,032...10,827,048
Ensembl chr19:10,826,032...10,827,049 Ensembl chr17:10,826,032...10,827,049 Ensembl chr X:10,826,032...10,827,049
|
|
G |
Mtor |
mechanistic target of rapamycin kinase |
multiple interactions |
ISO |
alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in decreased phosphorylation of MTOR protein] |
CTD |
PMID:22266097 |
|
NCBI chr 5:158,884,856...158,994,311
Ensembl chr 5:158,884,804...158,994,311
|
|
G |
Myc |
MYC proto-oncogene, bHLH transcription factor |
multiple interactions |
EXP ISO |
alpha-naphthoflavone inhibits the reaction [Benzo(a)pyrene results in decreased expression of MYC protein] alpha-naphthoflavone inhibits the reaction [4-hydroxyestradiol results in increased expression of MYC mRNA]; alpha-naphthoflavone inhibits the reaction [4-hydroxyestradiol results in increased expression of MYC protein] |
CTD |
PMID:22100782 PMID:31364906 |
|
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
|
|
G |
Myog |
myogenin |
multiple interactions |
ISO |
alpha-naphthoflavone inhibits the reaction [Benzo(a)pyrene results in decreased expression of MYOG protein] |
CTD |
PMID:24431215 |
|
NCBI chr13:45,745,455...45,748,044
Ensembl chr13:45,745,436...45,748,039
|
|
G |
Ncf1 |
neutrophil cytosolic factor 1 |
multiple interactions |
ISO |
alpha-naphthoflavone inhibits the reaction [Benzo(a)pyrene results in increased expression of NCF1 mRNA] |
CTD |
PMID:19559082 |
|
NCBI chr12:22,485,382...22,494,647
Ensembl chr12:22,485,451...22,494,646
|
|
G |
Ndufs1 |
NADH:ubiquinone oxidoreductase core subunit S1 |
multiple interactions |
ISO |
alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of NDUFS1 mRNA] |
CTD |
PMID:23152189 |
|
NCBI chr 9:64,546,430...64,579,751
Ensembl chr 9:64,546,225...64,579,893
|
|
G |
Ndufs3 |
NADH:ubiquinone oxidoreductase core subunit S3 |
multiple interactions |
ISO |
alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of NDUFS3 mRNA] |
CTD |
PMID:23152189 |
|
NCBI chr 3:76,876,646...76,883,824
Ensembl chr 3:76,876,646...76,883,824
|
|
G |
Nfatc1 |
nuclear factor of activated T-cells 1 |
multiple interactions |
ISO |
alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin affects the localization of NFATC1 protein] |
CTD |
PMID:19028555 |
|
NCBI chr18:74,046,422...74,156,041
Ensembl chr18:74,046,904...74,156,028
|
|
G |
Nos2 |
nitric oxide synthase 2 |
multiple interactions increases expression |
EXP ISO |
alpha-naphthoflavone inhibits the reaction [Benzo(a)pyrene results in increased expression of NOS2 protein] alpha-naphthoflavone results in increased expression of NOS2 protein |
CTD |
PMID:26086121 PMID:33722737 |
|
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
|
|
G |
Notch2 |
notch receptor 2 |
decreases acetylation increases methylation multiple interactions |
EXP |
alpha-naphthoflavone results in decreased acetylation of NOTCH2 promoter alpha-naphthoflavone results in increased methylation of NOTCH2 promoter alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in decreased acetylation of NOTCH2 promoter]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased expression of NOTCH2 mRNA]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased methylation of NOTCH2 promoter] |
CTD |
PMID:29094188 |
|
NCBI chr 2:185,610,594...185,744,088
Ensembl chr 2:185,610,589...185,744,088
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
increases activity increases expression |
EXP |
alpha-naphthoflavone results in increased activity of NQO1 protein alpha-naphthoflavone results in increased expression of NQO1 mRNA |
CTD |
PMID:16906435 PMID:17069994 |
|
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
|
|
G |
Nr1i3 |
nuclear receptor subfamily 1, group I, member 3 |
increases activity |
EXP |
alpha-naphthoflavone results in increased activity of NR1I3 protein |
CTD |
PMID:27732639 |
|
NCBI chr13:83,632,940...83,638,193
Ensembl chr13:83,632,899...83,637,906
|
|
G |
Nr2f1 |
nuclear receptor subfamily 2, group F, member 1 |
affects binding |
ISO |
[alpha-naphthoflavone binds to AHR protein] which binds to NR2F1 protein |
CTD |
PMID:10620335 |
|
NCBI chr 2:8,040,375...8,050,123
Ensembl chr 2:8,040,377...8,050,123
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
increases cleavage |
ISO |
alpha-naphthoflavone results in increased cleavage of PARP1 protein |
CTD |
PMID:30508555 |
|
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
|
|
G |
Pfkm |
phosphofructokinase, muscle |
multiple interactions increases expression |
ISO |
alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of PFKM mRNA] alpha-naphthoflavone results in increased expression of PFKM mRNA |
CTD |
PMID:23152189 |
|
NCBI chr 7:129,221,679...129,259,192
Ensembl chr 7:129,221,653...129,259,192
|
|
G |
Pgk1 |
phosphoglycerate kinase 1 |
multiple interactions increases expression |
ISO |
alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of PGK1 mRNA] alpha-naphthoflavone results in increased expression of PGK1 mRNA |
CTD |
PMID:23152189 |
|
NCBI chr X:71,271,454...71,287,429
Ensembl chr X:71,271,440...71,287,418
|
|
G |
Pgm1 |
phosphoglucomutase 1 |
increases expression multiple interactions |
ISO |
alpha-naphthoflavone results in increased expression of PGM1 mRNA alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of PGM1 mRNA] |
CTD |
PMID:23152189 |
|
NCBI chr 5:114,595,298...114,654,728
Ensembl chr 5:114,595,293...114,654,728
|
|
G |
Pgr |
progesterone receptor |
increases expression |
ISO |
alpha-naphthoflavone results in increased expression of PGR protein |
CTD |
PMID:22266097 |
|
NCBI chr 8:6,072,673...6,131,552
Ensembl chr 8:6,072,673...6,131,344
|
|
G |
Pkm |
pyruvate kinase M1/2 |
multiple interactions |
ISO |
alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of PKM mRNA] |
CTD |
PMID:23152189 |
|
NCBI chr 8:60,057,629...60,079,600
Ensembl chr 8:60,057,402...60,079,599
|
|
G |
Ppara |
peroxisome proliferator activated receptor alpha |
multiple interactions |
ISO |
alpha-naphthoflavone inhibits the reaction [beta-Naphthoflavone results in increased expression of PPARA protein] |
CTD |
PMID:21849270 |
|
NCBI chr 7:116,832,405...116,900,878
Ensembl chr 7:116,832,756...116,895,346
|
|
G |
Prdm1 |
PR/SET domain 1 |
multiple interactions |
ISO |
alpha-naphthoflavone inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of PRDM1 mRNA] |
CTD |
PMID:20562217 |
|
NCBI chr20:47,959,858...47,981,488
Ensembl chr20:47,959,858...47,981,488
|
|
G |
Prkcb |
protein kinase C, beta |
multiple interactions |
EXP |
alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin affects the localization of PRKCB protein]; alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased localization of PRKCB protein] |
CTD |
PMID:16797713 PMID:17222441 |
|
NCBI chr 1:176,832,173...177,163,539
Ensembl chr 1:176,832,226...177,163,536
|
|
G |
Prl |
prolactin |
multiple interactions |
EXP |
alpha-naphthoflavone promotes the reaction [beta-Naphthoflavone results in decreased expression of PRL mRNA] |
CTD |
PMID:22975028 |
|
NCBI chr17:37,859,999...37,870,062
Ensembl chr17:37,860,007...37,870,062
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
decreases expression multiple interactions increases expression |
ISO |
alpha-naphthoflavone results in decreased expression of PTGS2 mRNA alpha-naphthoflavone inhibits the reaction [Particulate Matter results in increased expression of PTGS2 mRNA] alpha-naphthoflavone inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of PTGS2 mRNA]; alpha-naphthoflavone inhibits the reaction [Chlorpyrifos results in increased expression of PTGS2 protein]; alpha-naphthoflavone inhibits the reaction [Hexachlorobenzene results in increased expression of PTGS2 protein]; alpha-naphthoflavone inhibits the reaction [Particulate Matter results in increased expression of PTGS2 mRNA]; alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA]; alpha-naphthoflavone inhibits the reaction [Vehicle Emissions results in increased expression of PTGS2 mRNA]; alpha-naphthoflavone promotes the reaction [Particulate Matter results in increased expression of PTGS2 mRNA] alpha-naphthoflavone results in increased expression of PTGS2 mRNA |
CTD |
PMID:21162728 PMID:21652769 PMID:22262711 PMID:26358519 PMID:27393915 PMID:32526215 More...
|
|
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Ptk2 |
protein tyrosine kinase 2 |
multiple interactions |
ISO |
alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in decreased phosphorylation of PTK2 protein] |
CTD |
PMID:16359657 |
|
NCBI chr 7:105,126,725...105,331,848
Ensembl chr 7:105,126,728...105,331,783
|
|
G |
Rack1 |
receptor for activated C kinase 1 |
multiple interactions |
EXP |
alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of RACK1 protein] |
CTD |
PMID:16797713 PMID:17222441 |
|
NCBI chr10:33,169,415...33,174,896
Ensembl chr10:33,169,169...33,174,975
|
|
G |
Rb1 |
RB transcriptional corepressor 1 |
multiple interactions |
ISO |
alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in decreased phosphorylation of RB1 protein] |
CTD |
PMID:15157999 |
|
NCBI chr15:48,371,295...48,502,473
Ensembl chr15:48,371,296...48,502,302
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
multiple interactions decreases expression |
ISO |
alpha-naphthoflavone inhibits the reaction [7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased phosphorylation of RELA protein]; alpha-naphthoflavone inhibits the reaction [Benzo(a)pyrene results in increased phosphorylation of RELA protein] alpha-naphthoflavone results in decreased expression of RELA protein |
CTD |
PMID:24431215 PMID:33722737 |
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Serpinb2 |
serpin family B member 2 |
multiple interactions decreases expression increases expression |
ISO |
alpha-naphthoflavone inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of SERPINB2 mRNA]; alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of SERPINB2 mRNA]; alpha-naphthoflavone inhibits the reaction [Tretinoin promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of SERPINB2 mRNA]] alpha-naphthoflavone results in decreased expression of SERPINB2 mRNA alpha-naphthoflavone results in increased expression of SERPINB2 mRNA |
CTD |
PMID:15075337 PMID:22262711 |
|
NCBI chr13:23,537,312...23,551,823
Ensembl chr13:23,541,400...23,550,408
|
|
G |
Slc2a1 |
solute carrier family 2 member 1 |
multiple interactions increases expression |
ISO |
alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of SLC2A1 mRNA] alpha-naphthoflavone results in increased expression of SLC2A1 mRNA |
CTD |
PMID:23152189 |
|
NCBI chr 5:132,717,196...132,745,416
Ensembl chr 5:132,717,196...132,745,416
|
|
G |
Slc5a5 |
solute carrier family 5 member 5 |
multiple interactions |
EXP |
alpha-naphthoflavone inhibits the reaction [2,3',4,4',5-pentachlorobiphenyl results in decreased expression of SLC5A5 protein] |
CTD |
PMID:26519956 |
|
NCBI chr16:18,546,709...18,556,698
Ensembl chr16:18,546,709...18,556,697
|
|
G |
Smad3 |
SMAD family member 3 |
multiple interactions |
ISO |
alpha-naphthoflavone inhibits the reaction [Hexachlorobenzene results in increased phosphorylation of SMAD3 protein] |
CTD |
PMID:27519288 |
|
NCBI chr 8:64,126,829...64,236,960
Ensembl chr 8:64,110,039...64,236,960
|
|
G |
Sp1 |
Sp1 transcription factor |
multiple interactions |
EXP |
alpha-naphthoflavone inhibits the reaction [Methylcholanthrene promotes the reaction [AHR protein binds to SP1 promoter]]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased acetylation of SP1 promoter]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased expression of SP1 mRNA] |
CTD |
PMID:29094188 |
|
NCBI chr 7:133,541,302...133,571,961
Ensembl chr 7:133,541,491...133,571,961
|
|
G |
Src |
SRC proto-oncogene, non-receptor tyrosine kinase |
multiple interactions increases phosphorylation |
ISO |
SRC protein affects the reaction [alpha-naphthoflavone results in increased expression of CYP1A1 mRNA]; SRC protein affects the reaction [alpha-naphthoflavone results in increased expression of DDIT3 protein] alpha-naphthoflavone results in increased phosphorylation of SRC protein |
CTD |
PMID:30508555 |
|
NCBI chr 3:146,091,969...146,139,492
Ensembl chr 3:146,091,841...146,139,476
|
|
G |
Stat5b |
signal transducer and activator of transcription 5B |
multiple interactions |
ISO |
[alpha-naphthoflavone binds to and results in decreased activity of AHR protein] inhibits the reaction [Hexachlorobenzene results in increased phosphorylation of and results in increased activity of STAT5B protein] |
CTD |
PMID:21205633 |
|
NCBI chr10:85,704,841...85,775,856
Ensembl chr10:85,705,670...85,775,668
|
|
G |
Tcf7 |
transcription factor 7 |
increases expression |
ISO |
alpha-naphthoflavone results in increased expression of TCF7 mRNA |
CTD |
PMID:18762178 |
|
NCBI chr10:36,423,443...36,454,350
Ensembl chr10:36,423,445...36,453,535
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
multiple interactions |
EXP ISO |
alpha-naphthoflavone promotes the reaction [beta-Naphthoflavone results in decreased expression of TGFB1 mRNA] alpha-naphthoflavone inhibits the reaction [Hexachlorobenzene results in increased expression of TGFB1 mRNA] |
CTD |
PMID:22975028 PMID:27519288 |
|
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
|
|
G |
Tiparp |
TCDD-inducible poly(ADP-ribose) polymerase |
decreases expression multiple interactions |
ISO |
alpha-naphthoflavone results in decreased expression of TIPARP mRNA alpha-naphthoflavone promotes the reaction [Particulate Matter results in increased expression of TIPARP mRNA] |
CTD |
PMID:18762178 PMID:21652769 |
|
NCBI chr 2:149,753,682...149,780,327
Ensembl chr 2:149,753,682...149,780,327
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions |
ISO |
alpha-naphthoflavone inhibits the reaction [3,4,3',4'-tetrachlorobiphenyl results in increased expression of TNF mRNA] alpha-naphthoflavone inhibits the reaction [Particulate Matter results in increased expression of TNF mRNA]; alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of TNF mRNA]; alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased secretion of TNF protein] |
CTD |
PMID:17934341 PMID:20801209 PMID:23099484 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tnfrsf1a |
TNF receptor superfamily member 1A |
multiple interactions |
ISO |
alpha-naphthoflavone inhibits the reaction [hydroquinone results in increased expression of TNFRSF1A protein] |
CTD |
PMID:34200499 |
|
NCBI chr 4:158,150,815...158,163,592
Ensembl chr 4:158,150,820...158,163,591
|
|
G |
Tnfrsf1b |
TNF receptor superfamily member 1B |
multiple interactions |
ISO |
alpha-naphthoflavone inhibits the reaction [hydroquinone results in increased expression of TNFRSF1B protein] |
CTD |
PMID:34200499 |
|
NCBI chr 5:157,070,642...157,104,216
Ensembl chr 5:157,070,642...157,104,206
|
|
G |
Tnfsf11 |
TNF superfamily member 11 |
multiple interactions |
ISO |
alpha-naphthoflavone inhibits the reaction [norisoboldine inhibits the reaction [TNFSF11 protein results in increased expression of VEGFA mRNA]] |
CTD |
PMID:26221077 |
|
NCBI chr15:53,673,850...53,705,325
Ensembl chr15:53,673,877...53,705,445
|
|
G |
Tp53 |
tumor protein p53 |
multiple interactions increases expression |
EXP ISO |
alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin inhibits the reaction [leptomycin B results in increased expression of TP53 protein]] alpha-naphthoflavone inhibits the reaction [[CYP1B1 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene] which results in increased expression of TP53 protein modified form] alpha-naphthoflavone results in increased expression of TP53 protein alpha-naphthoflavone inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased phosphorylation of TRP53 protein]; alpha-naphthoflavone inhibits the reaction [Benzo(a)pyrene affects the localization of TRP53 protein] |
CTD |
PMID:9006915 PMID:15459018 PMID:29274324 PMID:32553695 PMID:35908932 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Tpi1 |
triosephosphate isomerase 1 |
increases expression multiple interactions |
ISO |
alpha-naphthoflavone results in increased expression of TPI1 mRNA alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of TPI1 mRNA] |
CTD |
PMID:23152189 |
|
NCBI chr 4:157,615,283...157,618,813
Ensembl chr 4:157,615,386...157,619,541
|
|
G |
Vdr |
vitamin D receptor |
multiple interactions |
ISO |
alpha-naphthoflavone inhibits the reaction [Benzo(a)pyrene inhibits the reaction [Calcitriol promotes the reaction [VDR protein binds to CYP24A1 promoter]]] |
CTD |
PMID:19244278 |
|
NCBI chr 7:128,987,981...129,037,677
Ensembl chr 7:128,987,981...129,037,677
|
|
G |
Vegfa |
vascular endothelial growth factor A |
multiple interactions |
ISO EXP |
alpha-naphthoflavone affects the reaction [Hexachlorobenzene results in increased expression of VEGFA protein]; alpha-naphthoflavone inhibits the reaction [Hexachlorobenzene results in increased secretion of VEGFA protein]; alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of VEGFA protein]; alpha-naphthoflavone promotes the reaction [Chlorpyrifos results in increased expression of VEGFA protein] alpha-naphthoflavone inhibits the reaction [norisoboldine results in decreased expression of VEGFA mRNA] alpha-naphthoflavone inhibits the reaction [norisoboldine inhibits the reaction [TNFSF11 protein results in increased expression of VEGFA mRNA]] |
CTD |
PMID:19182260 PMID:26221077 PMID:26358519 PMID:32526215 |
|
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
|
|
G |
Vim |
vimentin |
multiple interactions |
ISO |
alpha-naphthoflavone inhibits the reaction [4-hydroxyestradiol results in increased expression of VIM mRNA]; alpha-naphthoflavone inhibits the reaction [4-hydroxyestradiol results in increased expression of VIM protein] |
CTD |
PMID:31364906 |
|
NCBI chr17:76,668,701...76,677,186
Ensembl chr17:76,668,647...76,677,187
|
|
G |
Wapl |
WAPL cohesin release factor |
multiple interactions |
ISO |
alpha-naphthoflavone promotes the reaction [3-methylcholanthrylene results in increased expression of WAPL mRNA] |
CTD |
PMID:15797623 |
|
NCBI chr16:10,005,520...10,075,270
Ensembl chr16:10,004,941...10,073,510
|
|
|
G |
Abca1 |
ATP binding cassette subfamily A member 1 |
multiple interactions |
ISO |
amentoflavone inhibits the reaction [malondialdehyde-low density lipoprotein, human results in decreased expression of ABCA1 protein] |
CTD |
PMID:34599948 |
|
NCBI chr 5:67,678,267...67,801,162
Ensembl chr 5:67,681,297...67,801,170
|
|
G |
Aif1 |
allograft inflammatory factor 1 |
multiple interactions |
ISO |
amentoflavone inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of AIF1 protein] |
CTD |
PMID:28185818 |
|
NCBI chr20:3,646,784...3,652,670
Ensembl chr20:3,646,777...3,652,668
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
multiple interactions |
ISO |
amentoflavone inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of BAX protein] |
CTD |
PMID:28185818 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
multiple interactions |
ISO |
amentoflavone inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of BCL2 protein] 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [amentoflavone inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of BCL2 protein]]; amentoflavone inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of BCL2 protein] |
CTD |
PMID:28185818 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Casp3 |
caspase 3 |
multiple interactions |
ISO |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [amentoflavone inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of CASP3 protein modified form]]; amentoflavone inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of CASP3 protein modified form] |
CTD |
PMID:28185818 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Cd36 |
CD36 molecule |
multiple interactions |
ISO |
amentoflavone inhibits the reaction [malondialdehyde-low density lipoprotein, human results in increased expression of CD36 mRNA]; amentoflavone inhibits the reaction [malondialdehyde-low density lipoprotein, human results in increased expression of CD36 protein]; CD36 protein inhibits the reaction [amentoflavone inhibits the reaction [malondialdehyde-low density lipoprotein, human results in increased expression of PPARG protein]] |
CTD |
PMID:34599948 |
|
NCBI chr 4:17,317,343...17,410,084
Ensembl chr 4:17,354,466...17,513,903
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
multiple interactions |
ISO |
amentoflavone inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of CDKN1A protein] |
CTD |
PMID:28185818 |
|
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
decreases activity |
ISO |
amentoflavone results in decreased activity of CYP1B1 protein |
CTD |
PMID:16271822 |
|
NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917
|
|
G |
Dct |
dopachrome tautomerase |
decreases expression |
ISO |
amentoflavone analog results in decreased expression of DCT mRNA; amentoflavone analog results in decreased expression of DCT protein |
CTD |
PMID:17473463 |
|
NCBI chr15:95,062,006...95,100,863
Ensembl chr15:95,062,003...95,100,836
|
|
G |
Gfap |
glial fibrillary acidic protein |
multiple interactions |
ISO |
amentoflavone inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of GFAP protein] |
CTD |
PMID:28185818 |
|
NCBI chr10:87,852,891...87,861,631
Ensembl chr10:87,852,890...87,861,589
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions |
ISO |
amentoflavone inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of IL1B protein] |
CTD |
PMID:28185818 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
multiple interactions |
ISO |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [amentoflavone inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased phosphorylation of MAPK1 protein]]; amentoflavone inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased phosphorylation of MAPK1 protein] |
CTD |
PMID:28185818 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
multiple interactions |
ISO |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [amentoflavone inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased phosphorylation of MAPK3 protein]]; amentoflavone inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased phosphorylation of MAPK3 protein] |
CTD |
PMID:28185818 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Nos2 |
nitric oxide synthase 2 |
decreases expression multiple interactions |
ISO |
amentoflavone results in decreased expression of NOS2 protein amentoflavone inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of NOS2 protein] |
CTD |
PMID:12144868 PMID:28185818 |
|
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
|
|
G |
Pparg |
peroxisome proliferator-activated receptor gamma |
multiple interactions |
ISO |
amentoflavone inhibits the reaction [malondialdehyde-low density lipoprotein, human results in increased expression of PPARG protein]; CD36 protein inhibits the reaction [amentoflavone inhibits the reaction [malondialdehyde-low density lipoprotein, human results in increased expression of PPARG protein]] |
CTD |
PMID:34599948 |
|
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
|
|
G |
Ptgds |
prostaglandin D2 synthase |
affects binding |
ISO |
amentoflavone binds to PTGDS protein |
CTD |
PMID:26456343 |
|
NCBI chr 3:8,281,899...8,284,833
Ensembl chr 3:8,281,899...8,284,833
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
decreases expression multiple interactions |
ISO |
amentoflavone results in decreased expression of PTGS2 mRNA; amentoflavone results in decreased expression of PTGS2 protein [amentoflavone results in decreased expression of PTGS2 protein] which results in decreased chemical synthesis of Dinoprostone |
CTD |
PMID:12144868 |
|
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Srebf1 |
sterol regulatory element binding transcription factor 1 |
decreases expression |
ISO |
amentoflavone results in decreased expression of SREBF1 mRNA |
CTD |
PMID:34599948 |
|
NCBI chr10:45,007,637...45,029,650
Ensembl chr10:45,007,637...45,029,650
|
|
G |
Th |
tyrosine hydroxylase |
multiple interactions |
ISO |
amentoflavone inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of TH mRNA]; amentoflavone inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of TH protein] |
CTD |
PMID:28185818 |
|
NCBI chr 1:198,071,500...198,078,832
Ensembl chr 1:198,071,503...198,109,767
|
|
G |
Tyr |
tyrosinase |
decreases activity |
ISO |
amentoflavone analog results in decreased activity of TYR protein |
CTD |
PMID:17473463 |
|
NCBI chr 1:141,115,036...141,210,207
Ensembl chr 1:141,115,036...141,210,207
|
|
G |
Ugt1a1 |
UDP glucuronosyltransferase family 1 member A1 |
decreases activity |
ISO |
amentoflavone results in decreased activity of UGT1A1 protein |
CTD |
PMID:29470958 |
|
NCBI chr 9:88,801,344...88,808,465
Ensembl chr 9:88,713,184...88,808,465
|
|
G |
Ugt1a2 |
UDP glucuronosyltransferase 1 family, polypeptide A2 |
decreases activity |
ISO |
amentoflavone results in decreased activity of UGT1A3 protein |
CTD |
PMID:29470958 |
|
NCBI chr 9:88,791,216...88,808,465
Ensembl chr 9:88,713,184...88,808,465
|
|
G |
Ugt1a5 |
UDP glucuronosyltransferase family 1 member A5 |
decreases activity |
ISO |
amentoflavone results in decreased activity of UGT1A4 protein |
CTD |
PMID:29470958 |
|
NCBI chr 9:88,762,250...88,808,465
Ensembl chr 9:88,713,184...88,808,465
|
|
G |
Ugt1a6 |
UDP glucuronosyltransferase family 1 member A6 |
decreases activity multiple interactions |
ISO |
amentoflavone results in decreased activity of UGT1A6 protein amentoflavone inhibits the reaction [UGT1A6 protein results in increased glucuronidation of 4-cresol] |
CTD |
PMID:29470958 PMID:32421801 |
|
NCBI chr 9:88,747,213...88,808,465
Ensembl chr 9:88,713,184...88,808,465
|
|
G |
Ugt1a9 |
UDP glucuronosyltransferase family 1 member A9 |
decreases activity |
ISO |
amentoflavone results in decreased activity of UGT1A9 protein |
CTD |
PMID:29470958 |
|
NCBI chr 9:88,696,981...88,808,465
Ensembl chr 9:88,713,184...88,808,465
|
|
G |
Ugt2b1 |
UDP glucuronosyltransferase 2 family, polypeptide B1 |
decreases activity |
ISO |
amentoflavone results in decreased activity of UGT2B17 protein |
CTD |
PMID:29470958 |
|
NCBI chr14:21,024,035...21,035,784
Ensembl chr14:21,024,006...21,035,986
|
|
|
G |
Acp1 |
acid phosphatase 1 |
decreases expression |
ISO |
Aminoglutethimide results in decreased expression of ACP1 protein |
CTD |
PMID:26102013 |
|
NCBI chr 6:47,506,380...47,522,021
Ensembl chr 6:47,506,380...47,522,021
|
|
G |
Anp32b |
acidic nuclear phosphoprotein 32 family member B |
decreases expression |
ISO |
Aminoglutethimide results in decreased expression of ANP32B protein |
CTD |
PMID:26102013 |
|
NCBI chr 5:60,743,077...60,765,726
Ensembl chr 5:60,743,443...60,765,717
|
|
G |
Basp1 |
brain abundant, membrane attached signal protein 1 |
decreases expression |
ISO |
Aminoglutethimide results in decreased expression of BASP1 protein |
CTD |
PMID:26102013 |
|
NCBI chr 2:75,816,130...75,863,801
Ensembl chr 2:75,816,122...75,864,043
|
|
G |
Bcap31 |
B-cell receptor-associated protein 31 |
decreases expression |
ISO |
Aminoglutethimide results in decreased expression of BCAP31 protein |
CTD |
PMID:26102013 |
|
NCBI chr X:151,397,567...151,429,666
Ensembl chr X:151,397,576...151,428,506
|
|
G |
Cct4 |
chaperonin containing TCP1 subunit 4 |
increases expression |
ISO |
Aminoglutethimide results in increased expression of CCT4 protein |
CTD |
PMID:26102013 |
|
NCBI chr14:96,991,853...97,004,732
Ensembl chr14:96,991,859...97,005,267
|
|
G |
Cct6a |
chaperonin containing TCP1 subunit 6A |
decreases expression |
ISO |
Aminoglutethimide results in decreased expression of CCT6A protein |
CTD |
PMID:26102013 |
|
NCBI chr12:26,872,736...26,883,125
Ensembl chr12:26,872,574...26,883,337
|
|
G |
Cct7 |
chaperonin containing TCP1 subunit 7 |
decreases expression |
ISO |
Aminoglutethimide results in decreased expression of CCT7 protein |
CTD |
PMID:26102013 |
|
NCBI chr 4:117,989,232...118,006,478
Ensembl chr 4:117,989,232...118,006,580
|
|
G |
Comt |
catechol-O-methyltransferase |
increases expression |
ISO |
Aminoglutethimide results in increased expression of COMT protein |
CTD |
PMID:26102013 |
|
NCBI chr11:82,568,052...82,587,642
Ensembl chr11:82,568,025...82,587,642
|
|
G |
Cuta |
cutA divalent cation tolerance homolog |
decreases expression |
ISO |
Aminoglutethimide results in decreased expression of CUTA protein |
CTD |
PMID:26102013 |
|
NCBI chr20:5,022,956...5,024,580
Ensembl chr20:5,022,956...5,024,552
|
|
G |
Cyp11a1 |
cytochrome P450, family 11, subfamily a, polypeptide 1 |
multiple interactions |
ISO |
Aminoglutethimide inhibits the reaction [Colforsin results in increased expression of CYP11A1 mRNA] |
CTD |
PMID:16935330 |
|
NCBI chr 8:58,422,807...58,434,342
Ensembl chr 8:58,404,669...58,434,338
|
|
G |
Cyp17a1 |
cytochrome P450, family 17, subfamily a, polypeptide 1 |
decreases expression |
ISO |
Aminoglutethimide results in decreased expression of CYP17A1 mRNA |
CTD |
PMID:16935330 |
|
NCBI chr 1:245,535,462...245,543,148
Ensembl chr 1:245,535,462...245,541,573
|
|
G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
multiple interactions increases activity decreases activity |
ISO |
Aminoglutethimide inhibits the reaction [Colforsin results in increased expression of CYP19A1 mRNA]; Aminoglutethimide inhibits the reaction [CYP19A1 protein affects the chemical synthesis of 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine]; Aminoglutethimide inhibits the reaction [CYP19A1 protein affects the metabolism of Methadone] Aminoglutethimide results in increased activity of CYP19A1 protein Aminoglutethimide results in decreased activity of CYP19A1 protein |
CTD |
PMID:15242824 PMID:15968818 PMID:16935330 PMID:17910019 PMID:20087668 |
|
NCBI chr 8:54,552,978...54,580,375
Ensembl chr 8:54,553,165...54,580,758
|
|
G |
Fshb |
follicle stimulating hormone subunit beta |
decreases expression multiple interactions |
ISO |
Aminoglutethimide results in decreased expression of FSHB protein Aminoglutethimide inhibits the reaction [[FSHB protein co-treated with LHB protein co-treated with Testosterone] results in increased abundance of Acetaldehyde] |
CTD |
PMID:9208491 PMID:22285649 |
|
NCBI chr 3:93,548,560...93,552,370
Ensembl chr 3:93,548,560...93,552,370
|
|
G |
Gatd3a |
glutamine amidotransferase class 1 domain containing 3A |
increases expression |
ISO |
Aminoglutethimide results in increased expression of GATD3 protein |
CTD |
PMID:26102013 |
|
NCBI chr20:10,514,793...10,522,894
Ensembl chr20:10,514,744...10,522,885
|
|
G |
Gns |
glucosamine (N-acetyl)-6-sulfatase |
decreases expression |
ISO |
Aminoglutethimide results in decreased expression of GNS protein |
CTD |
PMID:26102013 |
|
NCBI chr 7:56,889,148...56,923,173
Ensembl chr 7:56,889,232...56,923,151
|
|
G |
Gpx1 |
glutathione peroxidase 1 |
increases expression |
ISO |
Aminoglutethimide results in increased expression of GPX1 protein |
CTD |
PMID:26102013 |
|
NCBI chr 8:109,026,905...109,028,031
Ensembl chr 8:109,026,905...109,028,024
|
|
G |
Gsn |
gelsolin |
decreases expression |
ISO |
Aminoglutethimide results in decreased expression of GSN protein |
CTD |
PMID:26102013 |
|
NCBI chr 3:18,585,166...18,638,404
Ensembl chr 3:18,585,172...18,638,402
|
|
G |
H1f2 |
H1.2 linker histone, cluster member |
increases expression |
ISO |
Aminoglutethimide results in increased expression of H1-2 protein |
CTD |
PMID:26102013 |
|
NCBI chr17:41,391,106...41,392,597
Ensembl chr17:41,388,477...41,392,635
|
|
G |
H2ac12 |
H2A clustered histone 12 |
increases expression |
ISO |
Aminoglutethimide results in increased expression of H2AC12 protein |
CTD |
PMID:26102013 |
|
NCBI chr17:42,486,415...42,486,880
Ensembl chr17:42,486,415...42,486,941
|
|
G |
H2az1 |
H2A.Z variant histone 1 |
increases expression |
ISO |
Aminoglutethimide results in increased expression of H2AZ1 protein |
CTD |
PMID:26102013 |
|
NCBI chr 2:226,355,668...226,357,984
Ensembl chr 2:226,355,708...226,358,485
|
|
G |
H2bc12 |
H2B clustered histone 12 |
increases expression |
ISO |
Aminoglutethimide results in increased expression of H2BC12 protein |
CTD |
PMID:26102013 |
|
NCBI chr17:42,485,699...42,486,162
|
|
G |
H3c13 |
H3 clustered histone 13 |
increases expression |
ISO |
Aminoglutethimide results in increased expression of H3C13 protein |
CTD |
PMID:26102013 |
|
NCBI chr17:41,531,502...41,531,971
Ensembl chr 2:183,795,504...183,809,469 Ensembl chr17:183,795,504...183,809,469 Ensembl chr 2:183,795,504...183,809,469 Ensembl chr17:183,795,504...183,809,469 Ensembl chr17:183,795,504...183,809,469 Ensembl chr 2:183,795,504...183,809,469
|
|
G |
Hmgb2 |
high mobility group box 2 |
decreases expression |
ISO |
Aminoglutethimide results in decreased expression of HMGB2 protein |
CTD |
PMID:26102013 |
|
NCBI chr16:32,710,651...32,713,230
Ensembl chr16:32,710,658...32,713,140 Ensembl chr 1:32,710,658...32,713,140
|
|
G |
Hnrnph1 |
heterogeneous nuclear ribonucleoprotein H1 |
decreases expression |
ISO |
Aminoglutethimide results in decreased expression of HNRNPH1 protein |
CTD |
PMID:26102013 |
|
NCBI chr10:34,692,868...34,702,849
Ensembl chr10:34,693,555...34,702,846
|
|
G |
Hsd17b1 |
hydroxysteroid (17-beta) dehydrogenase 1 |
multiple interactions |
ISO |
[Colforsin co-treated with Aminoglutethimide] results in decreased expression of HSD17B1 mRNA |
CTD |
PMID:16935330 |
|
NCBI chr10:86,009,728...86,011,928
Ensembl chr10:86,009,728...86,011,927
|
|
G |
Hsd17b10 |
hydroxysteroid (17-beta) dehydrogenase 10 |
decreases expression |
ISO |
Aminoglutethimide results in decreased expression of HSD17B10 protein |
CTD |
PMID:26102013 |
|
NCBI chr X:21,089,142...21,091,603
Ensembl chr X:21,089,122...21,109,488
|
|
G |
Hsd17b4 |
hydroxysteroid (17-beta) dehydrogenase 4 |
multiple interactions decreases expression |
ISO |
Aminoglutethimide inhibits the reaction [Colforsin results in increased expression of HSD17B4 mRNA] Aminoglutethimide results in decreased expression of HSD17B4 mRNA |
CTD |
PMID:16935330 |
|
NCBI chr18:43,328,903...43,417,950
Ensembl chr18:43,328,824...43,417,952
|
|
G |
Hsd17b7 |
hydroxysteroid (17-beta) dehydrogenase 7 |
decreases expression |
EXP |
Aminoglutethimide results in decreased expression of HSD17B7 mRNA |
CTD |
PMID:9231770 |
|
NCBI chr13:82,170,079...82,190,018
Ensembl chr13:82,173,179...82,190,017
|
|
G |
Hspa1a |
heat shock protein family A (Hsp70) member 1A |
increases expression |
ISO |
Aminoglutethimide results in increased expression of HSPA1A protein |
CTD |
PMID:26102013 |
|
NCBI chr20:3,870,765...3,873,221
Ensembl chr20:3,856,006...3,873,227
|
|
G |
Hyou1 |
hypoxia up-regulated 1 |
increases expression |
ISO |
Aminoglutethimide results in increased expression of HYOU1 protein |
CTD |
PMID:26102013 |
|
NCBI chr 8:44,706,073...44,718,189
Ensembl chr 8:44,706,263...44,718,186
|
|
G |
Impdh2 |
inosine monophosphate dehydrogenase 2 |
decreases expression |
ISO |
Aminoglutethimide results in decreased expression of IMPDH2 protein |
CTD |
PMID:26102013 |
|
NCBI chr 8:109,256,705...109,261,365
Ensembl chr 8:109,256,728...109,261,359
|
|
G |
Lhb |
luteinizing hormone subunit beta |
decreases expression multiple interactions |
ISO |
Aminoglutethimide results in decreased expression of LHB protein Aminoglutethimide inhibits the reaction [[FSHB protein co-treated with LHB protein co-treated with Testosterone] results in increased abundance of Acetaldehyde] |
CTD |
PMID:9208491 PMID:22285649 |
|
NCBI chr 1:95,898,269...95,901,973
Ensembl chr 1:95,900,984...95,901,972 Ensembl chr 1:95,900,984...95,901,972
|
|
G |
Lmna |
lamin A/C |
decreases expression |
ISO |
Aminoglutethimide results in decreased expression of LMNA protein |
CTD |
PMID:26102013 |
|
NCBI chr 2:173,939,751...173,960,423
Ensembl chr 2:173,939,751...173,960,423
|
|
G |
Lmnb2 |
lamin B2 |
decreases expression |
ISO |
Aminoglutethimide results in decreased expression of LMNB2 protein |
CTD |
PMID:26102013 |
|
NCBI chr 7:8,792,628...8,808,665
Ensembl chr 7:8,789,314...8,808,665
|
|
G |
Mcm3 |
minichromosome maintenance complex component 3 |
decreases expression |
ISO |
Aminoglutethimide results in decreased expression of MCM3 protein |
CTD |
PMID:26102013 |
|
NCBI chr 9:23,219,169...23,237,314
Ensembl chr 9:23,219,169...23,237,314
|
|
G |
Mpo |
myeloperoxidase |
multiple interactions |
ISO |
[[MPO protein co-treated with Hydrogen Peroxide co-treated with 5,5-dimethyl-1-pyrroline-1-oxide] results in increased metabolism of Aminoglutethimide] which results in increased expression of MPO protein modified form; [Aminoglutethimide co-treated with Hydrogen Peroxide] results in increased oxidation of MPO protein; [MPO protein co-treated with Hydrogen Peroxide co-treated with 5,5-dimethyl-1-pyrroline-1-oxide] results in increased metabolism of Aminoglutethimide |
CTD |
PMID:20199096 PMID:26102013 |
|
NCBI chr10:72,594,883...72,608,862
Ensembl chr10:72,594,661...72,604,819
|
|
G |
Myo18a |
myosin XVIIIa |
decreases expression |
ISO |
Aminoglutethimide results in decreased expression of MYO18A protein |
CTD |
PMID:26102013 |
|
NCBI chr10:62,654,218...62,755,465
Ensembl chr10:62,654,281...62,755,468
|
|
G |
Npm3 |
nucleophosmin/nucleoplasmin, 3 |
decreases expression |
ISO |
Aminoglutethimide results in decreased expression of NPM3 protein |
CTD |
PMID:26102013 |
|
NCBI chr 1:244,595,638...244,597,623
Ensembl chr 1:244,595,644...244,597,591
|
|
G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
increases activity |
ISO |
Aminoglutethimide results in increased activity of NR1I2 protein |
CTD |
PMID:21068194 |
|
NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
|
|
G |
Nup210 |
nucleoporin 210 |
decreases expression |
ISO |
Aminoglutethimide results in decreased expression of NUP210 protein |
CTD |
PMID:26102013 |
|
NCBI chr 4:123,511,558...123,609,874
Ensembl chr 4:123,511,559...123,609,874
|
|
G |
Pgr |
progesterone receptor |
multiple interactions decreases expression |
ISO |
[Aminoglutethimide co-treated with 17 alpha-Hydroxyprogesterone Caproate] results in decreased expression of PGR protein Aminoglutethimide results in decreased expression of PGR protein |
CTD |
PMID:8565696 PMID:9208491 |
|
NCBI chr 8:6,072,673...6,131,552
Ensembl chr 8:6,072,673...6,131,344
|
|
G |
Pitpnb |
phosphatidylinositol transfer protein, beta |
increases expression |
ISO |
Aminoglutethimide results in increased expression of PITPNB protein |
CTD |
PMID:26102013 |
|
NCBI chr12:45,249,308...45,298,388
Ensembl chr12:45,249,333...45,298,314
|
|
G |
Ppp1ca |
protein phosphatase 1 catalytic subunit alpha |
decreases expression |
ISO |
Aminoglutethimide results in decreased expression of PPP1CA protein |
CTD |
PMID:26102013 |
|
NCBI chr 1:201,485,117...201,488,734
Ensembl chr 1:201,485,085...201,497,327
|
|
G |
Prdx3 |
peroxiredoxin 3 |
increases expression |
ISO |
Aminoglutethimide results in increased expression of PRDX3 protein |
CTD |
PMID:26102013 |
|
NCBI chr 1:260,001,642...260,014,064
Ensembl chr 1:260,001,637...260,014,111
|
|
G |
Psmb4 |
proteasome 20S subunit beta 4 |
decreases expression |
ISO |
Aminoglutethimide results in decreased expression of PSMB4 protein |
CTD |
PMID:26102013 |
|
NCBI chr 2:182,442,757...182,445,532
Ensembl chr 2:182,442,756...182,445,746
|
|
G |
Rtraf |
RNA transcription, translation and transport factor |
decreases expression |
ISO |
Aminoglutethimide results in decreased expression of RTRAF protein |
CTD |
PMID:26102013 |
|
NCBI chr15:4,447,243...4,457,973
Ensembl chr15:4,442,573...4,457,972
|
|
G |
Spp1 |
secreted phosphoprotein 1 |
decreases expression |
EXP |
Aminoglutethimide results in decreased expression of SPP1 mRNA |
CTD |
PMID:23558518 |
|
NCBI chr14:5,308,885...5,315,120
Ensembl chr14:5,308,885...5,315,162
|
|
G |
Ssb |
small RNA binding exonuclease protection factor La |
decreases expression |
ISO |
Aminoglutethimide results in decreased expression of SSB protein |
CTD |
PMID:26102013 |
|
NCBI chr 3:54,616,616...54,626,203
Ensembl chr 3:54,616,619...54,626,203
|
|
G |
Star |
steroidogenic acute regulatory protein |
decreases expression increases expression |
ISO |
Aminoglutethimide results in decreased expression of STAR mRNA Aminoglutethimide results in increased expression of STAR mRNA |
CTD |
PMID:10960482 PMID:16935330 |
|
NCBI chr16:66,267,094...66,274,368
Ensembl chr16:66,264,807...66,271,672
|
|
G |
Tpt1 |
tumor protein, translationally-controlled 1 |
decreases expression |
ISO |
Aminoglutethimide results in decreased expression of TPT1 protein |
CTD |
PMID:26102013 |
|
NCBI chr15:51,156,728...51,159,629
Ensembl chr15:51,146,154...51,159,625
|
|
G |
Ubc |
ubiquitin C |
increases expression |
ISO |
Aminoglutethimide results in increased expression of UBC protein |
CTD |
PMID:26102013 |
|
NCBI chr12:31,239,149...31,243,924
Ensembl chr12:31,239,152...31,243,925
|
|
G |
Ube2k |
ubiquitin-conjugating enzyme E2K |
decreases expression |
ISO |
Aminoglutethimide results in decreased expression of UBE2K protein |
CTD |
PMID:26102013 |
|
NCBI chr14:42,658,016...42,718,899
Ensembl chr14:42,658,016...42,718,630
|
|
G |
Wdr1 |
WD repeat domain 1 |
increases expression |
ISO |
Aminoglutethimide results in increased expression of WDR1 protein |
CTD |
PMID:26102013 |
|
NCBI chr14:72,258,032...72,291,768
Ensembl chr14:72,257,956...72,291,766
|
|
G |
Ywhaq |
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, theta |
increases expression |
ISO |
Aminoglutethimide results in increased expression of YWHAQ protein |
CTD |
PMID:26102013 |
|
NCBI chr 6:40,935,714...40,966,240
Ensembl chr 6:40,935,949...40,966,273
|
|
|
G |
Cycs |
cytochrome c, somatic |
multiple interactions |
ISO |
[Oleic Acid co-treated with anastrozole] affects the localization of CYCS protein; [Olive Oil co-treated with anastrozole] affects the localization of CYCS protein |
CTD |
PMID:24161488 |
|
NCBI chr 4:79,651,894...79,653,994
Ensembl chr 4:79,651,378...79,654,054 Ensembl chr18:79,651,378...79,654,054
|
|
G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
decreases activity |
ISO |
Anastrozole results in decreased activity of CYP19A1 protein |
CTD |
PMID:15837728 PMID:16001952 PMID:16023338 PMID:16023854 PMID:16034487 PMID:16054421 PMID:21341743 PMID:32764486 More...
|
|
NCBI chr 8:54,552,978...54,580,375
Ensembl chr 8:54,553,165...54,580,758
|
|
G |
Fshb |
follicle stimulating hormone subunit beta |
increases expression |
EXP |
anastrozole results in increased expression of FSHB protein |
CTD |
PMID:10657858 |
|
NCBI chr 3:93,548,560...93,552,370
Ensembl chr 3:93,548,560...93,552,370
|
|
G |
Gja1 |
gap junction protein, alpha 1 |
decreases expression |
ISO |
anastrozole results in decreased expression of GJA1 protein |
CTD |
PMID:29180066 |
|
NCBI chr20:35,756,007...35,768,481
Ensembl chr20:35,755,991...35,768,582
|
|
G |
Lhb |
luteinizing hormone subunit beta |
increases expression |
EXP |
anastrozole results in increased expression of LHB protein |
CTD |
PMID:10657858 |
|
NCBI chr 1:95,898,269...95,901,973
Ensembl chr 1:95,900,984...95,901,972 Ensembl chr 1:95,900,984...95,901,972
|
|
G |
Mki67 |
marker of proliferation Ki-67 |
multiple interactions decreases expression |
ISO |
[Tamoxifen co-treated with anastrozole] results in decreased expression of MKI67 protein anastrozole results in decreased expression of MKI67 protein |
CTD |
PMID:15767642 PMID:16002280 |
|
NCBI chr 1:190,496,319...190,522,983
Ensembl chr 1:190,496,319...190,522,762
|
|
G |
Pgr |
progesterone receptor |
decreases expression |
ISO |
anastrozole results in decreased expression of PGR protein |
CTD |
PMID:16002280 |
|
NCBI chr 8:6,072,673...6,131,552
Ensembl chr 8:6,072,673...6,131,344
|
|
G |
Por |
cytochrome p450 oxidoreductase |
decreases activity |
ISO |
Anastrozole results in decreased activity of POR protein |
CTD |
PMID:35206146 |
|
NCBI chr12:20,951,058...20,999,198
Ensembl chr12:20,951,058...20,999,245
|
|
G |
Slc22a2 |
solute carrier family 22 member 2 |
multiple interactions |
ISO |
anastrozole inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] |
CTD |
PMID:21599003 |
|
NCBI chr 1:48,121,061...48,163,268
Ensembl chr 1:48,121,061...48,163,268
|
|
|
G |
Aatf |
apoptosis antagonizing transcription factor |
decreases expression |
ISO |
beauvericin results in decreased expression of AATF mRNA |
CTD |
PMID:29203277 |
|
NCBI chr10:69,299,029...69,392,207
Ensembl chr10:69,299,037...69,392,201
|
|
G |
Abca1 |
ATP binding cassette subfamily A member 1 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of ABCA1 mRNA |
CTD |
PMID:31100301 |
|
NCBI chr 5:67,678,267...67,801,162
Ensembl chr 5:67,681,297...67,801,170
|
|
G |
Abcg1 |
ATP binding cassette subfamily G member 1 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of ABCG1 mRNA |
CTD |
PMID:31100301 |
|
NCBI chr20:9,126,687...9,182,948
Ensembl chr20:9,126,687...9,182,948
|
|
G |
Acat2 |
acetyl-CoA acetyltransferase 2 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of ACAT2 protein |
CTD |
PMID:32407736 |
|
NCBI chr 1:47,695,833...47,713,879
Ensembl chr 1:47,695,788...47,752,821
|
|
G |
Acin1 |
apoptotic chromatin condensation inducer 1 |
decreases expression |
ISO |
beauvericin results in decreased expression of ACIN1 mRNA |
CTD |
PMID:29203277 |
|
NCBI chr15:28,102,112...28,147,001
Ensembl chr15:28,102,112...28,147,001
|
|
G |
Acsl4 |
acyl-CoA synthetase long-chain family member 4 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of ACSL4 protein |
CTD |
PMID:32407736 |
|
NCBI chr X:105,942,794...106,006,573
Ensembl chr X:105,942,799...106,006,427
|
|
G |
Actb |
actin, beta |
decreases expression |
ISO |
beauvericin results in decreased expression of ACTB mRNA |
CTD |
PMID:29203277 |
|
NCBI chr12:11,663,112...11,666,697
Ensembl chr12:11,663,109...11,672,877
|
|
G |
Aen |
apoptosis enhancing nuclease |
decreases expression |
ISO |
beauvericin results in decreased expression of AEN mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 1:132,815,094...132,824,522
Ensembl chr 1:132,815,142...132,824,523
|
|
G |
Aifm1 |
apoptosis inducing factor, mitochondria associated 1 |
decreases expression |
ISO |
beauvericin results in decreased expression of AIFM1 mRNA |
CTD |
PMID:29203277 |
|
NCBI chr X:127,650,223...127,689,356
Ensembl chr X:127,650,226...127,689,256
|
|
G |
Ak4 |
adenylate kinase 4 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of AK4 mRNA |
CTD |
PMID:31100301 |
|
NCBI chr 5:116,039,222...116,099,064
Ensembl chr 5:116,039,616...116,098,618
|
|
G |
Aldh5a1 |
aldehyde dehydrogenase 5 family, member A1 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of ALDH5A1 protein |
CTD |
PMID:32407736 |
|
NCBI chr17:40,132,339...40,158,677
Ensembl chr17:40,130,883...40,158,677
|
|
G |
Aldoa |
aldolase, fructose-bisphosphate A |
decreases expression |
ISO |
beauvericin results in decreased expression of ALDOA mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 1:181,402,275...181,407,476
Ensembl chr 1:181,402,275...181,406,182
|
|
G |
Anapc13 |
anaphase promoting complex subunit 13 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of ANAPC13 protein |
CTD |
PMID:32407736 |
|
NCBI chr 8:103,205,520...103,213,936
Ensembl chr 8:103,205,520...103,213,936
|
|
G |
Aprt |
adenine phosphoribosyl transferase |
decreases expression |
ISO |
beauvericin results in decreased expression of APRT mRNA |
CTD |
PMID:29203277 |
|
NCBI chr19:50,626,201...50,628,491
Ensembl chr19:50,626,202...50,628,431
|
|
G |
Ar |
androgen receptor |
multiple interactions |
ISO |
beauvericin inhibits the reaction [Dihydrotestosterone results in increased expression of AR mRNA] |
CTD |
PMID:30716354 |
|
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
|
|
G |
Arhgdia |
Rho GDP dissociation inhibitor alpha |
decreases expression |
ISO |
beauvericin results in decreased expression of ARHGDIA mRNA |
CTD |
PMID:29203277 |
|
NCBI chr10:105,854,526...105,858,020
Ensembl chr10:105,854,533...105,858,023
|
|
G |
Arpp21 |
cAMP regulated phosphoprotein 21 |
increases expression |
ISO |
beauvericin results in increased expression of ARPP21 mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 8:112,034,636...112,199,273
Ensembl chr 8:112,034,642...112,194,297
|
|
G |
Atp1a1 |
ATPase Na+/K+ transporting subunit alpha 1 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of ATP1A1 protein |
CTD |
PMID:32407736 |
|
NCBI chr 2:189,020,722...189,048,826
Ensembl chr 2:189,020,722...189,048,837
|
|
G |
Atp1a3 |
ATPase Na+/K+ transporting subunit alpha 3 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of ATP1A3 protein |
CTD |
PMID:32407736 |
|
NCBI chr 1:80,572,790...80,601,936
Ensembl chr 1:80,572,796...80,601,918
|
|
G |
Atp5pb |
ATP synthase peripheral stalk-membrane subunit b |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of ATP5PB protein |
CTD |
PMID:32407736 |
|
NCBI chr 2:193,424,138...193,435,418
Ensembl chr 2:193,424,047...193,435,418
|
|
G |
Atp5pf |
ATP synthase peripheral stalk subunit F6 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of ATP5PF protein |
CTD |
PMID:32407736 |
|
NCBI chr11:23,881,594...23,889,581
Ensembl chr11:23,881,592...23,889,119
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
decreases expression multiple interactions |
ISO |
beauvericin results in decreased expression of BAX mRNA [zearalenol co-treated with beauvericin] results in increased expression of BAX mRNA |
CTD |
PMID:29203277 PMID:32956828 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
increases expression multiple interactions |
ISO |
beauvericin results in increased expression of BCL2 mRNA [zearalenol co-treated with beauvericin] results in increased expression of BCL2 mRNA |
CTD |
PMID:29203277 PMID:32956828 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Birc2 |
baculoviral IAP repeat-containing 2 |
increases expression |
ISO |
beauvericin results in increased expression of BIRC2 mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 8:4,968,856...4,989,325
Ensembl chr 8:4,968,842...4,988,732
|
|
G |
Birc3 |
baculoviral IAP repeat-containing 3 |
increases expression |
ISO |
beauvericin results in increased expression of BIRC3 mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 8:5,000,844...5,028,470
Ensembl chr 8:5,000,845...5,015,802
|
|
G |
Btf3l4 |
basic transcription factor 3-like 4 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of BTF3L4 protein |
CTD |
PMID:32407736 |
|
NCBI chr 5:123,567,902...123,587,527
Ensembl chr 5:123,567,907...123,586,866
|
|
G |
C1qtnf3 |
C1q and TNF related 3 |
decreases expression |
ISO |
beauvericin results in decreased expression of C1QTNF3 mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 2:59,917,099...59,939,519
Ensembl chr 2:59,917,188...59,939,433
|
|
G |
C1qtnf6 |
C1q and TNF related 6 |
increases expression |
ISO |
beauvericin results in increased expression of C1QTNF6 mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 7:110,077,867...110,084,584
Ensembl chr 7:110,077,878...110,084,412
|
|
G |
Caap1 |
caspase activity and apoptosis inhibitor 1 |
decreases expression |
ISO |
beauvericin results in decreased expression of CAAP1 mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 5:109,313,253...109,414,323
Ensembl chr 5:109,361,912...109,414,314
|
|
G |
Card11 |
caspase recruitment domain family, member 11 |
decreases expression |
ISO |
beauvericin results in decreased expression of CARD11 mRNA |
CTD |
PMID:29203277 |
|
NCBI chr12:13,621,140...13,758,115
Ensembl chr12:13,621,087...13,758,112
|
|
G |
Casp3 |
caspase 3 |
increases activity multiple interactions |
EXP ISO |
beauvericin results in increased activity of CASP3 protein [zearalenol co-treated with beauvericin] results in increased expression of CASP3 mRNA |
CTD |
PMID:25178661 PMID:32956828 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp7 |
caspase 7 |
increases activity |
EXP |
beauvericin results in increased activity of CASP7 protein |
CTD |
PMID:25178661 |
|
NCBI chr 1:255,437,438...255,476,737
Ensembl chr 1:255,437,172...255,476,729
|
|
G |
Casp8 |
caspase 8 |
increases expression |
ISO |
beauvericin results in increased expression of CASP8 mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
Casp9 |
caspase 9 |
increases expression |
ISO |
beauvericin results in increased expression of CASP9 mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Ccar2 |
cell cycle and apoptosis regulator 2 |
decreases expression |
ISO |
beauvericin results in decreased expression of CCAR2 mRNA |
CTD |
PMID:29203277 |
|
NCBI chr15:45,212,797...45,228,001
Ensembl chr15:45,212,803...45,227,636
|
|
G |
Ccdc124 |
coiled-coil domain containing 124 |
decreases expression |
ISO |
beauvericin results in decreased expression of CCDC124 mRNA |
CTD |
PMID:29203277 |
|
NCBI chr16:18,566,745...18,572,564
Ensembl chr16:18,566,745...18,572,564
|
|
G |
Ccdc180 |
coiled-coil domain containing 180 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of CCDC180 protein |
CTD |
PMID:32407736 |
|
NCBI chr 5:60,154,883...60,223,508
Ensembl chr 5:60,154,910...60,223,522
|
|
G |
Ccdc86 |
coiled-coil domain containing 86 |
decreases expression |
ISO |
beauvericin results in decreased expression of CCDC86 mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 1:207,590,167...207,596,547
Ensembl chr 1:207,590,168...207,596,544
|
|
G |
Ccng2 |
cyclin G2 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of CCNG2 mRNA |
CTD |
PMID:31100301 |
|
NCBI chr14:14,804,321...14,812,819
Ensembl chr14:14,804,322...14,812,830
|
|
G |
Cct5 |
chaperonin containing TCP1 subunit 5 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of CCT5 protein |
CTD |
PMID:32407736 |
|
NCBI chr 2:82,591,750...82,602,903
Ensembl chr 2:82,590,630...82,602,930
|
|
G |
Cd47 |
Cd47 molecule |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of CD47 protein |
CTD |
PMID:32407736 |
|
NCBI chr11:50,906,052...50,970,000
Ensembl chr11:50,906,177...50,969,425
|
|
G |
Cd81 |
Cd81 molecule |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of CD81 protein |
CTD |
PMID:32407736 |
|
NCBI chr 1:198,235,861...198,251,660
Ensembl chr 1:198,241,484...198,251,660
|
|
G |
Cdk2ap2 |
cyclin-dependent kinase 2 associated protein 2 |
decreases expression |
ISO |
beauvericin results in decreased expression of CDK2AP2 mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 1:201,391,056...201,393,137
Ensembl chr 1:201,391,466...201,393,137
|
|
G |
Cebpb |
CCAAT/enhancer binding protein beta |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of CEBPB mRNA |
CTD |
PMID:31100301 |
|
NCBI chr 3:156,398,035...156,399,466
Ensembl chr 3:156,397,052...156,399,473
|
|
G |
Cflar |
CASP8 and FADD-like apoptosis regulator |
increases expression |
ISO |
beauvericin results in increased expression of CFLAR mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 9:60,185,338...60,236,173
Ensembl chr 9:60,185,452...60,237,034
|
|
G |
Chchd2 |
coiled-coil-helix-coiled-coil-helix domain containing 2 |
decreases expression |
ISO |
beauvericin results in decreased expression of CHCHD2 mRNA |
CTD |
PMID:29203277 |
|
NCBI chr12:26,828,738...26,834,762
Ensembl chr12:26,828,736...26,834,755
|
|
G |
Ciapin1 |
cytokine induced apoptosis inhibitor 1 |
decreases expression |
ISO |
beauvericin results in decreased expression of CIAPIN1 mRNA |
CTD |
PMID:29203277 |
|
NCBI chr19:10,179,963...10,195,511
Ensembl chr19:10,180,100...10,195,503
|
|
G |
Cnp |
2',3'-cyclic nucleotide 3' phosphodiesterase |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of CNP protein |
CTD |
PMID:32407736 |
|
NCBI chr10:85,511,164...85,517,723
Ensembl chr10:85,511,160...85,517,720
|
|
G |
Coa6 |
cytochrome c oxidase assembly factor 6 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of COA6 protein |
CTD |
PMID:32407736 |
|
NCBI chr19:54,395,746...54,398,348
Ensembl chr19:54,395,742...54,399,407
|
|
G |
Coro1c |
coronin 1C |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of CORO1C protein |
CTD |
PMID:32407736 |
|
NCBI chr12:42,713,024...42,785,179
Ensembl chr12:42,712,991...42,785,179
|
|
G |
Cotl1 |
coactosin-like F-actin binding protein 1 |
decreases expression |
ISO |
beauvericin results in decreased expression of COTL1 mRNA |
CTD |
PMID:29203277 |
|
NCBI chr19:47,871,689...47,906,010
Ensembl chr19:47,871,694...47,911,689
|
|
G |
Cplane2 |
ciliogenesis and planar polarity effector complex subunit 2 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of CPLANE2 protein |
CTD |
PMID:32407736 |
|
NCBI chr 5:153,515,507...153,516,455
Ensembl chr 5:153,515,376...153,522,508
|
|
G |
Cpne1 |
copine 1 |
decreases expression |
ISO |
beauvericin results in decreased expression of CPNE1 mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 3:144,587,531...144,629,911
Ensembl chr 3:144,588,995...144,598,636
|
|
G |
Crim1 |
cysteine rich transmembrane BMP regulator 1 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of CRIM1 mRNA |
CTD |
PMID:31100301 |
|
NCBI chr 6:16,695,864...16,870,264
Ensembl chr 6:16,697,829...16,870,259
|
|
G |
Csdc2 |
cold shock domain containing C2 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of CSDC2 protein |
CTD |
PMID:32407736 |
|
NCBI chr 7:113,451,998...113,466,464
Ensembl chr 7:113,451,998...113,466,463
|
|
G |
Csk |
C-terminal Src kinase |
decreases expression |
ISO |
beauvericin results in decreased expression of CSK mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 8:58,029,748...58,048,742
Ensembl chr 8:58,029,749...58,048,292
|
|
G |
Ctps1 |
CTP synthase 1 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of CTPS1 protein |
CTD |
PMID:32407736 |
|
NCBI chr 5:134,125,022...134,154,155
Ensembl chr 5:134,125,025...134,154,180
|
|
G |
Ctsd |
cathepsin D |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of CTSD protein |
CTD |
PMID:32407736 |
|
NCBI chr 1:197,527,467...197,539,343
Ensembl chr 1:197,527,467...197,539,488
|
|
G |
Cyp4f39 |
cytochrome P450, family 4, subfamily f, polypeptide 39 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of CYP4F22 protein |
CTD |
PMID:32407736 |
|
NCBI chr 7:11,426,806...11,505,553
Ensembl chr 7:11,433,371...11,536,181
|
|
G |
Dcxr |
dicarbonyl and L-xylulose reductase |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of DCXR protein |
CTD |
PMID:32407736 |
|
NCBI chr10:106,006,404...106,008,293
|
|
G |
Ddias |
DNA damage-induced apoptosis suppressor |
decreases expression |
ISO |
beauvericin results in decreased expression of DDIAS mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 1:146,906,150...146,930,462
Ensembl chr 1:146,906,154...146,930,462
|
|
G |
Ddx47 |
DEAD-box helicase 47 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of DDX47 protein |
CTD |
PMID:32407736 |
|
NCBI chr 4:167,845,652...167,858,115
Ensembl chr 4:167,845,640...167,859,115
|
|
G |
Dhrs7 |
dehydrogenase/reductase 7 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of DHRS7 protein |
CTD |
PMID:32407736 |
|
NCBI chr 6:91,332,259...91,347,856
Ensembl chr 6:91,251,323...91,347,892
|
|
G |
Edem1 |
ER degradation enhancing alpha-mannosidase like protein 1 |
increases expression |
ISO |
beauvericin results in increased expression of EDEM1 mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 4:141,797,631...141,829,717
Ensembl chr 4:141,797,701...141,829,717
|
|
G |
Eif5a |
eukaryotic translation initiation factor 5A |
decreases expression |
ISO |
beauvericin results in decreased expression of EIF5A mRNA |
CTD |
PMID:29203277 |
|
NCBI chr10:54,640,104...54,644,845
Ensembl chr10:54,640,024...54,644,656
|
|
G |
Faim2 |
Fas apoptotic inhibitory molecule 2 |
increases expression |
ISO |
beauvericin results in increased expression of FAIM2 mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 7:130,632,368...130,659,353
Ensembl chr 7:130,633,348...130,659,168
|
|
G |
Fmc1 |
formation of mitochondrial complex V assembly factor 1 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of FMC1 protein |
CTD |
PMID:32407736 |
|
NCBI chr 4:67,274,104...67,282,140
Ensembl chr 4:67,274,104...67,282,140
|
|
G |
Gaa |
alpha glucosidase |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of GAA protein |
CTD |
PMID:32407736 |
|
NCBI chr10:104,529,673...104,546,836
Ensembl chr10:104,529,747...104,546,836
|
|
G |
Gna14 |
G protein subunit alpha 14 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of GNA14 protein |
CTD |
PMID:32407736 |
|
NCBI chr 1:213,714,993...213,900,083
Ensembl chr 1:213,716,020...213,897,423
|
|
G |
Gnai3 |
G protein subunit alpha i3 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of GNAI3 protein |
CTD |
PMID:32407736 |
|
NCBI chr 2:195,742,765...195,780,720
Ensembl chr 2:195,742,642...195,780,742
|
|
G |
Gnb1 |
G protein subunit beta 1 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of GNB1 protein |
CTD |
PMID:32407736 |
|
NCBI chr 5:166,075,508...166,142,223
Ensembl chr 5:166,075,629...166,142,124
|
|
G |
Golga1 |
golgin A1 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of GOLGA1 protein |
CTD |
PMID:32407736 |
|
NCBI chr 3:22,765,690...22,812,637
Ensembl chr 3:22,767,761...22,812,585
|
|
G |
Gpnmb |
glycoprotein nmb |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of GPNMB protein |
CTD |
PMID:32407736 |
|
NCBI chr 4:78,010,247...78,031,491
Ensembl chr 4:78,010,197...78,049,367
|
|
G |
Gpr18 |
G protein-coupled receptor 18 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of GPR18 mRNA |
CTD |
PMID:31100301 |
|
NCBI chr15:98,997,427...99,001,177
Ensembl chr15:98,997,259...99,001,470
|
|
G |
Hexb |
hexosaminidase subunit beta |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of HEXB protein |
CTD |
PMID:32407736 |
|
NCBI chr 2:28,483,997...28,504,165
Ensembl chr 2:28,484,012...28,504,223
|
|
G |
Hist2h2be |
histone cluster 2 H2B family member E |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of HIST2H2BE protein |
CTD |
PMID:32407736 |
|
NCBI chr 2:183,780,583...183,783,030
|
|
G |
Hmgcs1 |
3-hydroxy-3-methylglutaryl-CoA synthase 1 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of HMGCS1 mRNA |
CTD |
PMID:31100301 |
|
NCBI chr 2:51,649,368...51,667,100
Ensembl chr 2:51,649,497...51,667,100
|
|
G |
Hnrnpm |
heterogeneous nuclear ribonucleoprotein M |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of HNRNPM protein |
CTD |
PMID:32407736 |
|
NCBI chr 7:14,438,703...14,476,781
Ensembl chr 7:14,438,688...14,476,762
|
|
G |
Hnrnpu |
heterogeneous nuclear ribonucleoprotein U |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of HNRNPU protein |
CTD |
PMID:32407736 |
|
NCBI chr13:90,069,058...90,086,905
Ensembl chr13:90,074,181...90,086,588
|
|
G |
Hspa5 |
heat shock protein family A (Hsp70) member 5 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of HSPA5 mRNA |
CTD |
PMID:31100301 |
|
NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891
|
|
G |
Immt |
inner membrane mitochondrial protein |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of IMMT protein |
CTD |
PMID:32407736 |
|
NCBI chr 4:103,880,482...103,919,116
Ensembl chr 4:103,880,459...103,919,109
|
|
G |
Insig1 |
insulin induced gene 1 |
increases expression |
ISO |
beauvericin results in increased expression of INSIG1 mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 4:7,315,494...7,323,972
Ensembl chr 4:7,315,495...7,323,952
|
|
G |
Islr2 |
immunoglobulin superfamily containing leucine-rich repeat 2 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of ISLR2 protein |
CTD |
PMID:32407736 |
|
NCBI chr 8:58,608,165...58,616,246
Ensembl chr 8:58,608,709...58,614,650
|
|
G |
Itgb1 |
integrin subunit beta 1 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of ITGB1 protein |
CTD |
PMID:32407736 |
|
NCBI chr19:56,705,123...56,753,199
Ensembl chr19:56,705,171...56,753,195
|
|
G |
Klf12 |
KLF transcription factor 12 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of KLF12 protein |
CTD |
PMID:32407736 |
|
NCBI chr15:76,628,778...77,062,000
Ensembl chr15:76,637,654...77,062,056
|
|
G |
Kpnb1 |
karyopherin subunit beta 1 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of KPNB1 protein |
CTD |
PMID:32407736 |
|
NCBI chr10:82,145,662...82,174,437
Ensembl chr10:82,145,420...82,174,605
|
|
G |
Krt16 |
keratin 16 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of KRT16 protein |
CTD |
PMID:32407736 |
|
NCBI chr10:85,168,357...85,171,816
Ensembl chr10:85,066,802...85,171,799
|
|
G |
Krt27 |
keratin 27 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of KRT27 protein |
CTD |
PMID:32407736 |
|
NCBI chr10:84,298,684...84,303,967
Ensembl chr10:84,298,508...84,303,967
|
|
G |
Krt5 |
keratin 5 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of KRT5 protein |
CTD |
PMID:32407736 |
|
NCBI chr 7:132,846,132...132,851,861
Ensembl chr 7:132,846,136...132,851,850
|
|
G |
Krt76 |
keratin 76 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of KRT76 protein |
CTD |
PMID:32407736 |
|
NCBI chr 7:133,016,990...133,025,475
Ensembl chr 7:133,016,992...133,025,496
|
|
G |
Lamp2 |
lysosomal-associated membrane protein 2 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of LAMP2 protein |
CTD |
PMID:32407736 |
|
NCBI chr X:117,173,097...117,222,090
Ensembl chr X:117,057,606...117,260,522
|
|
G |
Lat |
linker for activation of T cells |
decreases expression |
ISO |
beauvericin results in decreased expression of LAT mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 1:180,936,536...180,941,561
Ensembl chr 1:180,936,534...180,941,578
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
decreases phosphorylation |
EXP |
beauvericin results in decreased phosphorylation of MAPK1 protein |
CTD |
PMID:25178661 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
decreases phosphorylation |
EXP |
beauvericin results in decreased phosphorylation of MAPK3 protein |
CTD |
PMID:25178661 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Matn4 |
matrilin 4 |
decreases expression |
ISO |
beauvericin results in decreased expression of MATN4 mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 3:153,120,605...153,135,628
Ensembl chr 3:153,120,632...153,135,865
|
|
G |
Mavs |
mitochondrial antiviral signaling protein |
increases expression |
ISO |
beauvericin results in increased expression of MAVS mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 3:118,451,650...118,466,094
Ensembl chr 3:118,451,743...118,466,094
|
|
G |
Med6 |
mediator complex subunit 6 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of MED6 protein |
CTD |
PMID:32407736 |
|
NCBI chr 6:101,270,410...101,283,929
Ensembl chr 6:101,270,410...101,283,876
|
|
G |
Moap1 |
modulator of apoptosis 1 |
increases expression |
ISO |
beauvericin results in increased expression of MOAP1 mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 6:121,882,565...121,884,500
Ensembl chr 6:121,882,366...121,898,643 Ensembl chr17:121,882,366...121,898,643
|
|
G |
Mrpl12 |
mitochondrial ribosomal protein L12 |
decreases expression multiple interactions |
ISO |
beauvericin results in decreased expression of MRPL12 mRNA [beauvericin co-treated with enniatins] results in decreased expression of MRPL12 mRNA |
CTD |
PMID:29203277 PMID:31100301 |
|
NCBI chr10:105,758,410...105,762,913
Ensembl chr10:105,758,410...105,762,913
|
|
G |
Mrpl4 |
mitochondrial ribosomal protein L4 |
decreases expression |
ISO |
beauvericin results in decreased expression of MRPL4 mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 8:19,539,593...19,545,608
Ensembl chr 8:19,539,593...19,545,608
|
|
G |
Mt-atp6 |
mitochondrially encoded ATP synthase membrane subunit 6 |
decreases expression multiple interactions |
ISO |
beauvericin results in decreased expression of ATP6 mRNA [beauvericin co-treated with enniatins co-treated with ochratoxin A] results in increased expression of ATP6 mRNA; [beauvericin co-treated with enniatins] results in decreased expression of ATP6 mRNA; [beauvericin co-treated with enniatins] results in increased expression of ATP6 mRNA; [Plant Extracts co-treated with beauvericin co-treated with enniatins] results in decreased expression of ATP6 mRNA; [Plant Extracts co-treated with beauvericin] results in decreased expression of ATP6 mRNA; [Plant Extracts co-treated with ochratoxin A co-treated with Zearalenone co-treated with beauvericin] results in decreased expression of ATP6 mRNA |
CTD |
PMID:29203277 PMID:31100301 PMID:34015425 |
|
NCBI chr MT:7,919...8,599 NCBI chr MT:7,919...8,599 NCBI chr MT:7,919...8,599 NCBI chr MT:7,919...8,599 NCBI chr MT:7,919...8,599 NCBI chr MT:7,919...8,599 NCBI chr MT:7,919...8,599 NCBI chr MT:7,919...8,599 NCBI chr MT:7,919...8,599
Ensembl chr MT:7,919...8,599
|
|
G |
Mt-atp8 |
mitochondrially encoded ATP synthase membrane subunit 8 |
decreases expression multiple interactions |
ISO |
beauvericin results in decreased expression of ATP8 mRNA [beauvericin co-treated with enniatins co-treated with ochratoxin A] results in decreased expression of ATP8 mRNA; [beauvericin co-treated with enniatins] affects the expression of ATP8 mRNA; [beauvericin co-treated with enniatins] results in decreased expression of ATP8 mRNA; [Plant Extracts co-treated with beauvericin co-treated with enniatins] results in decreased expression of ATP8 mRNA; [Plant Extracts co-treated with beauvericin] results in decreased expression of ATP8 mRNA; [Plant Extracts co-treated with ochratoxin A co-treated with Zearalenone co-treated with beauvericin] results in decreased expression of ATP8 mRNA |
CTD |
PMID:29203277 PMID:31100301 PMID:34015425 |
|
NCBI chr MT:7,758...7,961 NCBI chr MT:7,758...7,961 NCBI chr MT:7,758...7,961 NCBI chr MT:7,758...7,961 NCBI chr MT:7,758...7,961 NCBI chr MT:7,758...7,961 NCBI chr MT:7,758...7,961 NCBI chr MT:7,758...7,961 NCBI chr MT:7,758...7,961 NCBI chr MT:7,758...7,961
Ensembl chr MT:7,758...7,961
|
|
G |
Mt-co1 |
mitochondrially encoded cytochrome c oxidase I |
multiple interactions decreases expression |
ISO |
[beauvericin co-treated with enniatins co-treated with ochratoxin A] results in decreased expression of COX1 mRNA; [beauvericin co-treated with enniatins] affects the expression of COX1 mRNA; [beauvericin co-treated with enniatins] results in decreased expression of COX1 mRNA; [Plant Extracts co-treated with beauvericin co-treated with enniatins] results in decreased expression of COX1 mRNA; [Plant Extracts co-treated with beauvericin] results in decreased expression of COX1 mRNA; [Plant Extracts co-treated with ochratoxin A co-treated with Zearalenone co-treated with beauvericin] results in decreased expression of COX1 mRNA beauvericin results in decreased expression of COX1 mRNA |
CTD |
PMID:31100301 PMID:34015425 |
|
NCBI chr MT:5,323...6,867 NCBI chr MT:5,323...6,867 NCBI chr MT:5,323...6,867 NCBI chr MT:5,323...6,867 NCBI chr MT:5,323...6,867 NCBI chr MT:5,323...6,867 NCBI chr MT:5,323...6,867 NCBI chr MT:5,323...6,867 NCBI chr MT:5,323...6,867 NCBI chr MT:5,323...6,867
Ensembl chr MT:5,323...6,867
|
|
G |
Mt-co3 |
mitochondrially encoded cytochrome c oxidase III |
decreases expression multiple interactions |
ISO |
beauvericin results in decreased expression of COX3 mRNA [beauvericin co-treated with enniatins co-treated with ochratoxin A] results in decreased expression of COX3 mRNA; [beauvericin co-treated with enniatins] results in decreased expression of COX3 mRNA; [Plant Extracts co-treated with beauvericin co-treated with enniatins] results in decreased expression of COX3 mRNA; [Plant Extracts co-treated with beauvericin] results in decreased expression of COX3 mRNA; [Plant Extracts co-treated with ochratoxin A co-treated with Zearalenone co-treated with beauvericin] results in decreased expression of COX3 mRNA |
CTD |
PMID:29203277 PMID:31100301 PMID:34015425 |
|
NCBI chr MT:8,599...9,382 NCBI chr MT:8,599...9,382 NCBI chr MT:8,599...9,382 NCBI chr MT:8,599...9,382 NCBI chr MT:8,599...9,382 NCBI chr MT:8,599...9,382 NCBI chr MT:8,599...9,382 NCBI chr MT:8,599...9,382 NCBI chr MT:8,599...9,382
Ensembl chr MT:8,599...9,382
|
|
G |
Mt-cyb |
mitochondrially encoded cytochrome b |
decreases expression |
ISO |
beauvericin results in decreased expression of CYTB mRNA |
CTD |
PMID:29203277 |
|
NCBI chr MT:14,136...15,278 NCBI chr MT:14,136...15,278 NCBI chr MT:14,136...15,278 NCBI chr MT:14,136...15,278 NCBI chr MT:14,136...15,278 NCBI chr MT:14,136...15,278 NCBI chr MT:14,136...15,278 NCBI chr MT:14,136...15,278 NCBI chr MT:14,136...15,278 NCBI chr MT:14,136...15,278 NCBI chr MT:14,136...15,278 NCBI chr MT:14,136...15,278
Ensembl chr MT:14,136...15,278
|
|
G |
Mt-nd2 |
mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 2 |
decreases expression increases expression multiple interactions |
ISO |
beauvericin results in decreased expression of ND2 mRNA beauvericin results in increased expression of ND2 mRNA [beauvericin co-treated with enniatins co-treated with ochratoxin A] results in increased expression of ND2 mRNA; [beauvericin co-treated with enniatins] results in decreased expression of ND2 mRNA; [beauvericin co-treated with enniatins] results in increased expression of ND2 mRNA; [Plant Extracts co-treated with beauvericin co-treated with enniatins] results in increased expression of ND2 mRNA; [Plant Extracts co-treated with beauvericin] results in increased expression of ND2 mRNA; [Plant Extracts co-treated with ochratoxin A co-treated with Zearalenone co-treated with beauvericin] results in increased expression of ND2 mRNA |
CTD |
PMID:29203277 PMID:31100301 PMID:34015425 |
|
NCBI chr MT:3,904...4,942 NCBI chr MT:3,904...4,942 NCBI chr MT:3,904...4,942 NCBI chr MT:3,904...4,942 NCBI chr MT:3,904...4,942 NCBI chr MT:3,904...4,942 NCBI chr MT:3,904...4,942 NCBI chr MT:3,904...4,942 NCBI chr MT:3,904...4,942 NCBI chr MT:3,904...4,942 NCBI chr MT:3,904...4,942
Ensembl chr MT:3,904...4,942
|
|
G |
Mt-nd3 |
mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 3 |
decreases expression increases expression multiple interactions |
ISO |
beauvericin results in decreased expression of ND3 mRNA beauvericin results in increased expression of ND3 mRNA [beauvericin co-treated with enniatins co-treated with ochratoxin A] results in increased expression of ND3 mRNA; [beauvericin co-treated with enniatins] results in decreased expression of ND3 mRNA; [beauvericin co-treated with enniatins] results in increased expression of ND3 mRNA; [Plant Extracts co-treated with beauvericin co-treated with enniatins] results in increased expression of ND3 mRNA; [Plant Extracts co-treated with beauvericin] results in increased expression of ND3 mRNA; [Plant Extracts co-treated with ochratoxin A co-treated with Zearalenone co-treated with beauvericin] results in increased expression of ND3 mRNA |
CTD |
PMID:29203277 PMID:31100301 PMID:34015425 |
|
NCBI chr MT:9,451...9,798 NCBI chr MT:9,451...9,798 NCBI chr MT:9,451...9,798 NCBI chr MT:9,451...9,798 NCBI chr MT:9,451...9,798 NCBI chr MT:9,451...9,798 NCBI chr MT:9,451...9,798 NCBI chr MT:9,451...9,798 NCBI chr MT:9,451...9,798 NCBI chr MT:9,451...9,798 NCBI chr MT:9,451...9,798
Ensembl chr MT:9,451...9,798
|
|
G |
Mt-nd4 |
mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4 |
decreases expression multiple interactions |
ISO |
beauvericin results in decreased expression of ND4 mRNA [beauvericin co-treated with enniatins co-treated with ochratoxin A] results in decreased expression of ND4 mRNA; [beauvericin co-treated with enniatins] results in decreased expression of ND4 mRNA; [beauvericin co-treated with enniatins] results in increased expression of ND4 mRNA; [Plant Extracts co-treated with beauvericin co-treated with enniatins] results in increased expression of ND4 mRNA; [Plant Extracts co-treated with beauvericin] results in increased expression of ND4 mRNA; [Plant Extracts co-treated with ochratoxin A co-treated with Zearalenone co-treated with beauvericin] results in decreased expression of ND4 mRNA |
CTD |
PMID:29203277 PMID:31100301 PMID:34015425 |
|
NCBI chr MT:10,160...11,537 NCBI chr MT:10,160...11,537 NCBI chr MT:10,160...11,537 NCBI chr MT:10,160...11,537 NCBI chr MT:10,160...11,537 NCBI chr MT:10,160...11,537 NCBI chr MT:10,160...11,537 NCBI chr MT:10,160...11,537 NCBI chr MT:10,160...11,537 NCBI chr MT:10,160...11,537 NCBI chr MT:10,160...11,537
Ensembl chr MT:10,160...11,537
|
|
G |
Mt-nd4l |
mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4L |
decreases expression increases expression multiple interactions |
ISO |
beauvericin results in decreased expression of ND4L mRNA beauvericin results in increased expression of ND4L mRNA [beauvericin co-treated with enniatins co-treated with ochratoxin A] results in increased expression of ND4L mRNA; [beauvericin co-treated with enniatins] results in decreased expression of ND4L mRNA; [Plant Extracts co-treated with beauvericin co-treated with enniatins] results in increased expression of ND4L mRNA; [Plant Extracts co-treated with beauvericin] results in increased expression of ND4L mRNA |
CTD |
PMID:29203277 PMID:31100301 PMID:34015425 |
|
NCBI chr MT:9,870...10,166 NCBI chr MT:9,870...10,166 NCBI chr MT:9,870...10,166 NCBI chr MT:9,870...10,166 NCBI chr MT:9,870...10,166 NCBI chr MT:9,870...10,166 NCBI chr MT:9,870...10,166 NCBI chr MT:9,870...10,166 NCBI chr MT:9,870...10,166 NCBI chr MT:9,870...10,166 NCBI chr MT:9,870...10,166
Ensembl chr MT:9,870...10,166
|
|
G |
Mt-nd5 |
mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 5 |
decreases expression increases expression multiple interactions |
ISO |
beauvericin results in decreased expression of ND5 mRNA beauvericin results in increased expression of ND5 mRNA [beauvericin co-treated with enniatins co-treated with ochratoxin A] results in increased expression of ND5 mRNA; [beauvericin co-treated with enniatins] results in decreased expression of ND5 mRNA; [Plant Extracts co-treated with beauvericin co-treated with enniatins] results in increased expression of ND5 mRNA; [Plant Extracts co-treated with beauvericin] results in increased expression of ND5 mRNA |
CTD |
PMID:29203277 PMID:31100301 PMID:34015425 |
|
NCBI chr MT:11,736...13,565 NCBI chr MT:11,736...13,565 NCBI chr MT:11,736...13,565 NCBI chr MT:11,736...13,565 NCBI chr MT:11,736...13,565 NCBI chr MT:11,736...13,565 NCBI chr MT:11,736...13,565 NCBI chr MT:11,736...13,565 NCBI chr MT:11,736...13,565 NCBI chr MT:11,736...13,565 NCBI chr MT:11,736...13,565
Ensembl chr MT:11,736...13,565
|
|
G |
Mt-nd6 |
mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 6 |
decreases expression multiple interactions |
ISO |
beauvericin results in decreased expression of ND6 mRNA [beauvericin co-treated with enniatins co-treated with ochratoxin A] results in decreased expression of ND6 mRNA; [beauvericin co-treated with enniatins] results in decreased expression of ND6 mRNA; [Plant Extracts co-treated with beauvericin co-treated with enniatins] results in increased expression of ND6 mRNA; [Plant Extracts co-treated with beauvericin] results in increased expression of ND6 mRNA |
CTD |
PMID:34015425 |
|
NCBI chr MT:13,543...14,061 NCBI chr MT:13,543...14,061 NCBI chr MT:13,543...14,061 NCBI chr MT:13,543...14,061 NCBI chr MT:13,543...14,061 NCBI chr MT:13,543...14,061 NCBI chr MT:13,543...14,061 NCBI chr MT:13,543...14,061 NCBI chr MT:13,543...14,061 NCBI chr MT:13,543...14,061 NCBI chr MT:13,543...14,061 NCBI chr MT:13,543...14,061 NCBI chr MT:13,543...14,061
Ensembl chr MT:13,543...14,061
|
|
G |
Mtrf1l |
mitochondrial translation release factor 1 like |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of MTRF1L protein |
CTD |
PMID:32407736 |
|
NCBI chr 1:42,208,553...42,221,020
Ensembl chr 1:42,210,583...42,220,836
|
|
G |
Myo18a |
myosin XVIIIa |
increases expression |
ISO |
beauvericin results in increased expression of MYO18A mRNA |
CTD |
PMID:29203277 |
|
NCBI chr10:62,654,218...62,755,465
Ensembl chr10:62,654,281...62,755,468
|
|
G |
Nars1 |
asparaginyl-tRNA synthetase 1 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of NARS1 protein |
CTD |
PMID:32407736 |
|
NCBI chr18:57,989,308...58,005,584
Ensembl chr18:57,989,308...58,005,622
|
|
G |
Nars2 |
asparaginyl-tRNA synthetase 2, mitochondrial |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of NARS2 protein |
CTD |
PMID:32407736 |
|
NCBI chr 1:151,300,446...151,412,086
Ensembl chr 1:151,300,467...151,413,521
|
|
G |
Ndrg1 |
N-myc downstream regulated 1 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of NDRG1 protein |
CTD |
PMID:32407736 |
|
NCBI chr 7:98,684,487...98,725,869
Ensembl chr 7:98,684,487...98,725,880
|
|
G |
Nlrp1a |
NLR family, pyrin domain containing 1A |
increases expression |
ISO |
beauvericin results in increased expression of NLRP1 mRNA |
CTD |
PMID:29203277 |
|
NCBI chr10:55,778,560...55,833,639
Ensembl chr10:55,778,560...55,825,180
|
|
G |
Nod1 |
nucleotide-binding oligomerization domain containing 1 |
increases expression |
ISO |
beauvericin results in increased expression of NOD1 mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 4:84,060,871...84,111,668
Ensembl chr 4:84,060,880...84,111,404
|
|
G |
Nol3 |
nucleolar protein 3 |
increases expression |
ISO |
beauvericin results in increased expression of NOL3 mRNA |
CTD |
PMID:29203277 |
|
NCBI chr19:33,154,061...33,158,250
Ensembl chr19:33,154,062...33,158,250
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of NQO1 mRNA |
CTD |
PMID:31100301 |
|
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
|
|
G |
Nudt1 |
nudix hydrolase 1 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of NUDT1 protein |
CTD |
PMID:32407736 |
|
NCBI chr12:14,302,514...14,309,559
Ensembl chr12:14,302,694...14,305,826
|
|
G |
Oga |
O-GlcNAcase |
increases expression |
ISO |
beauvericin results in increased expression of OGA mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 1:244,598,285...244,633,835
Ensembl chr 1:244,598,292...244,634,359
|
|
G |
Ogt |
O-linked N-acetylglucosamine (GlcNAc) transferase |
increases expression |
ISO |
beauvericin results in increased expression of OGT mRNA |
CTD |
PMID:29203277 |
|
NCBI chr X:66,771,278...66,816,148
Ensembl chr X:66,771,349...66,816,146
|
|
G |
Osgin1 |
oxidative stress induced growth inhibitor 1 |
multiple interactions increases expression |
ISO |
[beauvericin co-treated with enniatins co-treated with ochratoxin A] results in decreased expression of OSGIN1 mRNA; [beauvericin co-treated with enniatins] results in decreased expression of OSGIN1 mRNA; [Plant Extracts co-treated with beauvericin] results in increased expression of OSGIN1 mRNA beauvericin results in increased expression of OSGIN1 mRNA |
CTD |
PMID:31100301 PMID:34015425 |
|
NCBI chr19:47,471,750...47,500,517
Ensembl chr19:47,492,171...47,500,516
|
|
G |
Ostc |
oligosaccharyltransferase complex non-catalytic subunit |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of OSTC protein |
CTD |
PMID:32407736 |
|
NCBI chr 2:219,250,549...219,266,076
Ensembl chr 2:219,236,952...219,266,107
|
|
G |
Parvg |
parvin, gamma |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of PARVG protein |
CTD |
PMID:32407736 |
|
NCBI chr 7:115,456,183...115,475,707
Ensembl chr 7:115,456,209...115,475,104
|
|
G |
Pawr |
pro-apoptotic WT1 regulator |
decreases expression |
ISO |
beauvericin results in decreased expression of PAWR mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 7:43,645,028...43,725,033
Ensembl chr 7:43,645,084...43,725,028
|
|
G |
Pdcd11 |
programmed cell death 11 |
decreases expression |
ISO |
beauvericin results in decreased expression of PDCD11 mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 1:245,980,840...246,021,999
Ensembl chr 1:245,980,880...246,021,999
|
|
G |
Pdcd2 |
programmed cell death 2 |
decreases expression |
ISO |
beauvericin results in decreased expression of PDCD2 mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 1:56,484,947...56,490,437
Ensembl chr 1:56,463,931...56,490,437
|
|
G |
Pdcd2l |
programmed cell death 2-like |
increases expression |
ISO |
beauvericin results in increased expression of PDCD2L mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 1:86,810,292...86,822,554
Ensembl chr 1:86,810,292...86,822,554
|
|
G |
Pdcd4 |
programmed cell death 4 |
decreases expression |
ISO |
beauvericin results in decreased expression of PDCD4 mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 1:252,921,342...252,944,278
Ensembl chr 1:252,921,392...252,944,275
|
|
G |
Pdcd5 |
programmed cell death 5 |
increases expression |
ISO |
beauvericin results in increased expression of PDCD5 mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 1:88,305,869...88,311,200
Ensembl chr 1:88,305,869...88,311,200
|
|
G |
Pdcd6ip |
programmed cell death 6 interacting protein |
increases expression |
ISO |
beauvericin results in increased expression of PDCD6IP mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 8:113,590,998...113,646,795
Ensembl chr 8:113,590,998...113,646,773
|
|
G |
Pdia4 |
protein disulfide isomerase family A, member 4 |
decreases expression |
ISO |
beauvericin results in decreased expression of PDIA4 mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 4:76,803,198...76,822,245
Ensembl chr 4:76,803,198...76,822,107
|
|
G |
Pfn1 |
profilin 1 |
decreases expression multiple interactions |
ISO |
beauvericin results in decreased expression of PFN1 mRNA [beauvericin co-treated with enniatins] results in increased expression of PFN1 protein |
CTD |
PMID:29203277 PMID:32407736 |
|
NCBI chr10:55,365,263...55,367,968
Ensembl chr10:55,365,262...55,527,631
|
|
G |
Pgam1 |
phosphoglycerate mutase 1 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of PGAM1 protein |
CTD |
PMID:32407736 |
|
NCBI chr 1:240,723,832...240,731,443
Ensembl chr 1:240,723,920...240,738,452
|
|
G |
Pgk1 |
phosphoglycerate kinase 1 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of PGK1 protein |
CTD |
PMID:32407736 |
|
NCBI chr X:71,271,454...71,287,429
Ensembl chr X:71,271,440...71,287,418
|
|
G |
Phgdh |
phosphoglycerate dehydrogenase |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of PHGDH protein |
CTD |
PMID:32407736 |
|
NCBI chr 2:185,906,962...185,936,054
Ensembl chr 2:185,906,966...185,935,944
|
|
G |
Phka2 |
phosphorylase kinase regulatory subunit alpha 2 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of PHKA2 protein |
CTD |
PMID:32407736 |
|
NCBI chr X:34,170,959...34,293,498
Ensembl chr X:34,171,323...34,293,466
|
|
G |
Pidd1 |
p53-induced death domain protein 1 |
decreases expression |
ISO |
beauvericin results in decreased expression of PIDD1 mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 1:196,536,815...196,542,808
Ensembl chr 1:196,536,834...196,542,699
|
|
G |
Plk1 |
polo-like kinase 1 |
decreases expression |
ISO |
beauvericin results in decreased expression of PLK1 mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 1:176,716,420...176,726,400
Ensembl chr 1:176,716,420...176,726,400
|
|
G |
Pls3 |
plastin 3 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of PLS3 protein |
CTD |
PMID:32407736 |
|
NCBI chr X:111,589,193...111,683,908
Ensembl chr X:111,589,254...111,683,891
|
|
G |
Ppa1 |
inorganic pyrophosphatase 1 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of PPA1 protein |
CTD |
PMID:32407736 |
|
NCBI chr20:29,590,733...29,617,711
Ensembl chr20:29,590,707...29,619,215
|
|
G |
Ppan |
peter pan homolog |
decreases expression |
ISO |
beauvericin results in decreased expression of PPAN mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 8:19,423,908...19,427,941
Ensembl chr 8:19,423,961...19,427,938
|
|
G |
Ppib |
peptidylprolyl isomerase B |
decreases expression |
ISO |
beauvericin results in decreased expression of PPIB mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 8:66,603,877...66,609,734
Ensembl chr 8:66,603,861...66,630,428
|
|
G |
Ppp1r14b |
protein phosphatase 1, regulatory (inhibitor) subunit 14B |
decreases expression |
ISO |
beauvericin results in decreased expression of PPP1R14B mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 1:204,165,210...204,167,320
Ensembl chr 1:204,163,299...204,167,319 Ensembl chr12:204,163,299...204,167,319
|
|
G |
Ppt1 |
palmitoyl-protein thioesterase 1 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of PPT1 protein |
CTD |
PMID:32407736 |
|
NCBI chr 5:135,121,164...135,142,048
Ensembl chr 5:135,121,163...135,142,048
|
|
G |
Prkca |
protein kinase C, alpha |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of PRKCA protein |
CTD |
PMID:32407736 |
|
NCBI chr10:92,889,390...93,288,013
Ensembl chr10:92,894,012...93,288,012
|
|
G |
Psma5 |
proteasome 20S subunit alpha 5 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of PSMA5 protein |
CTD |
PMID:32407736 |
|
NCBI chr 2:195,896,369...195,919,733
Ensembl chr 2:195,896,365...195,919,731
|
|
G |
Psme4 |
proteasome activator subunit 4 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of PSME4 protein |
CTD |
PMID:32407736 |
|
NCBI chr14:104,505,716...104,609,410
Ensembl chr14:104,505,716...104,609,408
|
|
G |
Ptges3 |
prostaglandin E synthase 3 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of PTGES3 protein |
CTD |
PMID:32407736 |
|
NCBI chr 7:490,698...507,759
Ensembl chr 7:490,656...508,084
|
|
G |
Ptprc |
protein tyrosine phosphatase, receptor type, C |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of PTPRC protein |
CTD |
PMID:32407736 |
|
NCBI chr13:49,596,193...49,708,283
Ensembl chr13:49,596,193...49,708,692
|
|
G |
Rab11fip5 |
RAB11 family interacting protein 5 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of RAB11FIP5 protein |
CTD |
PMID:32407736 |
|
NCBI chr 4:117,871,301...117,908,819
Ensembl chr 4:117,871,308...117,908,741
|
|
G |
Rab5a |
RAB5A, member RAS oncogene family |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of RAB5A protein |
CTD |
PMID:32407736 |
|
NCBI chr 9:6,483,906...6,512,877
Ensembl chr 9:6,484,469...6,512,873
|
|
G |
Rac3 |
Rac family small GTPase 3 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of RAC3 protein |
CTD |
PMID:32407736 |
|
NCBI chr10:106,002,808...106,005,243
Ensembl chr10:105,993,087...106,005,260
|
|
G |
Rap1a |
RAP1A, member of RAS oncogene family |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of RAP1A protein |
CTD |
PMID:32407736 |
|
NCBI chr 2:193,208,631...193,286,513
Ensembl chr 2:193,208,635...193,286,501
|
|
G |
Relt |
RELT, TNF receptor |
decreases expression |
ISO |
beauvericin results in decreased expression of RELT mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 1:155,206,976...155,224,609
Ensembl chr 1:155,206,976...155,214,196
|
|
G |
Rp2 |
RP2 activator of ARL3 GTPase |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of RP2 protein |
CTD |
PMID:32407736 |
|
NCBI chr X:1,872,582...1,916,704
Ensembl chr X:1,873,306...1,916,688
|
|
G |
Rpl37a |
ribosomal protein L37A |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of RPL37A protein |
CTD |
PMID:32407736 |
|
NCBI chr 9:74,298,843...74,300,926
|
|
G |
Rpl5 |
ribosomal protein L5 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of RPL5 protein |
CTD |
PMID:32407736 |
|
NCBI chr14:1,843,856...1,850,301
Ensembl chr14:1,843,770...1,850,290
|
|
G |
Rpl8 |
ribosomal protein L8 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of RPL8 protein |
CTD |
PMID:32407736 |
|
NCBI chr 7:108,626,194...108,628,485
Ensembl chr 7:108,622,324...108,628,482 Ensembl chr 3:108,622,324...108,628,482
|
|
G |
Rxra |
retinoid X receptor alpha |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of RXRA protein |
CTD |
PMID:32407736 |
|
NCBI chr 3:10,989,832...11,076,366
Ensembl chr 3:10,989,832...11,073,712
|
|
G |
Scml2 |
Scm polycomb group protein like 2 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of SCML2 protein |
CTD |
PMID:32407736 |
|
NCBI chr X:33,523,179...33,677,672
Ensembl chr X:33,524,530...33,652,742
|
|
G |
Sdf2l1 |
stromal cell-derived factor 2-like 1 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of SDF2L1 protein |
CTD |
PMID:32407736 |
|
NCBI chr11:83,872,659...83,874,902
Ensembl chr11:83,872,659...83,874,902
|
|
G |
Sdr42e2 |
short chain dehydrogenase/reductase family 42E, member 2 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of SDR42E2 protein |
CTD |
PMID:32407736 |
|
NCBI chr 1:175,361,630...175,382,769
Ensembl chr 1:175,362,150...175,382,050
|
|
G |
Sec13 |
SEC13 homolog, nuclear pore and COPII coat complex component |
decreases expression |
ISO |
beauvericin results in decreased expression of SEC13 mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 4:146,877,739...146,891,130
Ensembl chr 4:146,875,524...146,891,173
|
|
G |
Siva1 |
SIVA1, apoptosis-inducing factor |
decreases expression |
ISO |
beauvericin results in decreased expression of SIVA1 mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 6:131,705,323...131,709,697
Ensembl chr 6:131,705,323...131,709,690
|
|
G |
Slc1a5 |
solute carrier family 1 member 5 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of SLC1A5 protein |
CTD |
PMID:32407736 |
|
NCBI chr 1:77,456,849...77,470,952
Ensembl chr 1:77,456,694...77,470,952
|
|
G |
Slc2a1 |
solute carrier family 2 member 1 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of SLC2A1 protein |
CTD |
PMID:32407736 |
|
NCBI chr 5:132,717,196...132,745,416
Ensembl chr 5:132,717,196...132,745,416
|
|
G |
Slc3a2 |
solute carrier family 3 member 2 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of SLC3A2 protein |
CTD |
PMID:32407736 |
|
NCBI chr 1:205,604,468...205,618,931
Ensembl chr 1:205,604,468...205,618,931
|
|
G |
Snrpd2 |
small nuclear ribonucleoprotein D2 polypeptide |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of SNRPD2 protein |
CTD |
PMID:32407736 |
|
NCBI chr 1:78,798,377...78,801,227
Ensembl chr 1:78,798,377...78,803,351 Ensembl chr20:78,798,377...78,803,351
|
|
G |
Snrpd3 |
small nuclear ribonucleoprotein D3 polypeptide |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of SNRPD3 protein |
CTD |
PMID:32407736 |
|
NCBI chr20:13,130,112...13,145,947
Ensembl chr20:13,130,119...13,145,978
|
|
G |
Src |
SRC proto-oncogene, non-receptor tyrosine kinase |
decreases activity |
EXP |
beauvericin results in decreased activity of SRC protein |
CTD |
PMID:25178661 |
|
NCBI chr 3:146,091,969...146,139,492
Ensembl chr 3:146,091,841...146,139,476
|
|
G |
Srm |
spermidine synthase |
decreases expression |
ISO |
beauvericin results in decreased expression of SRM mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 5:159,025,875...159,029,076
Ensembl chr 5:159,025,873...159,029,405
|
|
G |
Srsf7 |
serine and arginine rich splicing factor 7 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of SRSF7 protein |
CTD |
PMID:32407736 |
|
NCBI chr 6:14,811,775...14,818,968
Ensembl chr 6:14,811,808...14,818,965
|
|
G |
Srxn1 |
sulfiredoxin 1 |
multiple interactions decreases expression |
ISO |
[beauvericin co-treated with enniatins co-treated with ochratoxin A] results in decreased expression of SRXN1 mRNA; [beauvericin co-treated with enniatins] results in decreased expression of SRXN1 mRNA; [Plant Extracts co-treated with beauvericin co-treated with enniatins] results in decreased expression of SRXN1 mRNA; [Plant Extracts co-treated with beauvericin] results in decreased expression of SRXN1 mRNA beauvericin results in decreased expression of SRXN1 mRNA |
CTD |
PMID:31100301 PMID:34015425 |
|
NCBI chr 3:140,604,490...140,610,050
Ensembl chr 3:140,599,608...140,628,448
|
|
G |
Ssbp1 |
single stranded DNA binding protein 1 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of SSBP1 protein |
CTD |
PMID:32407736 |
|
NCBI chr 4:69,266,024...69,276,135
Ensembl chr 4:69,266,102...69,276,135
|
|
G |
Tbc1d2b |
TBC1 domain family, member 2B |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of TBC1D2B protein |
CTD |
PMID:32407736 |
|
NCBI chr 8:90,746,220...90,814,867
Ensembl chr 8:90,746,233...90,814,832
|
|
G |
Tcn2 |
transcobalamin 2 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of TCN2 protein |
CTD |
PMID:32407736 |
|
NCBI chr14:78,813,343...78,828,549
Ensembl chr14:78,813,343...78,828,489
|
|
G |
Tcp11l1 |
t-complex 11 like 1 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of TCP11L1 protein |
CTD |
PMID:32407736 |
|
NCBI chr 3:91,047,006...91,092,687
Ensembl chr 3:90,998,270...91,092,006
|
|
G |
Tcp11l2 |
t-complex 11 like 2 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of TCP11L2 protein |
CTD |
PMID:32407736 |
|
NCBI chr 7:19,150,241...19,185,135
Ensembl chr 7:19,150,252...19,185,095
|
|
G |
Thyn1 |
thymocyte nuclear protein 1 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of THYN1 protein |
CTD |
PMID:32407736 |
|
NCBI chr 8:25,406,563...25,415,445
Ensembl chr 8:25,406,500...25,415,445
|
|
G |
Timm9 |
translocase of inner mitochondrial membrane 9 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of TIMM9 protein |
CTD |
PMID:32407736 |
|
NCBI chr 6:89,610,094...89,622,924
Ensembl chr 6:89,610,094...89,622,924
|
|
G |
Tk1 |
thymidine kinase 1 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of TK1 protein |
CTD |
PMID:32407736 |
|
NCBI chr10:103,034,755...103,046,125
Ensembl chr10:103,031,521...103,046,920
|
|
G |
Tmem263 |
transmembrane protein 263 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of TMEM263 protein |
CTD |
PMID:32407736 |
|
NCBI chr 7:18,610,151...18,628,311
Ensembl chr 7:18,610,149...18,628,534
|
|
G |
Tnfsf10 |
TNF superfamily member 10 |
decreases expression |
ISO |
beauvericin results in decreased expression of TNFSF10 mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 2:110,199,835...110,227,239
Ensembl chr 2:110,207,916...110,225,135
|
|
G |
Tomm22 |
translocase of outer mitochondrial membrane 22 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of TOMM22 protein |
CTD |
PMID:32407736 |
|
NCBI chr 7:111,223,508...111,228,671
Ensembl chr 7:111,216,571...111,246,799
|
|
G |
Tomm7 |
translocase of outer mitochondrial membrane 7 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of TOMM7 protein |
CTD |
PMID:32407736 |
|
NCBI chr 4:11,305,122...11,311,963
Ensembl chr 4:11,305,110...11,311,962
|
|
G |
Tuba1b |
tubulin, alpha 1B |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of TUBA1B protein |
CTD |
PMID:32407736 |
|
NCBI chr 7:130,090,663...130,093,644
Ensembl chr 7:130,081,032...130,196,186
|
|
G |
Tubb3 |
tubulin, beta 3 class III |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of TUBB3 protein |
CTD |
PMID:32407736 |
|
NCBI chr19:51,457,187...51,466,243
Ensembl chr19:51,457,184...51,466,243
|
|
G |
Tubb4a |
tubulin, beta 4A class IVa |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of TUBB4A protein |
CTD |
PMID:32407736 |
|
NCBI chr 9:1,917,841...1,925,286
Ensembl chr 9:1,917,845...1,925,291
|
|
G |
Tubb4b |
tubulin, beta 4B class IVb |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of TUBB4B protein |
CTD |
PMID:32407736 |
|
NCBI chr 3:8,037,838...8,040,294
Ensembl chr 3:8,037,799...8,040,296
|
|
G |
Tubb5 |
tubulin, beta 5 class I |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of TUBB protein |
CTD |
PMID:32407736 |
|
NCBI chr20:2,912,779...2,916,928
Ensembl chr20:2,912,778...2,916,940
|
|
G |
Txnip |
thioredoxin interacting protein |
increases expression multiple interactions decreases expression |
ISO |
beauvericin results in increased expression of TXNIP mRNA [beauvericin co-treated with enniatins co-treated with ochratoxin A] results in increased expression of TXNIP mRNA; [Plant Extracts co-treated with beauvericin co-treated with enniatins] results in increased expression of TXNIP mRNA; [Plant Extracts co-treated with beauvericin] results in increased expression of TXNIP mRNA beauvericin results in decreased expression of TXNIP mRNA |
CTD |
PMID:29203277 PMID:34015425 |
|
NCBI chr 2:184,093,079...184,096,882
Ensembl chr 2:184,092,991...184,096,886
|
|
G |
Ucp2 |
uncoupling protein 2 |
multiple interactions decreases expression |
ISO |
[beauvericin co-treated with enniatins co-treated with ochratoxin A] results in increased expression of UCP2 mRNA; [beauvericin co-treated with enniatins] results in decreased expression of UCP2 mRNA; [Plant Extracts co-treated with beauvericin co-treated with enniatins] results in increased expression of UCP2 mRNA; [Plant Extracts co-treated with beauvericin] results in increased expression of UCP2 mRNA; [Plant Extracts co-treated with ochratoxin A co-treated with Zearalenone co-treated with beauvericin] results in decreased expression of UCP2 mRNA beauvericin results in decreased expression of UCP2 mRNA |
CTD |
PMID:31100301 PMID:34015425 |
|
NCBI chr 1:154,839,242...154,845,612
Ensembl chr 1:154,839,209...154,845,611
|
|
G |
Ucp3 |
uncoupling protein 3 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of UCP3 mRNA |
CTD |
PMID:31100301 |
|
NCBI chr 1:154,815,777...154,828,764
Ensembl chr 1:154,815,777...154,828,762
|
|
G |
Ybx1 |
Y box binding protein 1 |
decreases expression |
ISO |
beauvericin results in decreased expression of YBX1 mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 5:132,882,137...132,898,885
Ensembl chr 5:132,882,145...132,898,862
|
|
G |
Ybx3 |
Y box binding protein 3 |
decreases expression |
ISO |
beauvericin results in decreased expression of YBX3 mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 4:165,129,747...165,153,101
Ensembl chr 4:165,129,758...165,153,161
|
|
G |
Ykt6 |
YKT6 v-SNARE homolog |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of YKT6 protein |
CTD |
PMID:32407736 |
|
NCBI chr14:80,832,187...80,843,394
Ensembl chr14:80,832,187...80,843,385
|
|
|
G |
Abcc2 |
ATP binding cassette subfamily C member 2 |
increases activity |
EXP |
Carbon Monoxide results in increased activity of ABCC2 protein |
CTD |
PMID:13678533 |
|
NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238
|
|
G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
multiple interactions increases expression |
EXP |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[Carbon Monoxide results in increased expression of ADIPOQ protein] which results in increased phosphorylation of AKT1 protein]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[Carbon Monoxide results in increased expression of ADIPOQ protein] which results in increased phosphorylation of NOS3 protein]; [Carbon Monoxide results in increased expression of ADIPOQ protein] inhibits the reaction [TNF protein results in increased activity of CASP3 protein]; [Carbon Monoxide results in increased expression of ADIPOQ protein] inhibits the reaction [TNF protein results in increased expression of ICAM1 protein]; [Carbon Monoxide results in increased expression of ADIPOQ protein] inhibits the reaction [TNF protein results in increased expression of VCAM1 protein]; [Carbon Monoxide results in increased expression of ADIPOQ protein] which results in increased phosphorylation of AKT1 protein; [Carbon Monoxide results in increased expression of ADIPOQ protein] which results in increased phosphorylation of NOS3 protein [Carbon Monoxide results in increased expression of ADIPOQ protein] which results in increased expression of PECAM1 protein; Carbon Monoxide results in increased expression of ADIPOQ protein |
CTD |
PMID:19356108 |
|
NCBI chr11:77,721,912...77,735,644
Ensembl chr11:77,721,912...77,735,564
|
|
G |
Adm |
adrenomedullin |
increases expression |
EXP |
Carbon Monoxide results in increased expression of ADM mRNA; Carbon Monoxide results in increased expression of ADM protein |
CTD |
PMID:10666155 |
|
NCBI chr 1:164,745,484...164,747,655
Ensembl chr 1:164,745,466...164,747,654
|
|
G |
Agr2 |
anterior gradient 2, protein disulphide isomerase family member |
multiple interactions |
ISO |
[Air Pollutants results in increased abundance of [Carbon Monoxide co-treated with Nitrogen Oxides co-treated with Sulfur Dioxide]] which results in increased expression of AGR2 mRNA |
CTD |
PMID:29621558 |
|
NCBI chr 6:52,708,602...52,729,378
Ensembl chr 6:52,708,602...52,729,371
|
|
G |
Agt |
angiotensinogen |
decreases response to substance |
ISO |
AGT protein results in decreased susceptibility to Carbon Monoxide |
CTD |
PMID:18174886 |
|
NCBI chr19:52,529,139...52,549,618
Ensembl chr19:52,529,185...52,540,977
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
multiple interactions increases phosphorylation |
ISO EXP |
AKT1 protein affects the reaction [Carbon Monoxide results in increased localization of NRF1 protein]; Carbon Monoxide inhibits the reaction [Doxorubicin results in decreased phosphorylation of AKT1 protein]; Carbon Monoxide results in increased phosphorylation of and results in increased activity of AKT1 protein; CAT protein inhibits the reaction [Carbon Monoxide results in increased phosphorylation of AKT1 protein] Carbon Monoxide inhibits the reaction [IL18 protein results in decreased phosphorylation of AKT1 protein] 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[Carbon Monoxide results in increased expression of ADIPOQ protein] which results in increased phosphorylation of AKT1 protein]; [Carbon Monoxide results in increased expression of ADIPOQ protein] which results in increased phosphorylation of AKT1 protein; Carbon Monoxide results in increased phosphorylation of and results in increased activity of AKT1 protein; CAT protein inhibits the reaction [Carbon Monoxide results in increased phosphorylation of and results in increased activity of AKT1 protein] |
CTD |
PMID:17179207 PMID:18037988 PMID:18215737 PMID:18845810 PMID:19356108 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Alad |
aminolevulinate dehydratase |
increases activity multiple interactions |
EXP |
Carbon Monoxide results in increased activity of ALAD protein Carbon Monoxide inhibits the reaction [[Phenobarbital co-treated with bromobenzene] results in decreased activity of ALAD protein] |
CTD |
PMID:1032310 PMID:6740708 |
|
NCBI chr 5:75,961,993...75,972,334
Ensembl chr 5:75,961,993...75,972,474
|
|
G |
Areg |
amphiregulin |
multiple interactions |
ISO |
[Air Pollutants results in increased abundance of [Carbon Monoxide co-treated with Nitrogen Oxides co-treated with Sulfur Dioxide]] which results in decreased expression of AREG mRNA |
CTD |
PMID:29621558 |
|
NCBI chr14:16,972,185...16,981,443
Ensembl chr14:16,972,187...16,981,535
|
|
G |
Bach1 |
BTB domain and CNC homolog 1 |
decreases phosphorylation |
ISO |
Carbon Monoxide results in decreased phosphorylation of BACH1 protein |
CTD |
PMID:18845810 |
|
NCBI chr11:26,939,429...26,974,876
Ensembl chr11:26,939,480...26,972,447
|
|
G |
Bad |
BCL2-associated agonist of cell death |
multiple interactions |
ISO |
Carbon Monoxide inhibits the reaction [Doxorubicin results in decreased phosphorylation of BAD protein] |
CTD |
PMID:18037988 |
|
NCBI chr 1:204,133,502...204,142,829
Ensembl chr 1:204,131,501...204,142,823
|
|
G |
Bcl2a1 |
BCL2-related protein A1 |
multiple interactions |
ISO |
BCL2A1 protein inhibits the reaction [NFKBIA protein inhibits the reaction [[HMOX1 protein results in increased chemical synthesis of Carbon Monoxide] which results in decreased susceptibility to TNF protein]]; MAPK14 protein affects the reaction [BCL2A1 protein inhibits the reaction [NFKBIA protein inhibits the reaction [[HMOX1 protein results in increased chemical synthesis of Carbon Monoxide] which results in decreased susceptibility to TNF protein]]] |
CTD |
PMID:11880364 |
|
NCBI chr 8:89,716,914...89,724,998
Ensembl chr 8:89,716,914...89,724,998
|
|
G |
Bdnf |
brain-derived neurotrophic factor |
multiple interactions decreases expression |
EXP |
Carbon Monoxide results in decreased expression of and results in decreased secretion of BDNF protein Carbon Monoxide results in decreased expression of BDNF mRNA |
CTD |
PMID:27113706 |
|
NCBI chr 3:96,165,042...96,215,621
Ensembl chr 3:96,165,042...96,215,615
|
|
G |
Birc3 |
baculoviral IAP repeat-containing 3 |
multiple interactions |
ISO |
BIRC3 protein inhibits the reaction [NFKBIA protein inhibits the reaction [[HMOX1 protein results in increased chemical synthesis of Carbon Monoxide] which results in decreased susceptibility to TNF protein]]; MAPK14 protein affects the reaction [BIRC3 protein inhibits the reaction [NFKBIA protein inhibits the reaction [[HMOX1 protein results in increased chemical synthesis of Carbon Monoxide] which results in decreased susceptibility to TNF protein]]] |
CTD |
PMID:11880364 |
|
NCBI chr 8:5,000,844...5,028,470
Ensembl chr 8:5,000,845...5,015,802
|
|
G |
Casp3 |
caspase 3 |
multiple interactions increases expression increases activity |
EXP ISO |
[Carbon Monoxide results in increased expression of ADIPOQ protein] inhibits the reaction [TNF protein results in increased activity of CASP3 protein]; Carbon Monoxide inhibits the reaction [Carbon Tetrachloride results in increased activity of CASP3 protein]; Carbon Monoxide results in increased cleavage of and results in increased activity of CASP3 protein; Hemin inhibits the reaction [Carbon Monoxide results in increased cleavage of and results in increased activity of CASP3 protein]; sulforaphane inhibits the reaction [Carbon Monoxide results in increased expression of CASP3 mRNA]; tin protoporphyrin IX inhibits the reaction [Hemin inhibits the reaction [Carbon Monoxide results in increased cleavage of and results in increased activity of CASP3 protein]] Carbon Monoxide results in increased expression of CASP3 protein [Air Pollutants results in increased abundance of [Particulate Matter co-treated with Carbon co-treated with Sulfur Dioxide co-treated with Nitrogen Oxides co-treated with Carbon Monoxide]] which results in increased expression of CASP3 mRNA Carbon Monoxide results in increased activity of CASP3 protein |
CTD |
PMID:17173083 PMID:19356108 PMID:19520142 PMID:25562542 PMID:31268311 PMID:37860845 More...
|
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp7 |
caspase 7 |
increases activity |
EXP |
Carbon Monoxide results in increased activity of CASP7 protein |
CTD |
PMID:25562542 |
|
NCBI chr 1:255,437,438...255,476,737
Ensembl chr 1:255,437,172...255,476,729
|
|
G |
Casp8 |
caspase 8 |
increases activity multiple interactions |
EXP ISO |
Carbon Monoxide results in increased activity of CASP8 protein [Air Pollutants results in increased abundance of [Particulate Matter co-treated with Carbon co-treated with Sulfur Dioxide co-treated with Nitrogen Oxides co-treated with Carbon Monoxide]] which results in increased expression of CASP8 mRNA |
CTD |
PMID:25562542 PMID:31268311 |
|
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
Casp9 |
caspase 9 |
increases activity multiple interactions increases expression |
EXP ISO |
Carbon Monoxide results in increased activity of CASP9 protein sulforaphane inhibits the reaction [Carbon Monoxide results in increased expression of CASP9 mRNA]; sulforaphane inhibits the reaction [Carbon Monoxide results in increased expression of CASP9 protein] Carbon Monoxide results in increased expression of CASP9 mRNA; Carbon Monoxide results in increased expression of CASP9 protein [Air Pollutants results in increased abundance of [Particulate Matter co-treated with Carbon co-treated with Sulfur Dioxide co-treated with Nitrogen Oxides co-treated with Carbon Monoxide]] which results in increased expression of CASP9 mRNA |
CTD |
PMID:25562542 PMID:31268311 PMID:37860845 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Cat |
catalase |
multiple interactions decreases expression |
ISO EXP |
CAT protein inhibits the reaction [Carbon Monoxide results in increased localization of NFE2L2 protein]; CAT protein inhibits the reaction [Carbon Monoxide results in increased phosphorylation of AKT1 protein] Carbon Monoxide results in decreased expression of CAT protein CAT protein inhibits the reaction [Carbon Monoxide promotes the reaction [NRF1 protein binds to TFAM promoter]]; CAT protein inhibits the reaction [Carbon Monoxide results in increased phosphorylation of and results in increased activity of AKT1 protein]; NFE2L2 protein inhibits the reaction [Carbon Monoxide results in decreased expression of CAT protein] |
CTD |
PMID:17179207 PMID:18845810 PMID:34032369 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Ccl1 |
C-C motif chemokine ligand 1 |
multiple interactions |
ISO |
[Air Pollutants results in increased abundance of [Carbon Monoxide co-treated with Nitrogen Oxides co-treated with Sulfur Dioxide]] which results in decreased expression of CCL1 mRNA |
CTD |
PMID:29621558 |
|
NCBI chr10:67,128,331...67,131,109
Ensembl chr10:67,128,331...67,131,159
|
|
G |
Cd86 |
CD86 molecule |
decreases expression |
EXP |
Carbon Monoxide results in decreased expression of CD86 protein |
CTD |
PMID:12201358 |
|
NCBI chr11:64,142,193...64,200,816
Ensembl chr11:64,163,828...64,200,818
|
|
G |
Clca1 |
chloride channel accessory 1 |
multiple interactions |
ISO |
[Air Pollutants results in increased abundance of [Carbon Monoxide co-treated with Nitrogen Oxides co-treated with Sulfur Dioxide]] which results in increased expression of CLCA1 mRNA |
CTD |
PMID:29621558 |
|
NCBI chr 2:233,938,677...233,964,369
Ensembl chr 2:233,938,677...233,964,369
|
|
G |
Col11a1 |
collagen type XI alpha 1 chain |
multiple interactions |
ISO |
[Air Pollutants results in increased abundance of [Carbon Monoxide co-treated with Nitrogen Oxides co-treated with Sulfur Dioxide]] which results in increased expression of COL11A1 mRNA |
CTD |
PMID:29621558 |
|
NCBI chr 2:201,820,715...202,013,853
Ensembl chr 2:201,820,715...202,013,853
|
|
G |
Crp |
C-reactive protein |
increases expression |
ISO |
Carbon Monoxide results in increased expression of CRP protein |
CTD |
PMID:18629312 |
|
NCBI chr13:85,135,384...85,175,178
Ensembl chr13:85,124,977...85,175,178
|
|
G |
Cxcl11 |
C-X-C motif chemokine ligand 11 |
multiple interactions |
ISO |
[Air Pollutants results in increased abundance of [Carbon Monoxide co-treated with Nitrogen Oxides co-treated with Sulfur Dioxide]] which results in increased expression of CXCL11 mRNA |
CTD |
PMID:29621558 |
|
NCBI chr14:15,689,432...15,692,207
Ensembl chr14:15,689,424...15,692,271
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
multiple interactions |
EXP |
Carbon Monoxide inhibits the reaction [CYP1A1 protein results in increased reduction of sodium chromate(VI)] |
CTD |
PMID:1903091 |
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
multiple interactions |
ISO |
Carbon Monoxide promotes the reaction [1-ethynylpyrene results in increased expression of CYP1B1 mRNA] |
CTD |
PMID:10581206 |
|
NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917
|
|
G |
Cyp2b1 |
cytochrome P450, family 2, subfamily b, polypeptide 1 |
multiple interactions |
EXP |
Carbon Monoxide inhibits the reaction [CYP2B1 protein results in increased reduction of sodium chromate(VI)] |
CTD |
PMID:1903091 |
|
NCBI chr 1:81,518,387...81,544,999
Ensembl chr 1:81,518,408...81,542,052
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
decreases activity multiple interactions |
ISO EXP |
Carbon Monoxide results in decreased activity of CYP2E1 protein Carbon Monoxide inhibits the reaction [CYP2E1 protein results in increased reduction of sodium chromate(VI)] |
CTD |
PMID:1903091 PMID:15036350 |
|
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
|
|
G |
Dnm1l |
dynamin 1-like |
multiple interactions increases expression |
EXP |
sulforaphane inhibits the reaction [Carbon Monoxide results in increased expression of DNM1L protein] |
CTD |
PMID:37860845 |
|
NCBI chr11:84,581,216...84,632,382
Ensembl chr11:84,581,216...84,631,482
|
|
G |
Duox2 |
dual oxidase 2 |
increases expression decreases expression |
EXP |
Carbon Monoxide results in increased expression of DUOX2 mRNA Carbon Monoxide results in decreased expression of DUOX2 protein |
CTD |
PMID:29223502 |
|
NCBI chr 3:109,223,809...109,247,023
Ensembl chr 3:109,226,924...109,245,902
|
|
G |
Edn1 |
endothelin 1 |
increases expression multiple interactions |
EXP ISO |
Carbon Monoxide results in increased expression of EDN1 mRNA; Carbon Monoxide results in increased expression of EDN1 protein Carbon Monoxide deficiency promotes the reaction [HMOX2 mutant form results in increased expression of EDN1 protein] |
CTD |
PMID:11781074 PMID:12969895 PMID:20197249 |
|
NCBI chr17:22,454,924...22,460,812
Ensembl chr17:22,454,420...22,460,885
|
|
G |
Egr1 |
early growth response 1 |
multiple interactions |
ISO |
Carbon Monoxide inhibits the reaction [Lipopolysaccharides results in increased expression of EGR1 mRNA]; Carbon Monoxide inhibits the reaction [Lipopolysaccharides results in increased expression of EGR1 protein]; UCP2 protein promotes the reaction [Carbon Monoxide inhibits the reaction [Lipopolysaccharides results in increased expression of EGR1 protein]] |
CTD |
PMID:22046279 |
|
NCBI chr18:26,462,967...26,466,766
Ensembl chr18:26,462,981...26,466,766
|
|
G |
Eno2 |
enolase 2 |
increases secretion |
ISO |
Carbon Monoxide results in increased secretion of ENO2 protein |
CTD |
PMID:34533065 |
|
NCBI chr 4:157,572,085...157,580,971
Ensembl chr 4:157,572,088...157,580,980
|
|
G |
Epo |
erythropoietin |
increases expression |
EXP |
Carbon Monoxide results in increased expression of EPO mRNA; Carbon Monoxide results in increased expression of EPO protein |
CTD |
PMID:9263988 |
|
NCBI chr12:19,204,258...19,207,948
Ensembl chr12:19,204,508...19,207,946
|
|
G |
Ero1a |
endoplasmic reticulum oxidoreductase 1 alpha |
increases expression |
EXP |
Carbon Monoxide results in increased expression of ERO1A mRNA |
CTD |
PMID:12752442 |
|
NCBI chr15:18,495,037...18,530,440
Ensembl chr15:18,492,945...18,530,478
|
|
G |
Ezr |
ezrin |
multiple interactions |
ISO |
[[Vehicle Emissions results in increased abundance of Air Pollutants] which results in increased abundance of Carbon Monoxide] which results in decreased expression of EZR protein |
CTD |
PMID:37141245 |
|
NCBI chr 1:46,967,961...47,011,505
Ensembl chr 1:46,967,658...47,011,505
|
| |